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ABSTRACT
ROLE OF METALS IN HUMAN IMMUNE SYSTEM: STUDY OF METAL-DEPENDENT
STRUCTURAL CHANGES OF S100A12 PROTEIN
By
Aleksey Aleshintsev
Advisor: Dr. Rupal Gupta
S100A12 protein belongs to the S100 family of calcium-binding proteins and participates in the
innate immune system. Antimicrobial proteins from the S100 family of the proteins (S100A12, S100A8/A9,
etc.) are secreted and expressed by neutrophils during microbial infection and perform their antimicrobial
activity through metal sequestration. While most S100 proteins function intracellularly, S100A12 is highly
expressed and secreted into the extracellular space by neutrophils during infection. Sequestration of Zn2+
by S100A12 is aided by the nanomolar zinc binding affinity of the protein at neutral pH conditions, which
is further enhanced upon calcium-binding. The Zn2+ binding scaffold in S100A12 is composed of a His3Asp
motif. Upon Zn2+ binding, human S100A12 self-assembles into multimeric assemblies, the order of which
depends on the protein concentration. While apo-S100A12 retains its strong metal affinity in the pH range
of 7.0 – 10.0, its Co2+/Zn2+ affinity progressively diminishes as the pH is reduced from 7.0 to 5.3. In the
presence of calcium, the viable pH range of metal-binding increases, and S100A12 retains its strong
Co2+/Zn2+ binding up to pH 5.7 in the Ca2+ bound state. The calcium induces enhanced Co2+/Zn2+ binding
assisting efficient metal sequestration during neutrophil activation, occurring at sub-neutral pH conditions.
We have employed various biophysical and molecular biology methods and tools such as nuclear
magnetic resonance (NMR) spectroscopy, electron paramagnetic resonance (EPR), and single point
mutations to understand the structural and functional nature of binding both zinc and calcium to the
S100A12. Our data shows the different roles of the calcium-binding motifs in the function of the S100A12.
Also, we determined that the modulation of viable pH range for Co2+/Zn2+ binding by calcium is employed
by restraining pH-dependent conformational changes to the EF-hand 1 loop that contains the Co2+/Zn2+
binding Asp25. We also performed a structural characterization of the metal-dependent self-assembly of
S100A12. The structural characterization demonstrated that the cooperative binding of Zn2+ to its metalbinding motifs and Ca2+ binding to protein’s EF-hand motifs induces reversible protein self-assembly. Both

iii

magic angle spinning and solution NMR spectroscopy on apo-, Zn2+-, Ca2+-, and Zn2+, Ca2+- S100A12
demonstrated the significant chemical shift perturbations (CSPs) induced by metal binding, which indicate
conformational changes throughout the polypeptide chain. We demonstrated that observed perturbations
are not from changes in the secondary structure of S100A12, and the secondary structure of the protein
remains primarily preserved. Notably, the reported metal-induced CSPs were observed for the functionally
relevant hinge region, which participates in target recognition and chemotaxis.
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Chapter 1 - Introduction
1.1 Abstract
Calgranulin C (S100A12), a member of the large family of calcium-binding S100 proteins, participates
in the human innate immune response by performing zinc sequestration. The proteins of the S100 family
include 27 members that play important biological roles and are mainly distributed in three groups: those
that cause regulatory effects in the intracellular space, these that cause regulatory effects in the
extracellular space, and these that have both intracellular and extracellular functions. S100 proteins are
unique since vertebrates can only express them. The 21 kDa homodimeric form of S100A12 binds two Zn2+
ions at its dimeric interface and undergoes oligomerization. The oligomerization of 100A12 plays an
essential role in sending the proinflammatory signal through oligomerization-assisted interaction with
multiligand receptors such as advanced glycation end products receptor (RAGE) and toll-like receptor 4
(TLR4). S100A12 binds the calcium ions to two of its EF calcium-binding motifs per monomer. One
canonical EF1 loop at C-termini loop with 12 highly conserved amino acid residues showing high affinity for
calcium, and one non-canonical EF2 loop at N-termini with 14-amino acid consensus sequence that is
specific for each S100 protein and binds calcium with markedly lower affinity. In each EF-hand motif, the
calcium-binding loop is flanked by two helices. The calcium-binding and zinc-binding allow the protein to
regulate its structure and function along a wide range of the pH level to perform its function. Bellow, we will
briefly go over the role of the S100 proteins in the immune system.
1.2 Introduction
The integrated immune response by the human organism is divided into two levels: the innate
response and adaptive. The importance of the innate immune system for the survival of all organisms on
Earth is highlighted by the fact that it exists in all living organisms. Only vertebrae added the adaptive level
to their immune system. However, there was a general lack of interest in researching the innate immune
system.1 From the 1908 works of the Nobel Prize-winning scientist Ilya Mechnikov2 until 2000, the innate
immune response was considered “non-specific immunity,” second to the adaptive immune response. The
interest in the innate immune system started to grow in the mid-1990s when protein Toll was discovered to
be critical in defending fruit flies against fungal infections.3
Consequently, Toll-like receptors (TLRs) were found in humans, and they play an essential role in the
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innate immune response.4-5 These proteins allow for discriminating recognition of different groups of
pathogens and enable proper immune response. Also, further interest in the innate immune system was
heated with discovering the link between the pro-inflammatory response and the innate immune response
through interaction with multiligand receptors for advanced glycation end products (RAGE), the crucial
player in the pro-inflammatory pathway.6-10
The innate immune system employs antimicrobial function by recognizing the threat to the host
organism by either recognizing specific conserved patterns for the pathogens or sensing the host factors
as “dangerous” when they are in wrong locations or altered due to different types of cellular stress.11 The
recognition of any of these threats will lead to immediate and rapid response. The pathogens will be
destroyed by ingestion, apoptosis, defragmentation, and sequestering critical nutrients needed for growth
and proliferation. At the same time, the innate immune system recruits the proinflammatory response to
bring anti-pathogen action to the site of infection. This response is diverse in its actions.
During the infection, the phagocytes called neutrophils move from the bloodstream to the site of
infection by adhering to the vascular endothelium and destroying the pathogens by engulfing the pathogens,
and releasing different chemicals such as antimicrobial proteins S100 protein family. The S100 family of
EF-hand calcium-binding proteins play an essential role in a wide range of cellular functions. Antimicrobial
proteins from the calcium-binding S100 family of the proteins (S100A12, S100A8/A9, and S100A7) during
microbial infection are secreted and expressed by neutrophils and perform their antimicrobial activity
through metal sequestration.12-17 During the pathogen invasion, which causes the infection to proliferate
and survive, the invading bacteria must access essential nutrient metals to occupy the host and promote
disease.18 A process called nutritional immunity is used to stop the bacterial invasion. Nutritional immunity
refers to the limitation of nutritional metal availability by certain factors produced by the host to starve
invaders. Also, extracellular S100 proteins act as damage-associated molecular patterns and act on pattern
recognition receptors and RAGE to recruit inflammatory responses.19-21 Calgranulin C (S100A12), a
member of the large family of calcium-binding S100 proteins, participates in the human innate immune
response by performing zinc-binding mediated nutritional immunity and is the target of this investigation.
1.2.1

Importance of zinc in the organism biology

2

Figure 1.1 Examples of zinc binding motifs in proteins

Figure 1.2 Crystal structures of zinc finger metal-binding motifs. A. Close up of His2Cys2 motif in ZIF268DNA complex (PDB: 1ZAA). B. Close up of Cys6 motif in GAL4-DNA recognition complex (PDB: 1D66)
A significant number of the proteins and enzymes in the biological organisms enroll transition metal
ions and ions of group IIB metals to exercise their biological functions to support life. About half of the
proteins use metals to facilitate their functions. The metalloproteins and metalloenzymes use these metal
ions for essential cell growth, cell differentiation, and oxygen transport. Zinc is only the 27th most abundant
element in the Earth's crust. At the same time, zinc is the second most presented in the proteins (Figure
1.1) behind iron only and only metal ion represented in all six classes of the enzymes across all living
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organisms on Earth with approximately 3000 Zn2+ protein in the human proteome alone.22-24 The largest
class of zinc-binding structural complexes is the zinc finger (Figure 1.2).22 Zinc is vital for the catalytic
activity of enzymes and their structural integrities.24 One hundred years ago, the importance of zinc for
growth was first established for fungi,25 and later, it was proved essential for the growth and development
of rats.26 Also, zinc deficiency leads to significant disorders in the human organism.27 The replication and
transcription factors interacting with DNA and RNA have zinc finger motifs24; therefore, cell proliferation
depends on the presence of zinc.
The metallothioneins in hepatocytes collect available free zinc in the liver by complexing up to 20% of
the intracellular zinc, acting as a cellular zinc storage/buffering system. Zinc level in the organism depends
on bioavailability through dietary intake, influenced by different factors such as age, sex, etc.24,28,29 The
average amount of zinc in the human body is about 2-4g, but in plasma, its average concentration is only
12 - 16 µM which is why zinc is called a trace element. While the amount of zinc is minimal in plasma (0.1%
of the total amount in the human body), it is crucial for the immune system.30-32 In the serum, albumin with
low affinity binds the most considerable portion of the zinc (60%), followed by α2-macroglobulin binding
zinc with higher affinity (30%), and transferrin binds last 10% of zinc.32 The main pool of zinc is located
intracellularly. The nucleus contains 30-45% of intracellular zinc, cytoplasm, and organelles contain 50%
zinc, with the cell membrane having the rest of the zinc.30 Most of zinc inside the cell exists in the proteinbound state. The small amount of “free” zinc is coordinated by different amino acids and is available for
cellular signaling.30
The widespread use of zinc by proteins comes from its properties. Zinc has two essential properties.
First, contrary to other metals, zinc is virtually non-toxic.34 The cellular mechanisms that regulate zinc
distribution and transport in and out of the cells and tissues are efficient, so there are no recorded disorders
associated with an excess of zinc. Second, the physiochemical properties of zinc include stable association
with various macromolecules. Next, coordination flexibility allows zinc to meet the demands of the proteins
and enzymes to execute their wide range of biological functions.35-37 Zinc is favorable along with other
metals because under physiological conditions does not participate in the redox reactions.38 This feature
promotes the stability of zinc in conditions that involve continuous changes in oxidoreductive potential. Also,
zinc is amphoteric because it can exist as the hydroxo and aqua metal complex at neutral pH.38 Additionally,
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zinc has biochemical versatility due to stereochemical adaptability and different coordination spheres,
allowing zinc to have different coordination geometries.39
Although zinc is an essential element in life processes, its study was delayed compared to other vital
metabolites.23 Zinc is a poor probe to study catalytic reactions, active sites, etc., as it has no unpaired
electrons or intrinsic color, rendering EPR, UV-Vis spectroscopic studies very difficult. Fortunately, it was
determined that cobalt ions could often substitute zinc without reduction of the activity of the protein.23,40
Cobalt ion exhibits visible spectra and is used in EPR spectroscopy. Also, earlier methods were inadequate
to detect zinc until atomic absorption spectroscopy was developed.41,42
Therefore, it is logical to assume that zinc is essential for the well-being of the host organisms. Zinc
and other metals such as iron, manganese, nickel, etc., are also critically vital for the invading pathogens
to successfully infect the host. Therefore, both host organisms and invading entities developed
sophisticated means to compete for the essential resources. The system by which host organisms deny
the nutrient metabolites to the pathogens is called nutritional immunity.
1.2.2

Nutritional immunity as part of innate immunity

In most cases, pathogen invasions resulting in the infections begin at epithelial barriers where
microbes attempt to transition into the host organism. Passing the epithelial barrier represents the major
constraint and requires essential metabolites to support successful expansion.43 As such, the success of
the invasion essentially depends on the ability of the invader to acquire the essential nutrients from the host
organism because once the pathogen reaches the microenvironment of the host, it can only depend on the
host’s pool of the metabolites for the pathogen’s growth and proliferation. For this reason, pathogens were
able to develop different strategies for stealing these nutrients for their metabolic pathways.44-47 At the same
time, the host organism evolved many strategies to deny pathogens from acquiring these nutrients.12-15,18
The outcome of this competition determines the pathogen invasion's progression, success, or failure.
In the middle of the last century, studies for the first time demonstrated a relationship between
immunity and the presence of the trace mineral.48,49 These studies discovered transferrin, a protein that
could bind iron. In human plasma, and egg whites, transferrin through iron sequestration prevented
infection.48,49 The term describing the process of sequestration first iron and later rest of the essential metals
such as zinc and manganese to deny it to pathogens as “nutritional immunity” was coined in 1975 by
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Weinberg.18,50 Under nutritional immunity, essential metabolites circulating in extracellular space are denied
for uptake by pathogens through transferring free minerals after sequestration to available storage tissues
such as the liver.43 Clinical observations reported a decrease in iron and zinc levels by 50% within the hours
after infusion of humans with endotoxin lipopolysaccharide (LPS), a membrane component able to cause
adverse effects of bacterial infections.51,52
The reduction of plasma-free zinc significantly reduces its availability to pathogens. The mechanism
involved in reducing free zinc in plasma aims to the secretion of inflammatory cytokines (IL-6) that regulate
the increase of expression of zinc transporters (ZIP) such as ZIP14 and metallothioneins in hepatocytes
and therefore collect available free zinc in the liver.53 ZIPs are zinc transporters responsible for moving zinc
out of the extracellular space into the cytosol.53,54 Metallothioneins are small (6-7 kDa) cysteine-rich proteins
that bind up to seven zinc ions.55 In addition to the above two mechanisms, zinc-binding antimicrobial S100
proteins further change the extracellular level of zinc ions. For example, Keratinocytes release S100A7
protein, which, through zinc sequestration, can kill Escherichia coli.56 Calprotectin (S100A8/A9) released
by neutrophils also through zinc sequestration can inhibit the growth of Staphylococcus aureus.57
Intracellularly, macrophages reduce the phagosome zinc content and therefore deny zinc to Histoplasma
capsulatum.58 Also, oppositely, the macrophages induce a high level of zinc ions that is toxic enough to kill
Mycobacterium tuberculosis.59
As with zinc ions, the reduction of the iron ions' availability to pathogens also decreases their
survivability and increases the defense of the host organism. The ability of iron to change from ferrous
(Fe2+) and ferric (Fe3+) forms and back in reactions involving the transfer of electrons with electrophile or
nucleophile molecules makes iron important in different biological processes.60 Therefore, biological
organisms evolved a different mechanism to gain access to iron from the environment. These mechanisms
play an important role in the competition for the limited resources of iron on the interface between hostpathogen interactions against pathogen invasion.61-63 While iron acquired from the diet is enough to replace
its physiological losses, for example, bleeding, it is not enough to produce new red blood cells (RBCs)
biosynthesis.64-66 The mechanism to gain the iron for the heme biosynthesis associated with the production
of new RBCs was developed by recycling iron in RBCs' hemoglobin.66-68 To recycle heme iron,
erythrophagocytic macrophages digest damaged RBCs and direct the iron ions to bone marrow for the
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subsequent renewal of RBCs.67
The host organism developed a number of mechanisms, both intra- and extracellularly, to reduce free
iron ions to deny pathogens iron. In the host, pathogens express siderophores, which are high-affinity ironbinding molecules.69 The host organism utilizes hypoferremia to reduce iron concentration in plasma to
prevent pathogens from acquiring iron.70,71 Hypoferremia is achieved through the secretion of hepcidin, a
small 25 residue peptide.72 Hepcidin inhibits cellular iron content by binding and degradation of iron
transporting membrane protein ferroportin.72 Studies have shown that restricted expression of hepcidin
leads to susceptibility to infections by different bacteria, such as Klebsiella pneumoniae.73 Another way host
organisms restrain microbes from gaining iron is through recruiting glycoprotein lactoferrin. Lactoferrin is a
member of the iron-binding transferrin family of proteins and is involved in the antimicrobial actions of breast
milk.74 Secreted by macrophages cells, this glycoprotein restricts the development of different pathogens
by binding ferric iron with very high affinity (10-20 M).74-76 The host organisms use three strategies to restrict
iron uptake by intracellular pathogens: decrease extracellular Fe2+ uptake, increase the release of Fe2+ into
extracellular space, and increase expression of ferritin to promote storage of Fe3+.71 Also, host organisms
utilize another way to restrict pathogen access to iron, especially from stripping hemoglobin of its heme iron
ions. Hemoglobin contains an almost unlimited source of iron and bacteria evolved different strategies to
draw iron from this source.62 The cytokines produced in response to infection lead to the expression of the
acute-phase heme scavenger hemopexin (HPX), which acts as a part of nutritional immunity by limiting the
effects of the hemoglobin damage by pathogens, therefore restricting pathogens hemoglobin bound heme
iron.77-79
Therefore, as mentioned above, the host organism utilizes different strategies to limit the essential
metals for access by the pathogens. Nutritional immunity is both the first line of defense and indiscriminate,
leading to adverse effects in the unaffected cells.
1.2.3

The innate immune system

Nutritional immunity is part of the larger innate immune response. Innate immunity is the first line of
defense responding to the microbial invasion followed by the adaptive immune system and appears in all
vertebrae organisms. This response is non-specific and rapid and often enough to stop the spread of the
infection. The innate immunity includes the following cellular components: monocytes/macrophages,
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granulocytes, mast cells, dendritic cells, and natural killer (NK).30 While nutritional immunity is a part of the
innate system, the latter is characterized by inflammation.30 The inflammation response of innate immunity
and nutritional immunity response are intertwined. Later, we can see that the proteins released to answer
the pathogen invasion participate in these immune responses.

Figure 1.3. TLR4 and RAGE signaling pathway. Pro-inflammatory signaling pathways in RAGE and TLRdependent manner upon activation by different ligands, including members of S100 calcium-binding protein
family. The involvement of the Myddosome complex in both cascades suggests possible cross-talk.80
Activation of the innate immune cells starts through recognition by cell receptors specific pathogen-
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associated molecular patterns or PAMs.81 Different groups of pathogens have different PAMs, which are
specific conserved molecular structures. These receptors are called pattern recognition receptors which
include, for example, the receptor for advanced glycation end products (RAGE) and Toll-like receptors
(TLRs).82,83 There are at least ten different TLRs in human organisms alone so that immune system cells
can recognize and differentiate various pathogens. For example, TLR4 detects lipopolysaccharides (LPS)
of gram-negative bacteria, and RAGE detects bacterial endotoxin.83-85 Once respective PPRs recognize
PAMs, it produces a signaling cascade which leads to various antimicrobial events. The innate immune
system's cytokine and chemokine secretion event establish communication to the following adaptive
immune system response.86
In the case of the TLR4 initiated signal pathway, after binding of LPS to TLR4, its intracellular domain
undergoes conformational changes leading to the formation of the myddosome complex (Figure 1.3).87 In
the sequence of the events, this complex formation recruits six myeloid differentiation primary response
gene (MyD) 88 adapter (MyD88) molecules, then four interleukin-1 receptor-associated kinase 4 (IRAK4)
molecules, and finally last four IRAK1/2 molecules to complete the formation of the Myddosome complex.
The formation of the Myddosome complex leads to activation of IRAK through its phosphorylation and
further recruitment and activation of tumor necrosis factor receptor-associated factor 6 (TRAF6). Activated
TRAF6 than downstream activates transforming growth factor [TGF]-β activated kinase 1 (TAK1). TAK1
then activates the nuclear factor kappa B (NF-κB) pathway, mitogen-activated protein kinase (MAPK)
enzymes, and interferon regulatory factor 5 (IRF5). MAPK activates cAMP response element-binding
protein (CREB) and activator protein 1 (AP-1) transcription factors. This transcription factor activation
primarily results in the production of pro-inflammatory cytokines and chemokines. Reports suggest that zinc
ions also regulate this TLR-dependent signaling pathway by influencing its signaling molecules.89
1.2.4 Role of S100 proteins in the innate immune response
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As mentioned above, certain members of the S100 calcium-binding family of proteins participate in the
innate immune response. S100 proteins were isolated for the first time almost fifty years ago in 1965.89
Human S100 proteins are generally small (about 21 kDa per dimer) twenty-one proteins.90 Among many
calcium-binding proteins, S100 proteins are different by their unique structures, specifically their dimeric
structures. Also, S100 proteins have unique functions both intracellularly and extracellularly.90-94 Most of
the proteins involved in the calcium-binding and transduction of the calcium signaling have a helix-loophelix or “EF-hand” Ca2+-binding motif (Figure 1.4). In S100 proteins, there are two EF-hands: S100specific,” non-canonical” N-terminal EF-hand, and second, “canonical” C-terminal EF-hand. The “canonical”
EF-hand forms a pentadentate coordination sphere around calcium ion, while binding a calcium ion by a
“non-canonical” EF-hand affords a lower coordination number.95 Together, these EF-hands form a fourhelix structure observable in all EF-hand proteins. S100 differs from other proteins because their dimeric
form is their basic structural unit.92 Except for S100G, which is C-terminally truncated, all S100 proteins
form mostly homodimers or heterodimers.96 Some S100 proteins can have two forms of dimerization, as in
S100B, which forms a homodimer, and a heterodimer as S100B/A1 complex.97 S100B also forms
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heterodimeric assembly in complex with S100A6.98 Also, S100A1/A4 and S100A8/A9 complexes are
heterodimeric.99 On the other hand, S100A12 forms a homodimer and does not form heterodimers with
S100A8, or S100A9.100 S100 proteins are also known to form the higher-order oligomeric assemblies.92
S100 family in humans contains 27 members exercising various biological functions. They participate
in inflammation,10,101-102 innate immune response,12,94,103 cell proliferation104-106 and are used as clinical
markers for different diseases associated with inflammation and cancers and targeted by drug
administration107-111. Several S100 proteins had been shown to participate in the innate immune response
by acting as part of nutritional immunity and through activation of inflammation pathways.94 Of the 27
members of S100 proteins, only S100A7 (psoriasis), S100A8/S100A9 (calprotectin; calgranulin A and B;
MRP-8 and 9), and S100A12 (calgranulin C) have antimicrobial and inflammatory functions. These proteins
acting as a damage-associated molecular pattern will initiate a pro-inflammatory response by binding with
pattern recognition receptors like RAGE.10,20 Also, their antimicrobial function comes from their participation
in nutritional immunity through nutrient metal limitation .12-15 S100 proteins, contrary to other calcium-binding
proteins, have two metal-binding motifs at their dimer interface. For example, in calprotectin, one metalbinding site coordinates zinc ions with high nanomolar affinity and magnesium ions with micromolar affinity.
At the same time, the second metal-binding site coordinates only zinc ions with high nanomolar affinity.12,112114

The crystallographic studies had shown that in S100A8/A9, zinc-binding involves four histidine residues.
On the other hand, the manganese ion binding site involves six histidine residues in S100A8 and

S100A9, with four of these residues involved in zinc binding (Figure 1.4).12,113,114 S100A12 and S100A7
form homodimers capable of binding two zinc ions per dimer across the dimer interface using three
histidines and one aspartic acid residue (Figure 1.4).115-118 Studies have shown that binding of Ca2+
increases binding affinity for the Zn2+ and vice versa.117 Additionally, Zn2+ binding to S100A12 promotes
protein oligomerization.117 We report evidence of Ca2+ binding to form structural rearrangement without
actual oligomerization, as was reported before.119
S100A7, S100A8/S100A9, and S100A12, similar to LPS mentioned above, induce an inflammatory
response and participate in the innate immune response beyond the nutritional immunity. They act as
ligands for both innate immune receptors: TLRs and RAGE. Above, we considered the TLR4 signaling
pathway, and now we will introduce how S100 proteins propagate the RAGE signaling pathway. RAGE as
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pattern recognition receptors is also expressed on the cells of the adaptive immune system (T-cells and Bcells).120,121 Therefore, playing an essential role in a human immune response. It is a member of the
immune-globulin family of proteins. It consists of the ligand-binding extracellular domain, transmembrane
helix domain, and short but essential for downstream signaling unstructured C-terminal cytoplasmic domain
(Figure 1.5).122-124 The ligand-binding domain contains three immunoglobulin-like domains: two C-type and
single V-type domains.125

Figure 1.5. Representations of soluble sRAGE domains and RAGE structure. The extracellular sRAGE is
based on the V and C1 domains (PDB: 3CJJ) and the C2 domain (PDB: 2ENS).
As a multiligand receptor, RAGE can bind different molecules with different properties. The AGE ligand
for RAGE was discovered first. AGE accumulates during diseases and with aging. Other discovered ligands
are S100 proteins which act as a damage-associated molecular pattern (DAMPs). DAMPs are originated
from the damaged tissues or cells actively secreting them during innate immune system response. The hint
that RAGE participates in the innate immune system also came from the discovery that it can recognize
LPSs of bacteria.126
The signaling pathway through the RAGE receptors shows some similarities with the TLR-dependent
pathway (Figure 1.3). The C-terminal tail of RAGE undergoes phosphorylation by PKCζ at serine 391 when
RAGE accepts different ligands such as S100 proteins or AGE (advanced glycation end-products).127 This
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recruits the TIRAP (TIR domain-containing adaptor protein) to RAGE, allowing to bridge the receptor with
downstream MyD88 activating signal cascade through complex formation with IRAK proteins and activating
transcription factor NF-κB.127 NF-κB enhances the secretion of proinflammatory chemokines with cytokines,
which also promotes activation in RAGE itself. Therefore, we can see that RAGE activation creates a
positive feedback loop in its signaling pathway, leading to a continuous increase of the inflammatory
response.132,133 RAGE activation induces synthesis of NF- kB p65 messenger RNA increasing NF-κB and
overcoming endogenous negative-feedback mechanisms.128 Continues unchecked inflammatory response
can lead to sustained inflammations as observed in various diseases such as arteriosclerosis,128,129
rheumatoid arthritis,132 neuroinflammation,133 and inflammatory kidney disorders134. The RAGE-dependent
signaling cascade suggests a possible connection with the TLR signaling pathway as they both recruits the
same MyD88 complex.
Therefore, S100 proteins, specifically S100A7, S100A8/S100A9, and S100A12, participate in all
aspects of the innate immune system: from the nutritional immunity by metal sequestration to promoting
inflammatory response by interaction with TLR and RAGE receptors. We will briefly consider the roles of
S100A7 and S100A8/A9 complexes in the innate immune system and inflammatory diseases. At the same
time, the S100A12 functions (Figure 1.6) and structures will be described extensively in the following
chapters.

Figure 1.6. Scheme of S100A12 biological functions
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1.2.4.1 S100A7 (psoriasin)
Human S100A7 is a small protein forming a 22 kDa homodimer (Figure 1.7 A) and, in contrast to
S100A12, does not go through oligomerization.116 Like all S100 proteins, S100A7 has calcium-binding
properties. This protein also participates in host-defense response through Zn2+ chelation when expressed
by epithelial cells.135,136 Each dimer’s monomer contains 101 residues and has two calcium-binding EFhand motifs (Figure 1.7 A). Contrary to other important S100 proteins of the innate immune system
(S100A8/A9 and S100A12), its EF-hand at the N-terminal is shorter by three residues and has Ser30
instead of Glu/Asp residue of other S100 proteins to coordinate calcium ion.116,137 S100A12 has two zinc
ion binding His3Asp motifs at the dimer interface (His18, Asp25, His87, and His91) (Figure 1.7 B). Studies
have also shown that calcium binding to S100A7 does not produce specific effects as in S100A12 and
S100A8/A9, such as improving antibacterial functions, modulation of zinc-binding, and quaternary
structure.138

Figure 1.7. Crystal structures of human S100A7. (A) The Ca2+- and Zn2+ bound S100A7 homodimer
structure (PDB entry 3PSR).120 (B) The close-up of the His3Asp motif.
S100A7 contributes to the innate immune system, cell differentiation, and tumorigenesis.116,139,140
Studies have shown that S100A7 has antimicrobial activity preventing skin and tongue infection by
Escherichia coli.56,141 Later, it was reported that S100A7 also has an antifungal function, fighting filamentous
fungi.142 Both reports revealed that Zn2+-binding plays a role in the S100A7 host defense function,
contributing to nutritional immunity.56,142 Also, an elevated level of S100A7 was reported in humans having
inflammatory skin diseases.56 S100A7 was reported to promote tumorigenesis in breast cancer through
activation of the Akt signaling pathway leading to activation of transcription factor NF-κB, which leads to
increased expression of inflammatory inducing cytokines.108.143
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1.2.4.2 S100A8/A9 (Calprotectin)
Calprotectin (CP) is another protein of the S100 family of proteins participating in the host-defense
mechanism. CP participate in nutritional immunity when released by neutrophils. Once CP is released at
the infection site, they limit the availability of essential metals in the extracellular space through metal
sequestration. CP is sequestering two metal ions: zinc and manganese.18,57,63,144 CP is different from
S100A12 as it forms heterodimers and tetramers with two different proteins: S100A8 (10.8 kDa) and
S100A9 (13.2 kDa) (Figure 1.8 A).92,145-148
As with other S100 proteins, each of the Calprotectin subunits binds calcium ions to their two EF-hand
motifs. Reports show that CP forms heterotetramer upon Ca2+ binding.145-148 Crystal structure analysis
reveals two metal-binding sites at the dimer interface (Figure 1.8 B and C).112 Both S100A8 and S100A9
add two residues to the metal-binding motif. The first metal-binding motive at the N terminal is similar to the
S100A12 and S100A7 zinc-binding motif consisting of three histidines and one aspartic acid. The second
metal-binding motif at the C terminal has four histidines. The His27 of S100A8 is responsible for the
appearance of the His4 motif (Figure 1.8 C) with several Asp/Glu residues of S100A9 in its vicinity. Such a
His4 metal-binding motif is rare in S100 proteins, and along with the His3Asp motif, CP demonstrates
complex coordination chemistry involving different metal ions.113 Both His3Asp and His4 metal-binding sites
demonstrated calcium-dependent zinc-binding.113 The addition of calcium to CP induces binding affinity for
zinc to change from nano- to pico-molar range.113 Also, CP is unique among metal-chelating proteins
participating in the host-defense response as it is the only protein that binds manganese ions.149 In a highaffinity C-terminal site, Mn2+ is coordinated by six ligands, four of which come from the histidines of His4
motif and two others histidine His103 and His105 from C-terminal tail S100A9 forming together His6
manganese binding motif (Figure 1.8 C).150 Recent studies demonstrated that in addition to Zn2+ and Mn2+,
CP could sequester other divalent first-row transition metals such as Fe2+, Ni2+, and Cu2+.151-153
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Figure 1.8. Crystal structures of human S100A8/A9 complex. (A) Structure of Ca2+ bound S100A8/A9
complex (PDB entry 1XK4), with His20 and Asp30 belonging to S100A9 and His87 and His83 belonging to
S100A8 subunit. (B) Close-up shows the His3Asp motif of site 1. (C) Close-up shows the His6 motif with
bound Mn2+ (PDB entry 4XJK). Four histidines (His91, His95, His103, and His105) belong to S100A9, and
two histidines (His17 and His27) belong to the S100A8 subunit. Zn2+ is bound to four histidines (His17,
His27, His91, and His95), forming a zinc-binding His4 motif.
CP represents the largest population of cytoplasmic protein in neutrophils. Around 40% of all proteins
inside neutrophils are CPs.154 During the onset of the infection, white blood cells travel to the site of infection
and express CP, releasing them with other antimicrobial proteins such as lysosomes into the extracellular
space.63,155 It was demonstrated that bacteria require two classes of Mn2+ importers for their growth: Nramptype transporters (MntH) and ATP-binding cassette (MntABC) importers.156 These importers shuttle Mn2+
into the cytoplasm. Studies have shown that CP inhibits the growth of the Staphylococcus Aureus, where
CP competes with Mn2+ importers for the Mn2+.15 CP also shows antibacterial activity against Gram-positive
and -negative bacteria such as Borrelia burgdorferi, Listeria monocytogenes, Staphylococcus Typhimurium,
Klebsiella spp., and P. gingivalis implicated in the human pathologies.17,157-159 Additional studies
demonstrated that CP exhibit the zinc-reversible antifungal function.144,160,161 CP contributes to

16

cardiovascular disease, cancer, inflammation, and autoimmune diseases.162-169
The activation of the proinflammatory signaling cascades in TLR and RAGE-dependent manner is
more complex than in S100A7 or S100A12. For example, in murine bone marrow cells, S100A8 interaction
with TLR4 receptor induces expression of proinflammatory cytokines such as tumor necrosis factor (TNFα) and lymphocyte activating factor (IL-1β) through MyD88-dependent pathway. In contrast, the S100A9 or
S100A8/A9 complex does not induce TNF-α.19,164 S100A8/A9 also mediates RAGE-dependent
cardiomyocyte dysfunction and rheumatoid arthritis through increased proinflammatory cytokine expression
following activation of p38 MAPK and NF-κB.170,171
1.3 Conclusion
We have surveyed the importance of metals in the biological functions of living organisms and
demonstrated that the success of the microbial invasion or success of the host defense mechanisms
essentially depends on the ability of one side to acquire adequate essential nutrients, successfully denying
the other side these nutrients. Pathogens evolved to obtain essential nutrients from the host organisms
while they evolved to sequester essential nutrients via nutritional immunity. Our brief review showed that
few S100 calcium-binding proteins play an essential role in nutritional immunity and promote inflammatory
responses.
1.4 Project goal
The long-term goal of this research is to perform structural and electronic characterization of metalbinding properties of S100A12 and characterization of the structural changes of S100A12 in response to
metal binding. The critical steps to achieve this goal are covered in chapters 2 to 5 by addressing specific
aims. First, investigate the electronic properties of the S100A12 bound metal ions and their coordination
environment using NMR spectroscopy. Second, determine structural changes at the zinc and calciumbinding sites of S100A12 and their roles in the induction of oligomerization at biological functions of the
protein with the help of the NMR and other biochemical methods.
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Chapter 2 - Ca2+ and Zn2+ binding to S100A12 cooperate to induce the structural changes
and modulate reversible self-assembly of S100A12
The contents of this chapter were published as:
Wang, Qian, Aleksey Aleshintsev, David Bolton, Jianqin Zhuang, Michael Brenowitz, and Rupal
Gupta. "Ca (II) and Zn (II) cooperate to modulate the structure and self-assembly of S100A12."
Biochemistry 58, no. 17 (2019): 2269-2281.
2.1 Abstract

S100A12 (Calgranulin C) is a member of the large Ca2+ binding S100 family of proteins that plays an
essential function in the human innate immune system. In response to the pathogen invasion, the
neutrophils overexpress and release S100A12 proteins into extracellular space, where S100A12
sequesters the nutrient zinc ions to help destroy the pathogen. We show that the binding of Ca2+ to
S100A12’s two EF-hand motifs and Zn2+ to its dimeric interface cooperate to modulate reversible selfassembly of the protein. Magic angle spinning (MAS) and solution nuclear magnetic resonance
spectroscopy experiments on apo-, Ca2+-, Zn2+-, and Ca2+, Zn2+-S100A12 revealed significant chemical
shift perturbations upon metal binding representing conformational changes through the protein polypeptide
chain. At the same time, these chemical shift perturbations are not from changes in the secondary structure
of the S100A12 protein, which remains predominantly preserved. While Ca2+ binding to S100A12
dominates the protein's overall structural change, adding Zn2+ to calcium bound S100A12 exerts additional
conformational changes to Helix II (residues 2-21) and the hinge domain (residues 38–53). The hinge region
of S100A12 plays an important role in protein function, providing molecular interactions that promote acute
inflammatory responses, generate edema, and chemotaxis for human monocyte. In Ca2+-S100A12, the
proinflammatory function structurally originates through helix II and the hinge domain, which bind to the Ctype immunoglobulin domain of the receptor for advanced glycation products (RAGE). Here, we discuss
how interactions of S100A12 with such target proteins as RAGE or Toll-like receptors can be affected by
these small additional conformational changes in the helix II and hinge domain induced by Zn2+ binding.
2.2 Introduction

The human innate immune system combats the pathogen invasion through its antimicrobial activity,
inhibiting pathogen growth and proliferation by sequestering critical nutrients such as metal ions. Before
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the onset of proinflammatory response, the “natural immunity” system is considered the first level of
protection against pathogen invasion.18,63 The nutrient metal ions such as Fe2+, Mn2+, Zn2+, and Ni2+ play a
critical role in the cellular mechanisms of the host cells and invading microbes. By limiting these nutrient
metal ions, the immune cells prevent the pathogen from accessing these critically important nutrients.
Logically, this type of limitation of metal ions from the host defense system leads to a “fight over metals” at
the host-pathogen interface.18,50 Several members of the large calcium-binding S100 family of proteins
participate in this limitation of the nutrient metals during infection following overexpression and secretion by
neutrophils into extracellular space.18,94 Members of S100 family, S100A8 and S100A9 bind several metal
ions Mn2+, Ni2+, Fe2+, and Zn2+ ,57,113,114,149,151 while S100A12 and S100A7 sequester Zn2+.18,56,94,172,173 S100
proteins are small Ca2+ binding polypeptides that play important roles in many biologically important
functions such as cell proliferation, cell differentiation, signal transduction, cell cycle regulation,
transcription, and more.90,91
S100A12 (also often reported as Calgranulin C) is responsible for many antimicrobial functions
mediated through Zn2+ binding.18,94 In vitro, the antimicrobial activity of S100A12 had been reported against
Brugia malayi, human gastrointestinal pathogen Listeria monocytogenes, and several pathogenic fungi,
where it inhibited pathogen growth by sequestering Zn2+ from standard microbial growth media.173,174 Also,
the elevated levels of S100A12 in the clinical setting had been reported in gastric biopsies of these patients
who had Helicobacter pylori disease.175 Naturally, such findings led to the apparent conclusion that
sequestration of Zn2+ exerted by S100A12 is responsible for the protein’s antimicrobial properties. Once
neutrophils are recruited to the place of the pathogen invasion, they release S100A12, which in turn not
only responds with limitation of Zn2+ to the pathogen but also initiates pro-inflammatory signaling cascade
through the interaction with several proteins capable of recognizing molecules frequently found in
pathogens (also known as pattern recognition receptors (PPR) such for example Toll-like receptor 4 (TLR4)
and the receptor for advanced glycation end products (RAGE).18,9,10,20,176 Clinically, the patients suffering
from metabolic, neoplastic, and neurodegenerative disorders had been reported to have increased serum
levels of S100A12.177 Farther, it has been suggested to use S100A12 levels as a marker for disease and
infection.178-180 It is evident from these discoveries that in the innate immune system, S100A12 plays a
critical

role

by

mediating

both

proinflammatory
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and

antimicrobial

activities.

Figure 2.1. Amino acid sequence and structure of Zn2+-bound S100A12. (a) Crystal structure of Zn2+S100A12 (PDB entry 2WCB). (b) Close-up showing the zinc-binding motif with residues H15 and D25
(orange) from one monomer and H85 and H89 (blue) from the second monomer. (c) Polypeptide sequence
and secondary structure of the apoprotein based on the crystal structure (PDB entry 2WCF). Gray and
purple spheres denote zinc and sodium ions, respectively.
The primary sequence of S100A12 consists of 92-amino acid residues. Structurally, S100A12 being
a member of the calcium-binding family of proteins, has two Ca2+ binding motifs [G9–T37 and I54–A85]
with important Ca2+ binding EF-hand loops [G22–G31 and Q63–F70] (Figure 2.1) and four α-helices
(helices I–IV).122,123,181 Two Ca2+ binding motifs are connected by a “hinge” motif spanning from helixes II
to III (K38–V53). The hinge region/motif plays a critical role in members of the S100 family as it is
responsible for their wide functional diversity despite a high degree of sequence similarity. This hinge
domain, in human S100A12, is responsible for generating in vivo proinflammatory responses and
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edema and in vitro starting chemotactic activity for human monocytes.182 The structural studies of apoS100S12 determined it to be homodimeric, and this dimer is excessively stabilized by interactions between
hydrophobic residues in helix IV and helix I.117 The interface of the S100A12 dimer creates a motif to bind
Zn2+ and Cu2+, while for the latter one, we still need to establish its biological role.117,183 The four residues,
H85 and H89 from one subunit monomer and H15 and D25 from the second subunit monomer (Figure 2.1)
on the interface of the dimer in S100A12 compose metal-binding motif His3Asp. This results in binding two
metal ions per dimer.
Many S100 proteins show self-assembly behavior. For example, Calprotectin forms tetramers.112
As in Calprotectin, metal-binding initiates the self-assembly of S100A12. The crystallography studies show
the formation of S100A12 hexamers in the presence of excess calcium.181 In the presence of Zn2+,
investigations show crystalized tetramers.184 This self-assembly of S100 proteins has been established to
be functionally relevant.185,186 The blood serum and human tissue samples show the higher-order S100A12
assemblies.187,188 Additionally, S100A12 in its hexametric form had been reported to interact with RAGE
and Toll-like receptor 4 (TLR-4).176,189,190 This suggests that S100A12 must assume the oligomeric
conformation to bind with membrane receptors to initiate cellular signaling and inflammation. Therefore, we
need to conduct structural studies to understand how this oligomerization is responsible for the S100A12
biological role.
Previous nuclear magnetic resonance (NMR)191 and X-ray crystallography studies provided insights
into the structure of apo and Ca2+-, Ca2+-, and Cu2+, Zn2+-bound forms of S100A12,117,119,183 but before our
investigation, no structure of S100A12 simultaneously bound to Zn2+ and Ca2+ existed. The current
consensus is that the architecture of S100A12 is entirely dominated by Ca2+ binding, and binding of Zn2+ ion
to Ca2+-S100A12 form of protein induces only minor changes into the structure. Therefore, the lack of the
S100A12 in the form of the dual divalent cation-bound structure presents an important lack of knowledge
about the protein as Ca2+ concentration in serum is high, and zinc sequestration-mediated antimicrobial
activity by S100A12 must involve the calcium-bound protein. It was reported that such cooperativity in
binding both metal ions is necessary for S100A12 to propagate TLR-4 signaling.176 The insights mentioned
above contribute to the conduction of studies of previously unexplored structural characterizations of cationmediated activation of S100A12, which plays an important role in the immune response.
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We designed our structural and assembly studies of S100A12 to separate the effects of unique
Ca2+ or Zn2+ binding to protein at the physiologically relevant condition and simultaneous binding of these
metal ions at the same conditions. Although Zn2+ induces larger S100A12 self-assembly than Ca2+, we
observed both metal ions' synergies to promote higher-order assembly. Both solid-state magic angle
spinning (MAS) and solution-state NMR studies of and Zn2+, Ca2+- and separately Zn2+- bound oligomeric
S100A12 show the binding of Zn2+ modulates significant conformational changes to Ca2+-S100A12. These
conformational changes contrast with previously known studies showing that Ca2+ binding introduces
significant structural perturbations into the apo-S100A12 with expected domination of calcium-binding in
simultaneously bound Zn2+, Ca2+-bound oligomeric S100A12. Reported structural rearrangements may
induce self-assembly of energetically favorable multimeric assemblies of S100A12 and interact with target
membrane receptors. Based on investigated reversible self-assembly of S100A12 after adding Zn2+ and/or
Ca2+ and structural perturbations induced by zinc-binding, we propose a model of S100A12 antimicrobial
function in the extracellular space. We hypothesize that the overexpression and secretion of S100A12 by
neutrophils at the site of infection and following binding of Ca2+ and Zn2+ leads to protein self-assembly. The
structural perturbations reported here in S100A12 induced upon binding Ca2+ and Zn2+ are hypothesized to
modulate specific disease activities and pro-inflammatory cellular signaling. Our model suggests that these
cellular signaling pathways in healthy cells are not initiated since normal S100A12 expression is expected
and protein is predominantly present in dimeric form.
2.3 Materials and methods
2.3.1 Cloning, expression, and purification

The human S100A12 (UniProt entry P80511) cDNA was synthesized and subcloned into the pET41a(+) vector by GenScript. The cloned plasmid was then transformed into competent BL21(DE3)
Escherichia coli cells, plated on Luria broth (LB) with kanamycin, and left overnight at 37 °C. A single fresh
colony from the plate was inoculated into starter LB media with kanamycin (50 mg/L) and let to grow
overnight at 37 °C. The grown cells then were resuspended in 1L M9 minimal media containing [U-15N
NH4Cl and/or [U-13C]-D-glucose or 1L LB to produce uniformly

15

N,

13

C-labeled or unlabeled protein,

respectively. The cells were allowed to grow at 37 °C until the OD600 ranged from 0.6 – 0.8. Upon induction
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of expression by 1.0 mM isopropyl β-D-1-thiogalactopyranoside (IPTG), cells in LB were grown for 4 hours
at 37 °C, and cells in M9 media were grown at 18 °C for 20 h. Cells were harvested by centrifugation at
4000 rpm for 20 min. The cell pellets were then resuspended in no salt lysis buffer containing 50 mM TrisHCl (pH 7.4). We started protein purification with sonication of resuspended cells. The cells were sonicated
on ice to prevent heat denaturation at 45% power with microtip for 20 min of total processing time with 4
sec on and 1 sec off. The produced lysate was centrifuged at 15000 rpm and 4.0 °C for 40 min. To collect
the supernatant, no-salt buffer (50 mm Tris-HCl, pH 7.4) was added at a 3:1 ratio to reduce salt
concentration. The supernatant was then injected onto a diethylaminoethanol (DEAE) anion exchange
column pre-equilibrated with loading buffer (50 mM Tris-HCl, pH 7.4). SDS-Page was used to determine
fractions containing S100A12 and their purity. Fractions with S100A12 were pulled, and 10.0 mM
ethylenediaminetetraacetic acid (EDTA) was added to remove contaminate divalent metal ions, followed
by dialysis to remove excess EDTA. To further purify S100A12, a size exclusion chromatography (SEC)
(GE Healthcare Life Science, HiLoad 16/600 Superdex 75 prep grade) was used. The SEC column was
equilibrated with10 mM HEPES (pH 7.0) and a 150 mM NaCl running buffer. SEC was conducted two times
to make sure removal of any trace amount of EDTA left after dialysis. SDS-Page was used to determine
fractions containing S100A12 and their purity after SEC. The fractions containing pure S100A12 were
combined and concentrated by microconcentration using Centricon with membrane cutoff at 10.0 kDa. To
verify the formation of the apoprotein, we performed cobalt titration of purified S100A12, observing
absorption at 556 nm. Apo S100A12 should be saturated with one equivalent of cobalt (addition of more
cobalt will not increase absorption at 556 nm), indicating that no other metals are bound to the metal-binding
site and no EDTA competing for cobalt ions.
2.3.2 NMR sample preparation

To prepare zinc bound S100A12 NMR samples, two equivalents of Zn2+ were added to 100 μM
protein followed by the concentration of this solution to the desired protein concentration. For the NMR
samples containing calcium ions, twenty equivalents of Ca2+ were added to Zn2+-S100A12 or apoS100A12 samples. The samples for solution NMR measurements were prepared by combining 1.0 mM
S100A12 in 20 mM HEPES, 150 mM NaCl buffer (pH 7.5) with 5% D2O and 200 μM 4,4-dimethyl-4-
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silapentane-1-sulfonic acid (DSS). MAS NMR samples were prepared similar to a protocol previously
reported by gradual addition of a 30% (w/v) PEG-3350 aqueous solution to 2 mM protein samples in 20
mM HEPES with 150 mM NaCl buffer (pH 7.5).192
2.3.3 Size exclusion chromatography

Concentrated stock apo-S100A12 was diluted to 10, 50, and 100 µM, respectively. Protein
concentration was determined spectroscopically by monitoring the 280 nm band (ε = 2980 M-1 cm-1) with
the proper amount of Zn2+ and/or Ca2+ ions added to each sample. The holo-S100A12 protein samples
were loaded into HiLoad 16/600 Superdex 75 prep grade gel-filtration (GF) column (GE Healthcare Life
Science) connected to an ÄKTA FPLC (Amersham Pharmacia Biotech) instrument. The GF column was
equilibrated with a buffer containing the same concentration of metals as the sample. Flow rate for all
Size exclusion chromatography (SEC) experiments was kept at 1.0 mL/min. The calibration curve was
obtained (Figure 2.2).

Figure 2.2. SEC calibration curve of the Superdex75 16/600 column.
2.3.4 NMR Spectroscopy.

We performed 1H−15N HSQC193 and three-dimensional (3D) NOESY-HSQC194,195, 1H−15N−13C
CBCACONH196, and 1H−15N TOCSY-HSQC197 solution NMR experiments at 14.1 T (600 MHz) on a
Varian NMR spectrometer outfitted with an HCN cryoprobe. The Larmor frequencies were 599.93,
150.87, and 60.79 MHz for 1H, 13C, and 15N, respectively. 25 °C was maintained for all samples through
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the NMR experiments. Also, A 3D 1H−15N−13C HNCACB198 experiment was performed at the City
University of New York’s Advanced Science Research Center (ACRC) at 16.4 T (700 MHz) on a
standard bore Bruker Avance III HD spectrometer equipped with a 5 mm quadruple resonance inverse
QCI-F cryoprobe. The solution NMR measurements of Ca2+-S100A12 were conducted following the
previously reported conditions in literature at 14.1 T.191

13

C−13C dipolar assisted rotational resonance

(DARR)207 MAS NMR experiments were conducted at 14.1 T on a Varian NMR spectrometer using a
1.6 mm probe. MAS frequency of 12 kHz was sustained for the spectra acquisition with the temperature
at 4.0 ± 0.1 °C. For 1H and

13

C, the typical pulse lengths were 2.4 μs and 2.2 μs, respectively. The

1

H−13C cross-polarization (CP) contact time was 1.5 ms and conducted at a linear amplitude ramp

(80−100%). The DARR mixing time was 15 ms. A two-pulse phase modulation (TPPM)200 decoupling
was applied during data acquisition. 3D NCOCX and NCACX spectra were acquired at 17.6 T (750 MHz)
and 21.15 (900 MHz), respectively, on a Bruker Avance II spectrometer outfitted with a 3.2 mm HCN
EFree probe at the New York Structural Biology Center (NYSBC). MAS frequency of 14 kHz was used
for the spectra acquisition during all 3D experiments. 3D MAS NMR experiments utilized SPECIFICCP201 heteronuclear magnetization transfer from 15N to 13Cα/13CO using a 4 ms tangent amplitude ramp
on the 15N channel, followed by the DARR mixing sequence. The 1H−15N cross-polarization (CP) contact
time was 1.5 ms with 2.0 s recycle delay for all experiments.

2.3.5 NMR Data Processing

The acquired NMR spectra were first processed with NMRpipe202 and then analyzed with Sparky
software203. For the data processing, we used forward linear (LP) prediction to double the number of original
data points followed by zero fillings (ZF) to twice the total number of points used for all experiments. For
the solution NMR spectra, the water suppression function (POLY) with 30°- and 60°-shifted sine bell
apodization (SP) were used for both dimensions. For solid-state NMR spectra, 30°-, 45°-, 60°-, or 90°shifted sine bell apodization was used followed by a Lorentzian-to-Gaussian transformation in all
dimensions.
2.3.6 Secondary Structure Propensity (SSP) Calculations
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The secondary structure propensity (SSP) of S100A12 was determined by a method described
earlier204 with the help of SSP software (provided by the authors) by providing 13Cβ and 13Cα chemical
shifts as input. The combination of chemical shifts allows the software to calculate a single score for each
residue in the data. This score represents the expected theoretical fraction of α or β secondary structure
propensities. How close the SSP value to 1.0, -1.0, or 0 will predict α-, β-, or random-coil structures,
respectively. For example, if we have an SSP score equal to -1, it represents a fully formed β structure, and
if the SSP score is equal to 1, it indicates the presence of a fully formed α structure.
2.3.7 Chemical shift perturbation analysis

To calculate chemical shift perturbations (CSP) for backbone amides between initial and final states
1, 2 were the following equation was used205.
(1)

𝐶𝐶𝐶𝐶𝐶𝐶 = �[(𝛿𝛿𝐻𝐻2 − 𝛿𝛿𝐻𝐻1 )2 + 𝛼𝛼 ∗ (𝛿𝛿𝑁𝑁2 − 𝛿𝛿𝑁𝑁1 )2 ]

Where δH1,2 and δN1,2 are the 1H and 15N chemical shifts for states 1 and 2, respectively, with α = 0.2.
2.4 Results
2.4.1 Dependence of the Self-assembly of S100A12 on Metal Ions

To investigate the effect of metal ions on the oligomerization of S100A12, SEC was performed
(Figure 2.3). Our experiments carefully minimized metal ion contamination by treating glassware, protein
samples, and buffers with EDTA to remove adventitious metal ions (see Materials and Methods). ApoS100A12 elutes at 70 mL retention volume, corresponding to 23 kDa molecular weight based on the
calibration of the gel filtration column. This elution volume agrees with the expected dimeric structure of
the protein in the apo form.117 No change in the retention volume was observed upon adding calcium (20
– 200 equivalents) to the apoprotein, suggesting that calcium-binding does not induce oligomerization of
S100A12 (Figure 2.3b). In the presence of an excess of zinc (4 – 40 equivalents), higher-order oligomers
were observed, as indicated by the reduction in the elution volume (Figure 2.3 c, e, and g). Although
nanomolar Kd values for Zn2+ binding to S100A12 have been reported,13 these SEC experiments were
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performed in the presence of excess zinc to ensure complete binding. Identical retention volumes were
obtained when the experiments mentioned above were performed in the presence of one equivalent (per
monomer) of Zn2+ (data not shown).
Furthermore, the order of oligomerization depended on the concentration of S100A12: smaller sized
assemblies were observed at lower S100A12 concentration of 10 μM (elution volume = 62 mL), and the
oligomer size increased as the concentration of protein was increased to 50 and 100 μM. Based on the
calibration of the size exclusion column, the size of S100A12 assemblies at 10.0 μM corresponds to
approximately 40 kDa, while at 50 and 100 μM concentrations, the expected molecular weight is 55 and 58
kDa, respectively. Although the exact molecular weight cannot be determined by SEC, the difference in
elution volumes indicate a distinct concentration-dependent change in the assembly size.

Figure 2.3. Size exclusion chromatograms of S100A12 in presence of Zn2+ and/or Ca2+. (a) Apo S100A12,
(b) S100A12 with 2 mM Ca2+. 10 μM S100A12 with 400 μM Zn2+ and (c) no Ca2+; (d) 2 mM Ca2+. 50 μM
S100A12 with 400 μM Zn2+ and (e) no Ca2+; (f) with 2 mM Ca2+. 100 μM S100A12 with 400 μM Zn2+ and
(g) no Ca2+; (h) with 2 mM Ca2+.

27

Based on the results of Zn2+ binding, the effect of calcium on oligomerization was investigated by
repeating the experiments described above in the presence of 2 mM Ca2+. As shown in Figure 2.3c-h, the
oligomeric assemblies of S100A12 eluted at the same volume in the presence and absence of calcium,
suggesting that calcium does not alter the order of S100A12 assemblies and only Zn2+ is necessary for its
oligomerization. It is noteworthy that these results do not agree with the previous X-ray crystallographic
studies that reported the formation of hexamers upon calcium-binding to the apoprotein.181 A plausible
explanation for this discrepancy could be that the previous studies had Zn2+ or other metal ion impurities.

2.4.2 Characterization of Apo-S100A12 and Metal-Bound S100A12

To understand structural changes in S100A12, which would propagate when divalent metal cations
induce oligomerization, we need first to characterize the apoprotein in its dimeric form by conducting
solution NMR spectroscopy. In this study, as we expected, apo-S100A12 stays stable under the
experimental conditions in the absence of divalent cations. The results of sedimentation velocity (SV)
experiments performed by Dr. David Bolton119 at protein concentrations from 6 to 233 μM (Figure 2. 4) are
consistent with a monodisperse dimer at S100A12. The time derivate profiles show a normal distribution,
and experimentally determined values of S increase with reduction of protein concentration. The
sedimentation and diffusion coefficients ratio for a monodisperse particle provides an accurate estimate of
the molecular protein weight (Table 2.1). The coefficients calculated by HydroPro software for S100A12
dimers from the crystal structure of PDB entry 2WCF are in agreement with experimentally resolved ones
(Table 2.1)
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Figure 2. 4. Sedimentation velocity (SV) analyses of (a) apo-S100A12 and (b and c) Zn2+-S100A12 with
the cation present in 2-fold molar excess relative to the protein. Panels A and C show the time-derivative
distributions and the best fits of the data to a single-component (normal) distribution (Table 1 for panel A).
In panel A, apo-S100A12 was analyzed at 233 μM (red), 23 μM (black), and 6 μM (blue). Sedimentation of
the first sample was tracked at 280 nm; the latter samples were tracked at 230 nm. Panel C shows two of
the Zn2+-S100A12 samples that were analyzed: 196 μM (black) and 6.9 μM (blue) tracked at 280 and 230
nm, respectively. Panel B shows that S20,w increases with S100A12 concentration for the eight protein
concentrations analyzed; the solid blue and black symbols represent the two distributions shown in panel
C. The dotted line depicts a linear regression that highlights the upward trend of the data and does not
represent a particular assembly model.
Table 2.1: Summary of the sedimentation parameters determined from velocity centrifugation of apoS100A12
S100A12a

233 µM

23 µM

6 µM

PDB:2WCFb

S (20,w) [S]

2.195 (2.185, 2.205)

2.165 (2.163, 2.167)

2.483 (2.469, 2.497)

2.4

S/D (Mw) [kDa]

19.90 (19.25, 20.55)

20.75 (20.57, 20.93)

18.15 (17.11, 19.12)

20.3

D (20,w) [F]

10.53 (10.20, 10.86)

9.96 (9.87, 10.04)

13.05 (12.29, 13.89)

9.7

a

The parameters were obtained from fitting the time-derivative distributions shown in Fig. 2119 to a
single component.
b
The hydrodynamic parameters were calculated from the indicated crystal structure using the
program HydroPro as described in the Methods and Materials in our published article.119
H−15N HSQC spectrum of the apoprotein at 14.1 T is shown in Figure 2.5. The NMR spectrum

1

shows 110 well-resolved peaks, of which 91 originate from the backbone amide nitrogen atoms. With the
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addition of the 3D 1H−15N TOCSY-HSQC, NOESY-HSQC (Figure 2.6), and 1H−13C−15N CBCACONH and
HNCACB experiments (Figure 2.7), we assigned 80 of 92 backbone and 86 side chain (of 110) resonances.
Resolved assignments are presented on the 1H−15N HSQC spectrum in Figure 2.5. For the calcium bound
S100A12, previous NMR studies resolved a number of the residues.191 The chemical shifts obtained from
the above experiments matched these from the previously reported assignments,191 which allowed us to
assign 73 of 91 backbone resonances.

Figure 2.5. 14.1 T 1H−15N HSQC spectrum of apo-S100A12 with the assignment of resonances
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Figure 2.6 Strip plots from 1H−15N NOESY-HSQC (blue) and TOCSY HSQC (red) spectra for residues
G9−F14.

Figure 2.7. Sequential assignments showing strip plots from 1H-13C-15N CBCACONH (orange) and
HNCACB (blue) NMR spectra of Ca2+-S100A12 acquired at 14.1 T for residues A41-K48.

31

Figure 2.8. a) Overlay of 18.8 T 1H-15N HSQC spectra of apo-S100A12 homodimer (green) and Zn2+ bound
S100A12 (blue) and; b) 1H-15N HSQC spectrum of Zn2+ bound S100A12 with contour level adjusted so
that the spectral noise is visible.
In contrast to the apo-S100A12, Zn2+-S100A12 demonstrates a dramatic loss of NMR signal
intensities. The 2D 1H−15N HSQC spectrum of Zn2+-S100A12 shows only a small number of signals (Figure
2.8). The same issue was observed in Ca2+, Zn2+-S100A12 HSQC spectra. These NMR results are
apparently from the increased molecular weight of the oligomeric S100A12 assemblies, and this mass
increase prevents the signal from resolving in the solution state due to attenuated molecular tumbling.
In contrast to apo-S100A12, the level of sedimentation of zinc bound S100A12 increases with an
increase in protein concentration (Figure 2. 4b). The AUC studies show that the zinc-bound protein system
undergoes reversible self-assembly (Figure 2. 4c). Therefore, for this system, molecular weight is not
accurately reported by the sedimentation and diffusion constants ratio.
The sedimentation equilibrium (SE) approach in AUC reports the weight-average molecular weight
(Mw). SE was applied to S100A12 samples in a buffer containing Ca2+, Zn2+, or both Zn2+ and Ca2+. The
results of SE analysis demonstrate that Zn2+ is much more prepositioned for S100A12 self-assembly than
Ca2+. Both metal ions are loaded simultaneously, cooperating to drive the self-assembly. When data fit a
single-component model, the molecular weight values did not correspond to multiples of the dimer [21146,
42292, and 63439 Da for the dimer, tetramer, and hexamer, respectively] (Figure 2. 9 and Table 2.2).
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Figure 2.9. Sedimentation equilibrium analysis of S100A12 equilibrated in a buffer containing (a) 20 mM
Ca2+, (b) 0.2 mM Zn2+, and (c) 20 mM Ca2+ and 0.2 mM Zn2+. The protein concentrations loaded into
each sector of the six-channel centerpiece were 33 μM (left), 98 μM (middle), and 327 μM (right). The
concentration gradients were determined using the absorption optics set at 280 nm. The best global fits of
the dimer−octamer model to the three protein concentrations equilibrated at 12000 (black), 24000 (blue),
and 30000 rpm (red) are shown along with the residuals; the resolved Kd values (Table 2.2).
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Attempts to fit each of these data sets in Figure 2.9 to various self-assembly models failed to yield
a “clear winner” displaying random residuals. One issue is that sufficiently high protein concentrations
cannot be analyzed to significantly populate terminal oligomers of each self-assembly reaction if the
assembly can reach saturation. We invoked Occam’s razor and reported the Kd values from fits to the
dimer−octamer assembly model that can embrace all three conditions (Table 2.2). These results
successfully explain why NMR measurements of Zn2+- and Ca2+-bound S100A12 demonstrated the
dramatic loss of NMR signal intensity as was mentioned above. It demonstrated that the cooperative effect
of the simultaneous binding of calcium and zinc metal ions produces high-order oligomeric forms too large
for solution NMR analysis. Therefore, we used solid-state NMR structural studies to characterize the
oligomeric zinc and calcium bound S100A12 assemblies

Table 2.2: Summary of the Sedimentation Parameters Determined by Equilibrium Centrifugation of
S100A12 Complexed with Ca2+, Zn2+, and Both Zn2+ and Ca2+
metal ion
Mw (Da)
Kd(DX-O) (μM)
20 mM Ca2+

32750 (28610, 37489)

4585.3 (4005.7, 5248.8)

0.2 mM Zn2+

47320 (41005, 54607)

56.7 (49.1, 65.4)

0.2 mM Zn2+ and 20 mM Ca2+

68225 (59228, 78588)

13.2 (11.5, 15.2)

2.4.3 MAS NMR Spectra of Dimeric and Oligomeric S100A12

Figure 2.10 demonstrates 2D MAS NMR

13

C−15N (12 kHz MAS; Bo = 16.4T) and

13

C−13C (12 kHz

MAS; Bo = 14.1 T) correlation spectra of apo-S100A12, which displays highly resolved NMR spectra of
protein in the solid-state. With the help of 3D CBCACONH and HNCACB solution NMR experimental
measurements, we assigned 81 residues in the 2D 13C−13C correlation MAS NMR spectrum (Figure 2.10).
The almost-perfect alignment solution- and solid-state spectra demonstrates that the structure of the apoS100A12 in the solution-state NMR is identical to that in the solid. This demonstrates that the protein's
overall structure is not disrupted by the sample preparation protocol utilized for MAS NMR measurements
while keeping a hydrated environment that imitates conditions of a solution-like state. We used the same
strategy for the Ca2+-S100A12. The 2D MAS NMR 13C−13C (12 kHz MAS; Bo = 14.1 T) correlation spectrum
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measurements of calcium bound S100A12 were made and compared with 3D CBCACONH and HNCACB
solution NMR data to assign Cα and Cβ resonances. The detection of both Ca2+, Zn2+-S100A12, and Zn2+S100A12 oligomeric forms required MAS NMR measurements. For the Zn2+-S100A12, we observed wellresolved NMR spectra in the solid-state, suggesting S100A12 assemblies. Figure 2.11a revealed several
chemical shift perturbations (CSPs) in the Cα and Cβ resonances of the overlay of 13C−13C MAS correlation
spectra of the apoprotein and zinc bound protein. In particular, for Cα atoms, significant CSPs (around 1.0
ppm) were observed. From these perturbations and 3D NCOCX and 3D NCACX measurements, we
assigned 57 of 92 amino acids in the zinc-bound oligomeric assemblies (Figure 2.11b-d and Figure 2.12).

Figure 2.10. MAS NMR spectra of apo- and Zn2+-S100A12. 2D

13

C−15N NCACX (16.4 T) and

13

C−13C

DARR (14.1 T) correlation spectra of apo-S100A12 with resonance assignments (left) and strip plots from
1

H−13C−15N CBCACONH (blue) and HNCACB (orange) solution NMR spectra for residues T26−S28 (right).

Signals belonging to an assigned residue in MAS and solution spectra are connected with the same color.
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Figure 2.11. MAS NMR spectra of apo- and Zn2+-S100A12 (a) Overlay of Zn2+-S100A12 (orange) and apoS100A12 (blue)

13

C−13C DARR MAS spectra acquired at 14.1 T. (b−d) Close-ups of the panel a with

assignments of the perturbed residues. All-solid-state NMR spectra were acquired at 12 kHz MAS.
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Figure 2.12. Sequential NCACX (blue) and NCOCX (orange) backbone-walk used to assign 13C-13C
DARR correlation spectrum of Zn bound S100A12 protein showing strip plots for residues S28-Q34.
3D (15N−13C, NCACX, and NCOCX; Bo = 16.4 T; Figure 2.13) and 2D (13C−13C DARR; Bo = 14.1
T) MAS NMR spectra of double-loaded Ca2+, Zn2+-S100A12 let us make 66 out of 91 amino acids in an
S100A12 polypeptide chain. We observe line widths approximately 0.46−0.62 ppm. This narrow width
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indicates a high degree of conformational homogeneity. Because calcium is known to produce significant
major structural rearrangements into the apo-S100A12, the protein loaded with Zn2+ and Ca2+ was
compared with Ca2+-S100A12 to analyze structural rearrangements upon Zn2+ binding. The 13C−13C MAS
NMR spectrum of Ca2+- bound S100A12 overlays well on the spectrum of Ca2+, Zn2+-S100A12 (Figure
2.14), which suggests that zinc binding to Ca2+- S100A12 largely does not alter the structure. Metal-binding
residues observed expected large CSP. However, a closer investigation revealed that several residues not
participating in metal binding also demonstrated significant perturbations. Figure 2.14 shows some of these
residues at close-up. Bellow, we have a detailed description of these perturbations.

Figure 2.13. Sequential NCOCX (orange) and NCACX (blue) and backbone-walk used to assign

13

C-13C

DARR correlation spectrum of Ca2+, Zn2+- S100A12 protein showing strip plots for residues L60-E66.
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Figure 2.14. Overlay of

13

C−13C correlation MAS NMR spectra of Ca2+, Zn2+-S100A12 (blue), and Ca2+-

S100A12 (orange). Panels a−c are close-ups with assignments showing perturbed residues. Residues
marked in red show significant CSP upon zinc binding. The experimental conditions were the same as
those described in Figures 2.11.
2.4.4 Chemical Shift Perturbations upon binding of Zn2+ to apo- and Ca2+-S100A12.

We observed several CSPs for both Cα and Cβ nuclei in 13C−13C correlation spectra when adding
zinc to Ca2+- and apo-S100A12. As shown in Figure 2.15, these CSPs, calculated from both 2D and 3D
spectra, were plotted against the residue numbers for Cα, Cβ, and NH nuclei. Considering the line widths of
the

13

C−13C MAS NMR signals, a perturbation in the backbone Cα chemical shift of >0.3 ppm was thought

to describe changes in the local configuration of the S100A12. The residues with conserved structural
domains are to be considered for perturbation with CSP < 0.15 ppm. Both crystal structures of the calcium
bound and apo S100A12 demonstrate four helices (helices I−IV) connected by loop regions. When zinc
ions bind to the apo-S100A12, it induces conformational changes in the whole polypeptide chain, as
demonstrated by CSPs. We observe large CSPs for two helices (helices I and IV), which indicate significant
structural perturbations in these helices. In contrast, most residues in helix II exhibited small CSPs of ∼0.3

ppm (Figure 2.15, top). The hinge region (residues K38−V53), which plays an essential role in the immune
system as it was responsible for target recognition,165,182,206 demonstrated CSPs of > 0.3 ppm for its several
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residues. Figure 2.15 also shows CSPs for backbone

15

N amide nitrogen nuclei (NH), deduced from NMR

measurements. Most residues share significant perturbations simultaneously in Cα, NH, and Cβ chemical
shifts.

Figure 2.15. Site-specific CSPs for zinc binding to apo-S100A12 (top) and Ca2+-S100A12 (bottom). Cα, NH,
and Cβ perturbations are colored pink, yellow, and blue, respectively. The secondary structure of the
apoprotein determined from the crystal structure (PDB entry 2WCF) is displayed at the top: α-helices (blue
bars), β-strands (yellow arrows), and loop regions (cyan lines). The dashed horizontal lines represent CSPs
of 0.15 and 0.3 ppm for Cα and Cβ and 0.50 and 1.00 ppm for NH.
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In contrast, conformation changes induced by zinc demonstrated through all domains on the apoS100A12, the structural perturbations upon adding calcium are more specific and in the bottom panel of
Figure 2.15. Zinc ion binding to S100A12 as expected perturbed zinc ion binding residues in helices I and
IV (H15, D25, H85, and H89) and residues in their vicinity. The helix III majority residues show Cα CSPs of
<0.3 ppm. However, most of the hinge region and helix II residues demonstrate major CSPs reflecting
structural variations in this region as protein changes from dimeric to oligomeric form. This proposes that
the hinge region's structural conformation and helix II are influenced by binding zinc to calcium bound
S100A12.
2.4.5 Secondary Structure Propensities

We calculated SSP for the apo-S100A12, Ca2+-, Zn2+-, and Zn2+, Ca2+-S100A12 states using both
Cα and Cβ chemical shifts (see Method section) and plotted data versus residues numbers in Figure 2.16.
Based on the SSP values for the apo-S100A12, it has been predicted to have a β-sheet propensity for
several loop residues and four helical domains (helices I - IV). This is in good agreement with X-ray
crystallography data for the secondary structure Figure 2.16.176 These observations show that MAS NMR
results agree with the predicted secondary structure of the apo-S100A12 and that the overall conformation
of the protein is not influenced during sample spinning or sample preparation. When comparing SSPs for
zinc bound and apo S100A12 (Figure 2.16A), we observe that zinc binding does not disrupt the overall
domain-wise secondary structure of apo-protein. In the apoprotein, the loop regions with β-sheet propensity
(such as residues 24−27) and helical domains retain their conformation upon self-assembly. However,
interestingly, when comparing to apo-S100A12, several residues at the C-terminus of the oligomeric states
demonstrate significantly increased α-helical propensity, suggesting an extension of helix IV upon Zn2+
binding. Similarly, the overall secondary structure of Ca2+-S100A12 does not change with Zn2+ binding, as
can be observed in Figure 2.16B. Similar to apo-protein, the extension of helix IV upon binding Zn2+ is also
observed for Ca2+-S100A12.
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Figure 2.16. Comparison of the SSPs predicted from Cα and Cβ chemical shifts: apo-S100A12 (pink bars)
and Zn2+-S100A12 (empty blue bars) (A) and Ca2+-S100A12 (pink bars) and Ca2+, Zn2+-S100A12 (empty
blue bars) (B). The secondary structure of the apoprotein and Ca2+-bound protein determined from the
crystal structure (PDB entries 2WCF and 1E8A) is displayed at the top: α-helices (blue bars), β-strands
(yellow arrows), and loop regions (cyan lines).
2.5. Discussion
In both in vivo and in vitro, oligomeric S100A12 had been observed, and these high-order oligomers
have been determined to participate in cellular signaling.184,187,188,190 While it is clear that divalent cations
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enable S100A12 self-assembly, the literature does not have a clear answer on conditions that induce
S100A12 self-assembly. For example, calcium hexameric oligomers were detected when S100A12 was
crystalized,181 although both calcium and zinc ions have been proposed to be necessary for forming
oligomeric assemblies.184 The observed extreme peak broadening in our NMR analysis of 0.2 – 2 mM
S100A12 in buffers containing Zn2+ and Ca2+ suggests that S100A12 assembles higher-order oligomers in
the presence of both divalent metal cations.
While our AUC analyses could not resolve discrete oligomers and assembly models, it is clear that
adding zinc is two orders of magnitude more effective than calcium in promoting S100A12 self-assembly.
Also, both Zn2+ and Ca2+ cooperate to enhance oligomer assembly. It does make structural sense that both
divalent metal cations cooperate since each of these cations bind to discrete crystallographically identified
sites. While our results could not determine the terminal oligomeric assemblies formed by Zn2+- and Ca2+bound S100A12, they successfully demonstrate that both divalent metal cations induce reversible S100A12
self-assembly. This propensity is most probably related to S100A12 selective cellular regulation.
Our AUC experiments determined that the binding of zinc to already calcium-bound S100A12 affords
increased propensity for self-assembly. We conducted an extensive NMR investigation of the apoS100A12, Zn2+-, and Ca2+-bound protein. Utilizing 2D and 3D 1H−13C−15N correlation solution NMR
spectroscopy, we mostly completed (88%) backbone peak assignments for apo-S100A12 and Ca2+S100A12 81% of amino acids based on reported assignments.191 Zn2+- and Ca2+, Zn2+-bound S100A12
oligomeric assemblies prevented their characterization by solution NMR due to their high molecular weight.
Results of our AUC experiments support the formation of their high molecular weight assemblies. The solidstate, MAS NMR spectra of Zn2+- and Ca2+, Zn2+-S100A12 provided us with well-resolved NMR spectra,
which allowed us to conduct the structural comparison with Ca2+-bound S100A12 and apo-S100A12. Even
though backbone assignments for Ca2+, Zn2+- and only Zn2+-S100A12 are not available, we must mention
that our current assignments are done throughout the polypeptide backbone. Therefore the data analysis
shown here is not biased toward a specific structural domain of the protein.
2.5.1. Comparison of Apo- and Zn2+-S100A12
Figure 2.17 shows the observed Cα CSPs are overlaid on the crystal structure of apo-protein. From
the crystal structure (PDB entry 2WCF), we can observe that in apo-S100A12, its four main helices are
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linked by loops and short β-strands.117 Significant structural perturbations are observed in helices I and IV,
suggesting the presence of significant conformational changes in these domains upon Zn2+ binding. The
binding of zinc ions to protein induces CSPs in several residues of calcium-binding EF-hand I loop near
zinc-binding D25 and in several C-terminal residues near zinc-binding histidines H85 and H89. Our results
demonstrate that all four helices experience conformational changes when zinc is added to the protein. A
comparison of SSPs of Zn2+- and apo-S100A12 demonstrated that the helical regions preserve their
secondary structure upon oligomerization. This observation suggests that calculated CSPs do not reflect a
change in the secondary structure of these structural domains.
Similarly, although large CSPs were observed for only a few residues, the SSP of the functionally
important hinge region remains unperturbed. In both states, this important motif stays primarily in its αhelical conformation. Importantly, calculated SSPs from the MAS NMR measurements predict that few loop
residues following helix IV in the apo-S100A12 with β-sheet propensity obtain an α-helical conformation in
zinc bound oligomeric state. The extension of helix IV through increased helical propensity was also shown
in the zinc-bound S100A12 crystal structure. It can be induced by binding Zn2+ to metal binding histidines
(H85 and H89) at the C-terminus. The comparision of the crystal structures of apo- and Zn2+-S100A12 at
the zinc-binding site demonstrates that the addition of Zn2+ rotates the His89, K90, and E91 to lock these
residues in the α-helical conformation forming H-bonds with residues before them (Figure 2.18).

Figure 2.17. Observed Cα CSPs mapped onto the crystal structure of apo-S100A12 (PDB entry 2WCF).
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Color scheme: gray for unassigned residues, blue for residues with CSPs between 0 and 0.15 ppm, cyan
for residues with CSPs between 0.15 and 0.3 ppm, gradient from orange to red for residues with CSPs
between 0.30 and 2.00 ppm, and red for residues with CSPs of >2.00 ppm.

Figure 2.18. The C-terminal residues in A. the crystal structure of apo-S100A12(PDB: 2WCF) and B. the
crystal structure of Zn2+-S100A12 (PDB: 2WCB).

Figure 2.19. An overlay of the crystal structures of apo (PDB: 2WCF) and zinc bound (PDB: 2WCB)
S100A12. The figure shows only the S100A12 monomers for clarity.
Previously, the crystal structure of zinc bound S100A12 had been reported in the literature.117 Here,
we report a close association of two dimeric Zn2+-S100A12 units to organize a clearly defined tetrameric
oligomeric assembly, suggesting a tetramerization interface. Comparing the differences in the crystal
structures of apo- and Zn2+-S100A12 (PDB entries 2WCB and 2WCF, respectively) reveals minor variations
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in helix I, as indicated by the calculated RMSD of 1.18 Å and shown in in the overlay of the two structures
in Figure 2.19. These observations suggest that helix I participates in the tetramer interface, which is
proposed to be stabilized by the extension of helix IV. Perturbations induced upon metal binding are the
reason for the observed CSPs in helix I in our studies,119 including a metal-binding histidine H15.
2.5.2. Comparison of Ca2+- and Ca2+, Zn2+-S100A12.

Figure 2.20. An overlay of the crystal structures of apo (PDB: 2WCF) and calcium bound (PDB: 1E8A)
S100A12. The figure shows only the S100A12 monomers for clarity.

The binding of Zn2+ to the apo-S100A12 induces structural perturbations, as observed in
crystallographic studies and presented here. However, the binding of Ca2+ to apo-S100A12 produces
significant structural rearrangement in two helices (helix II and helix III), as can be observed in the overlay
of the two structures in Figure 2.20. Therefore, calcium-induced perturbations in apo-S100A12 are
expected to dominate the overall structure of Zn2+, Ca2+-S100A12. While a structure of Zn2+, Ca2+-S100A12,
is not available, the structures of protein bound to Ca2+ and Cu2+ have been studied by X-ray
crystallography.183 Surprisingly, when we overlay both Ca2+- and Cu2+, Ca2+-S100A12 crystal structures,
we observe no major differences in these structures (Figure 2.21). Because both copper and zinc share
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the His3Asp metal-binding motif, the structure of Cu2+, Ca2+-S100A12 is expected to be similar to that of
Zn2+, Ca2+-S100A12, and it is being used as a structure surrogate to Ca2+, Zn2+-S100A12.

Figure 2.21. An overlay of the crystal structures of calcium (PDB: 1E8A) and copper, calcium bound (PDB:
1ODB) S100A12. The figure shows only the S100A12 monomers for clarity.

Our solid-state MAS NMR studies demonstrate that, as a whole, the secondary structure is
conserved between both Ca2+- and Ca2+, Zn2+-S100A12. The

13

C−13C correlation spectra of Ca2+, Zn2+-

S100A12, and Ca2+-S100A12 overlay well, with the majority of the regions of the polypeptide chain
demonstrating only minor perturbations, which suggests that the overall structural architecture of the
S100A12 is influenced by calcium binding to protein and consistent with the resemblances between the
Ca2+, Cu2+-S100A12, and Ca2+-S100A12 crystal structures. Logically, zinc-binding to S100A12 induces
CSPs into terminal helices (helix I and IV) at the metal-binding motif residues and neighboring residues.
However, major CSPs for helix II and the hinge region were revealed upon a closer look (Figure 2.22).
Helix II and the hinge region of the polypeptide chain do not contain zinc-coordinating residues of the
His3Asp motif, and major CSPs for these residues suggest that Zn2+ binding to S100A12 modulates longrange conformational changes induced into the protein. Therefore, our results demonstrate that Cu2+, Ca2+-
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S100A12 crystal structure, which does not have similar conformational changes, should not be considered
similar to the structure of the Ca2+- and Zn2+-bound S100A12.
Many proteins of S100 family such as S100B, S100A1, S100A2, S100A3, S100A5, S100A6,
S100A7, S100A8/A9, S100A12, and S100A16 bind zinc ions. The overall architecture upon calcium binding
to S100A12 is preserved after zinc ligation.207 S100A7, for which crystal structures of both Ca2+- and Ca2+,
Zn2+- bound protein exists, allows for more systematic comparison.116 In both these structures, the addition
of zinc to protein does not alter helix II's conformation. On the other hand, adding zinc to calcium-bound
S100B introduces more pronounced helices III and IV alterations.208,209 The comparisons of these structures
for different S100 proteins suggest that while Ca2+ binding dominates the architecture of most S100
proteins, the nature and magnitude of zinc-mediated structural variations possibly are not the same for all
S100 proteins.

Figure 2.22. Observed Cα CSPs observed upon binding of Zn2+ to Ca2+-S100A12 mapped onto the crystal
structure of hexameric S100A12 (PDB entry 1GQM). The CSPs are mapped on the monomeric chain for
the sake of clarity. Color scheme: gray for unassigned residues, blue for residues with CSPs between 0
and 0.15 ppm, cyan for residues with CSPs between 0.15 and 0.3 ppm, gradient from orange to red for
residues with CSPs between 0.30 and 2.00 ppm, and red for residues with CSPs of >2.00 ppm. Gray
spheres denote calcium ions.

48

Helix II and hinge domain provide an interface for the C-type immunoglobulin domain of RAGE to
bind to Ca2+-S100A12.189 The perturbations in the helix II and hinge domain, which we demonstrated
through our MAS NMR studies, reflect biologically relevant structural changes in S100A12 induced by
binding of Zn2+ to S100A12. These changes could promote interactions of S100A12 with membrane
receptor targets such TLR-4 and RAGE. Four residues of the hinge region (Leu40, Ile44, Ile47, and Ile53)
have been demonstrated to play an important role in S100A12-induced edema and chemotaxis.182
Interestingly, in our NMR studies, these residues demonstrate large CSPs when Zn2+ binds to Ca2+S100A12. The observed perturbations in these regions, which indicate conformational changes, could have
a pronounced effect on the metal binding dependent abovementioned functions of the hinge region of
S100A12.
It is reasonable to suggest that S100A12 upon secretion into the extracellular space by neutrophils
is bound to calcium since serum has a high calcium concentration. Therefore, when S100A12 conducts
zinc sequestration as part of protein antimicrobial response, our results predict that the protein will exist in
an oligomeric state. S100A12 interacts with various membrane receptor targets to initiate proinflammatory
signaling downstream cascade as part of the overall immune response.10,94 The high oligomeric forms could
exist through the self-assembly of S100A12 during the antimicrobial response and are necessary for
initiating the inflammatory response.
Formed oligomers may interact with membrane receptor targets to promote pro-inflammatory
response and induce cellular signaling. Here are some of our bottom-line thoughts on how the observed
reversible S100A12 self-assembly and the differences in the formation of oligomeric assemblies propagate
a feedback loop in the human innate immune system, allowing the cells to control inflammation. When the
organism goes through the infection, neutrophils overexpress and then excrete S100A12 into the
extracellular space. This results in S100A12 forming the oligomers when zinc binds to it. We suggest that
in a healthy cell under normal S100A12 expression level, S100A12 exists in the dimeric form, which does
not initiate a pro-inflammatory response. Considering S100A12 interactions with membrane receptors, the
protein’s ability to assemble plays a significant biological role reversibly. Our results demonstrate that we
should not consider S100A12 in discrete tetrameric or hexameric oligomeric forms but as a protein
concentration-dependent continuum. Structurally distinctive forms of S100A12 are necessary to bind to
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different physiological targets such as RAGE and induction of Toll-like receptor 4.176 Finally, zinc-binding
induces the long-range conformational changes to helix II and the hinge region, which suggests that more
studies are needed to be focusing on the role of these domains in the interactions with membrane receptor
targets so we can learn insights into the mechanism of S100A12-induced cellular signaling specifically and
role of these interactions in the immune response in general.

2.6. Conclusion
S100A12, a member of the calcium-binding S100 family of proteins, self-assembles when it binds
the Zn2+, showing that this protein, also a member of the human innate immune response, is most likely to
be in an oligomeric state while performing its antimicrobial functions. We proved that while adding calcium
to S100A12 can alone initiate protein self-assembly, calcium and zinc must cooperate to increase the
S100A12 to self-assemble. The solid-state MAS NMR studies show that the binding of Zn2+ to Ca2+S100A12 introduces major CSPs to the functionally important helix II and the hinge region. These CSPs
may indicate the functionally relevant structural and conformational changes that could affect the S100A12
interactions with membrane receptor targets, affecting cellular signaling pathways. The conformational
changes induced by metal binding in the hinge region can impact the S100A12-initiated inflammatory and
chemotactic responses. Altogether, our work demonstrates that zinc-induced structural changes in
S100A12 should be an essential factor in the mechanism of biological actions of the protein in human
immune response and inflammatory pathways.
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Chapter 3 - Calcium promotes the antimicrobial activity of S100A12 to bind metal at pH < 7.
The contents of this chapter were published as:
Wang, Qian, Aleksey Aleshintsev, Aneesha N. Jose, James M. Aramini, and Rupal Gupta. "Calcium
regulates S100A12 zinc sequestration by limiting structural variations." Chembiochem: a European
journal of chemical biology 21, no. 9 (2020): 1372.
3.1 Abstract

The pathogen invasion exerts the response of the innate immune system. The host organism
recruits a wide range of cellular responses to destroy the invaders and prepare the adaptive immune
system for further combat if the innate immune system does not stop the invaders. During the innate
immune response to infection, the neutrophils release a range of chemical agents, including
antimicrobial proteins of the S100 calcium-binding family. Some of these S100 antimicrobial proteins
(Calprotectin: S100A8/A9 and Calgranulin C: S100A12) are expressed and released by neutrophils in
great numbers to sequester nutrient metal ions and to promote pro-inflammatory signaling. S100A12
protein at neutral pH binds Zn2+ with tight, nanomolar affinity, and calcium-binding further promotes
zinc sequestration. During infection, the pH homeostasis at the site of the infection shifts toward the
sub-neutral range. In our investigation of how in vitro zinc sequestration by human S100A12 depends
on pH level, we used a spectroscopically active Co2+ surrogate. We determined that at above neutral
pH range between pH 7.0 and 10.0 apo-S100A12 shows strong binding affinity to Co2+, but as pH
decreases to 5.3 from 7.0, this binding affinity progressively diminishes. UV-Vis experiments show
calcium bound S100A12 retains nanomolar Co2+ binding affinity up to pH 5.7. Our NMR spectroscopic
measurements determined that the side-chain protonation of the Co2+/Zn2+ binding histidine residues
at the metal-binding active site was not affected by calcium-binding. On the contrary, NMR
spectroscopic measurements revealed the role of the calcium-binding modulation of metal
sequestration through the limitation of pH-dependent conformational changes to calcium-binding EF
loop 1, which also contains Co2+ /Zn2+ binding Asp25 residue. Here we report that the availability of
the calcium to S100A12 enhances its Co2+/Zn2+ binding affinity and, in general, can assist in prolonging
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antimicrobial activities of calcium-binding S100 proteins released by neutrophils under sub-neutral pH
conditions.
3.2 Introduction

The subset of the large S100 calcium-binding family of proteins which includes calgranulins
S100A7, A100A8, S100A9, and S100A12, were identified to play an important antimicrobial function
through participating in the innate immune response.15 Both intracellularly and extracellularly, the
proteins of the family of S100 proteins were discovered to function in calcium-dependent mode, with
each member of this large family of proteins having two calcium-binding EF-hand motifs.90 The
neutrophils release calgranulins S100A7, S100A8, S100A9, and S100A12 into the extracellular space
at the site of the infection to allow them to sequester nutrient metals.207 The Zn2+ homeostasis is
maintained by the homodimeric forms of S100A7 and S100A1218,56,94,172,173 while Mn2+, Ni2+, Fe2+, and
also

Zn2+

metal

sequestrations

are

maintained

by

S100A8/A9

heterodimer

called

calprotectin57,113,114,151,152. Elevated antimicrobial activity of S100A7, S100A8, S100A9, and S100A12
protein limits availability of nutrient metal ions to pathogens preventing the development of infection since
these metal ions are critical for spreading the pathogen in the organism. Our investigation concentrates on
the S100A12 (also known as calgranulin C) protein, primarily expressed in neutrophils and considered
one of the human innate immune responses.177 Clinically, an elevated level of the S100A12 in humans has
been observed in correlation with many diseases due to its pro-inflammatory effect. For example, the serum
level of S100A12 had been elevated was observed in severe bacterial infections,210 in patients suffering
from neurodegenerative,10.188,211 cystic fibrosis,212 metabolic and neoplastic disorders177. Also, it had
been reported that S100A12 inhibits the growth of the pathogen and reduces their virulence, as in the
example of Helicobacter pylori infection in humans.175
The X-ray crystallography studies determined that zinc binds at the interface of the homodimeric
S100A12 through a His3Asp motif which includes an aspartic acid residue and a histidine (Asp25 and
His15) of one monomer and two histidine residues (His85 and His89) from the second (Figure
3.1B).117,213 The symmetric S100A12 homodimer structure, therefore, results in two His3Asp zinc-
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binding sites.117 The presence of two His3Asp metal-binding motifs is different from S100A8/A9, where
two different motifs form metal-binding sites: one His4 and one His3Asp.112,214

Figure 3.1. A) the primary sequence of human S100A12 showing Zn2+ binding residues). The EFhand loops are colored using the same color scheme as panel A (cyan) and EF-hand loops. The
secondary structure elements are presented above the sequence and displayed as blue bars for
helices, pink arrows for b-strands, and cyan lines for loops. B) An expansion of Zn2+-bound S100A12
crystal structure showing the zinc (PDB ID: 2WCF, blue) and Ca2+-bound S100A12 (PDB ID: 1E8A,
orange binding site (PDB ID: 2WCB). The two monomers are colored blue and gray. The zinc and
sodium ions are colored purple and blue, respectively. C) An overlay of the crystal structures of apoS100A12

At the neutral pH range, human S100A12 binds Zn2+ with nanomolar binding affinity, which allows
the protein to efficiently performs its antimicrobial functions with Ca2+ binding enhancing binding to
Zn2+ even more tightly.173 S100A12 protein structure includes two EF calcium-binding motifs which
coordinate Ca2+ in pentagonal bipyramidal configuration.213 Two calcium-binding motifs are connected
by functionally important “hinge” region (Figure 3.1 A). These two motifs are different in the binding
affinity to calcium and mode of the coordination of calcium ions. The C-terminal 12 residue canonical
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EF-hand motif (EF-hand II) binds to calcium ion with Kd ≈ 10-5 – 10-7 and coordinates this ion with
carboxylate groups of Asp61, Asn63, Asp65, Glu72, and the carbonyl group of Gln67.213 The Nterminal 14 residue so-called non-canonical or pseudo-EF hand motif (EF-hand I) binds calcium ion
with much lower affinity (Kd ≈ 10-3 – 10-4) and coordinates this ion with peptide carbonyls of Ser18,
Lys21, His23, Thr26, and the carboxylate group of Glu31.213 Also, interestingly, aspartic acid residue
Asp25 of EF-hand I motif participates in the zinc ion binding as part of the His3Asp metal-binding motif.
Therefore, it is logical to predict that calcium ion binding to S100A12, particularly EF-hand I, could
affect the metal ion coordination geometry through Asp25, linking binding affinities of calcium and zinc
in S100A12. Both apo and calcium-bound protein crystal structures have shown that calcium binding
to S100A12 exerts significant conformational changes to helix III with smaller changes to both helixes
I and IV, which hold the His3Asp metal-binding motifs (Figure 3.1C).117,213 Despite these available
structures, they do not completely describe the connection between the previously reported calcium
ion and zinc ion binding affinities. Since there is a high millimolar concentration of calcium in the
extracellular space, it is expected that when secreted into the blood, S100A12 will be calcium bound
during the execution of its antimicrobial functions of metal sequestration. The presence of extracellular
acidosis was observed during the activation of S100A12 by neutrophils.215,216 Under extracellular
acidosis conditions linked to the inflammatory reactions against microbial agents, pH values of blood
serum in the sub-neutral range (5.5 – 7.0) had been reported.215,216 A transient increase in intracellular
calcium ion concentration has also been reported during these conditions.215 Gathering all these
findings together, we reasonably propose that despite the cellular acidosis conditions during the
infection, S100A12 can still bind calcium to perform its antimicrobial functions upon secretion into
blood serum. Previously, metal binding affinities of S100A12 only had been investigated at the neutral
pH values. For the first time, we had investigated metal binding affinities of S100A12 at the
physiologically relevant conditions of pH 5.5–7.0 values. We researched how Zn2+ sequestration by
S100A12 depends on pH conditions. To do so, we used Co2+ as a surrogate ion to observe the Co2+
binding to S100A12. Our investigations show that the S100A12 metal binding in the range of pH 5.3–
7.0 significantly drops, and it can be recovered with the addition of calcium. This suggests, first, that
without calcium, S100A12 loses its ability to perform its antimicrobial function to sequester zinc during

54

cellular acidosis, particularly between pH 5.3 – 7.0. The addition of calcium is necessary to perform
protein function during infection. To investigate the origins of why and how apo-S100A12 loses the
ability to bind Co2+/Zn2+ ions but can retain the metal binding affinity by Ca2+-S100A12 at identical pH
conditions, we conducted solution NMR studies of both apo and Ca2+-S100A12 by varying pH
conditions. Since the previous investigation was conducted at pH 7.5 and zinc-binding was reported
in the sub-nanomolar range for human S100A12,173 it was not easy to understand the role of calcium
in S100A12 in defense from the pathogens without going in sub neutral pH range. However, our results
point out that in the conditions of cellular acidosis at the site of the infection under physiologically
relevant sub-neutral pH conditions, S100A12 released by neutrophils will not be able to efficiently
sequester nutrient metal ions such as Zn2+ to fight pathogens without the help of bound calcium ions.
Thus, we can refer that it is necessary to have a high concentration of calcium in blood serum for
S100A12 protein to participate in human innate immune response efficiently. Our studies also suggest
the importance of in vivo and in vitro investigations of other proteins participating in the innate human
response, particularly nutritional immunity. The suggested target for the investigation could be other
members of the S100 family of proteins such as S100A8/A9 heterodimer, which also participates in
metal sequestration, and its antimicrobial activities may be modulated by pH and calcium-binding
similarly to S100A12.
3.3 Materials and Methods

3.3.1 S100A12 expression and purification
We synthesized cDNA of human S100A12 (UniProt ID P80511) and subcloned it into a vector
provided by GenScript company, the pET- 41a(+). This was followed by transforming the vector into
BL21(DE3) Escherichia coli competent cells. Cells were plated on Luria Broth (LB)/Kanamycin plate
and incubated at 37°C overnight. The E. coli cell culture inoculated from a single colony from the
overnight plate was incubated in LB at 37°C with shaking at 220 rpm or M9 minimal medium, which
consisted of both U-15N NH4Cl and U-13C6 d-glucose or only U-15N NH4Cl. We inducted cell culture
when OD was 0.6 – 0.8 with isopropyl b-d- 1-thiogalactopyranoside (IPTG; 1 mM). The cell culture in
M9 minimal media continued to grow at the lower temperature, 18°C. The cell culture in LB continued
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to grow at 37°C for another 4-5 hours. Cells were collected and stored at 4°C for 30 minutes and then
collected by centrifuge at 4000 rpm and 4oC for 20 minutes. The harvested cell pellet was carefully
resuspended in no salt lysis buffer (50 mm Tris-HCl, pH 8.3). We initiated protein purification with
sonication of resuspended cells. The cells were kept on ice and sonicated at 45% power with microtip
for 20 min of total processing time with 4 sec on and 1 sec off. After sonication, cell lysate was collected
and centrifuged at 17000 rpm at 4°C for 50 minutes. The supernatant was collected and diluted with
no salt buffer (50 mm Tris-HCl, pH 8.3) to reduce salt concentration, followed by injection into
diethylaminoethanol (DEAE) anion exchange column pre-equilibrated with loading buffer (50 mm TrisHCl, pH 8.3). For purification with the DEAE column, we gradually applied a gradient of 0–20% over
the volume of 100 mL (buffer A, 50 mm Tris-HCl, pH 8.3; buffer B, 50 mm Tris-HCl, 1m NaCl, pH 8.3).
The flow rate for all DEAE was kept at 1.0 mL/min. 5mL fractions were collected, and these containing
S100A12 were identified by SDS-PAGE gel electrophoresis. Fractions containing S100A12 were
combined and concentrated for the next purification steps. To avoid contamination of S100A12 with
divalent metals, we added 10mM ethylenediaminetetraacetic acid (EDTA) to ensure the formation of
the apo form of the protein. Dialysis and buffer exchange was used to remove excess EDTA. For the
next purification step, we performed size exclusion chromatography (SEC) (GE Healthcare Life
Science, HiLoad 16/ 600 Superdex 75 prep grade) on pre-equilibrated 20 mm HEPES pH 7.5, 150
mm NaCl column. The flow rate for SEC was kept at 1.0 mL/min. As before, 3-ml fractions containing
S100A12 were collected, and protein purity was tested with SDS-PAGE. The molar extinction
coefficient (ε = 2980 M-1 cm-1) was used to determine protein concentration by observing the 280 nm
absorbance. We used the previously reported method to validate the amino acid sequence of purified
S100A12.119
3.3.2 UV/Vis spectroscopy
The sample of S100A12 at 0.1 mM or 0.2 mM concentration was prepared for UV/Vis
spectroscopy with the addition of 1 equivalent of Co2+. The initial buffer for the samples was 20 mm
HEPES, 150 mm NaCl, pH 7.5 buffer. For pH titration experiments, buffer pH was lowered to pH 3.5
with dilute HCl or increased to pH 10.4 with 0.1m sodium carbonate–sodium bicarbonate buffer. The
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sample of the calcium bound S100A12 for UV/Vis measurements was prepared by adding 20
equivalents of calcium to Co2+-S100A12. Co2+-S100A12 and Ca2+- Co2+-S100A12 complexes were
detected and monitored by observing the absorbance at 556 nm. All quantification used previously
reported molar extinction coefficient of Co2+-S100A12 complex (ε = 820 M-1 cm-1 for S100A12
dimers).173
3.3.3 NMR sample preparation

Uniformly

13

C or/and

15

N-labeled samples of S100A12 for the solution NMR measurements were

prepared in 20 mm HEPES, 150 mm NaCl pH 7.5 buffer or in 20 mm 2-(N-morpholino) ethanesulfonic acid
(MES), 150 mm NaCl at pH 6.0 buffer, with the addition of 10% D2O. 200 mm 4, 4-dimethyl-4-silapentane1-sulfonic acid (DSS) was also added to the NMR samples. For the NMR measurements, samples of 0.7
mM S100A12 concentration were prepared. NaOH and HCl were used to adjust the pH of buffers during
pH titration experiments.
3.3.4 NMR spectroscopy and NMR Data Processing

We acquired NMR spectra at 16.8 T (750 MHz) on Bruker NMR spectrometer at the City University
of New York’s Advanced Science Research Center or 14.1 T (600 MHz) on a Varian Inova NMR
spectrometer outfitted with an HCN cryoprobe. The sample temperature during the measurements was
maintained at 25 or 37°C, and the Larmor frequencies (at 14.1 T) were 599.93, 60.79, 150.87 MHz for 1H,
15

N, and

13

C, respectively. The acquired NMR spectra were first processed with NMRpipe202 and then

analyzed with Sparky software203. For the data processing, we used forward linear (LP) prediction to
double the number of original data points followed by zero fillings (ZF) to twice the total number of points
used for all experiments. The water suppression function (POLY) with 30°- and 60°-shifted sine bell
apodization (SP) were used for both dimensions. 2D

1

H,

15

N HSQC193, 3D HNCACB198, and

HN(CO)CACB196 experiments were used for backbone assignments of Cα and NH. To detect long-range
(LR) correlation between Nδ1/Nε2 and Hε1/Hδ2 histidine side-chain nuclei through 2JN-H couplings217, we
conducted 1H,
pattern 1H,

15

N HMQC193 experiment using a 22.4 ms delay period. The intensities and cross peak

15

N LR-HMQC NMR spectra217-219 can be used to probe the tautomeric states of histidine
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residues, as shown in Figure 3.2. We used 2D 1H, 13C (HB)CB(CGCD)HD220 and (HB)CB(CGCDCE)HE220
correlation spectra that provided a correlation between known Cβ chemical shifts and Hε1/Hδ2 nuclei to
make Histidine side-chain Hε1/Hδ2 assignments.

Figure 3.2: Schematic representation of the three histidine tautomeric states showing approximate
Nδ1/ε2and HN chemical shifts and expected cross-peak pattern in long-range 1H-15N HMQC spectra for the
A) Nδ1H tautomer, B) Nε2H tautomer and; C) the protonated form of histidine.
3.3.5 Secondary structure propensity calculation

The secondary structure propensity (SSP) of S100A12 was determined with the help of SSP
software204 by providing NH and Cα chemical shifts as input. A combination of NH and Cα allowed calculation
score for each residue in the data. This score represents the expected theoretical fraction of α or β
secondary protein structures. How close the SSP value to 1.0, -1.0, or 0 will predict α-, β-, or random-coil
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structures, respectively. For example, if we have an SSP score equal to -1, it represents a fully formed β
structure, and if the SSP score is equal to 1, it indicates the presence of a fully formed α structure.
3.3.6 Chemical shift perturbation analysis

The following equation was used to calculate chemical shift perturbations (CSP) for backbone
amides between two states 1, 2.205
𝐶𝐶𝐶𝐶𝐶𝐶 = �[(𝛿𝛿𝐻𝐻2 − 𝛿𝛿𝐻𝐻1 )2 + 𝛼𝛼 ∗ (𝛿𝛿𝑁𝑁2 − 𝛿𝛿𝑁𝑁1 )2 ]
Where δH1,2 and δN1,2 are the 1H and 15N chemical shifts for states 1 and 2, respectively, with α = 0.2.
3.3.7 Size exclusion chromatography

Concentrated stock apo-S100A12 was diluted to 100 µM. Protein concentration was determined
spectroscopically by monitoring the 280 nm band (ε = 2980 M-1 cm-1). The holo-S100A12 protein was
prepared by addition of 100 µM of metal ion (Co2+, Zn2+, Cd2+, Cu2+) samples were loaded into HiLoad
16/600 Superdex 75 prep grade gel-filtration (GF) column (GE Healthcare Life Science) connected to an
ÄKTA FPLC (Amersham Pharmacia Biotech) instrument. The GF column was equilibrated with 50 mM
Tris, 150 mM NaCl buffer at various pH values. Flow rate for all Size exclusion chromatography (SEC)
experiments was kept at 1.0 mL/min.
3.3.8 Electron Paramagnetic Resonance (EPR) spectroscopy
X-band (9.65 GHz) EPR spectra were recorded on a Bruker Elexsys spectrometer outfitted with a
dual-mode resonator and an Oxford ESR 910 cryostat. The microwave frequency, generated by a Gunn
diode, was measured by a frequency counter and an NMR gaussmeter calibrated the magnetic field. A
modulation frequency and amplitude of 100 kHz and 1.0 mTpp were used. To determine species
concentration participating in the experiments, the quantitative EPR simulations were performed by
utilizing the SpinCount developed by M. P. Hendrich.221 The software diagonalizes the spin Hamiltonian
H = βe B g S + D [(Sz2–S(S + 1)/3) + E/D (Sx2 – Sy2)], where all parameters have their usual definition. The
concentration of the Co2+- and Ca2+-S100A12 species derived from the simulations of all EPR spectra
agreed with the expected concentration of the protein by observing the 280 nm absorbance with molar
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extinction coefficient (ε = 2980 M-1 cm-1). The EPR samples of S100A12 for EPR measurements were
prepared in 50 mM Tris, 150 mM NaCl pH 7.5 or in 20 mm 2-(N-morpholino) ethanesulfonic acid (MES),
150 mm NaCl at pH 6.0 with the addition of 10% glycerol. For EPR measurements, samples of 1mM
concentration were prepared. Cobalt bound S100A12 samples were prepared by adding 0.9 equivalents
of the Co2+ to apo S100A12. To prepare a Co2+/Ca2+ metal-bound protein sample, 3.0 equivalents of Ca2+
were added to Co2+-S100A12 prepared as above. Experimental condition: 9.643 GHz (microwave
frequency); 12.3 K (temperature); 20 dB (microwave power).
3.4 Results
3.4.1 pH variations affect the protein size

To observe how the pH variations affect the oligomerization of the S100A12, we initially conducted
size exclusion chromatography experiments. We varied the pH from pH 8.5 to 6.0. The 100 µM S100A12
was loaded with one zinc equivalent without the calcium. The results of the experiments are shown in
Figure 3.3. Although oligomer formation was observed for pH 6.8, 7.5, 8.5, at pH 6.0, the protein mainly
remained dimeric.

Figure 3.3. Size exclusion chromatograms of S100A12 in presence of one equivalent of Zn2+ at different
pH conditions: (a) pH 8.5, (a) pH 7.5, (c) pH 6.8, (d) pH 6.0. Buffer is 50 mM Tris and 150 mM NaCl.
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3.4.2 pH variations do not disrupt the tertiary structures of apo and Ca2+-S100A12

Figure 3.4: 1H,

15

N HSQC spectra at 14.1 T shows overlays of the S100A12 at pH 8.3 (blue), 6.0 (pink),

and 4.5 (light green) for A) apoprotein and B) calcium bound S100A12. The residues involved in the His3Asp
Zn2+ binding motif are labeled in red.
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To understand the pH dependence of antimicrobial activities of S100A12, we investigated if the protein
keeps its conformation to be well-folded and still soluble under different pH conditions we applied in our
investigation. We had performed a series of 1H-15N HSQC measurements while changing pH from 10.4 to
4.5 in steps of 0.5 pH points. Figure 3.4 demonstrates an overlay of HSQC spectra. For clarity, the figure
shows spectra acquired at pH values of 4.5, 6.0, and 8.3 for both apo-S100A12 and Ca2+-S100A12. Under
all measured pH conditions, the backbone amide nuclei showed the resonances in the well-distributed
state with sufficiently narrow line widths. This indicates that the protein’s 3D structure stays folded in this
pH range. We observed 88 out of 91 expected backbone resonances for apoprotein, with 89 well-resolved
signals exhibited in the calcium-bound form of protein. With the aid of 1H,

13

C,

15

N heteronuclear

experiments, we made backbone assignments for 86 protein residues, as we reported previously.119 The
triple-resonance experiments for calcium-bound S100A12 were performed to confirm the reported
literature resonance assignments191 and add backbone resonance assignment to 83 out of 91 residues.
The NMR and X-ray crystallography studies have shown that Ca2+ binding to apo-S100A12 induces
significant conformational rearrangement to the protein tertiary structure, especially in helices II and III
(Figure 3.1 B).213,191 This conformational rearrangement is evident in the 1H, 15N HSQC spectra of calcium
bound S100A12, which indicates significant perturbations in the amide resonances relative to the
apoprotein. We also demonstrated from acquiring 1H,

15

N HSQC spectra of Ca2+-S10A12 in the pH range

of 4.5 to 8.3 that calcium binding to S100A12 is kept under these conditions (Figure 3.5) since we did not
detect resonance corresponding to the apoprotein form.
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Figure 3.5: A) Overlay of 14.1 T HSQC spectra of apo (pink) and calcium (green) bound S100A12 at pH
4.5. Plots of 15N amide chemical shift of Ca2+- S100A12 at pH 4.5 vs. B) apo S100A12 at pH 4.5 with
correlation coefficient value of 0.625, and C) Ca2+-S100A12 at pH 7.4 with a correlation coefficient value of
0.987.

We observed significant pH-dependent perturbations for several residues in the 1H,

15

N HSQC

spectra in both apo-S100A12 and Ca2+-S100A12. Observed perturbations in the backbone amide
resonances possibly originated from changes in their local electronic environment. The changes in pH
conditions might be responsible for perturbations induced by changes of the side chain of charged residues
protonation/deprotonation states or conformational changes.

3.4.3 The metal binding to apoprotein is inhibited at low pH
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Figure 3.6. pH dependence of Co2+ binding to S100A12 in the presence (blue) and absence (orange) of
Ca2+ shown with a plot of absorbance at 556 nm versus pH at room temperature. At a pH range greater
than 7.3, minor protein precipitation in the Ca2+- S100A12 was observed that interfered with the baselines
of the absorption spectra, introducing irregular absorption maxima under these conditions.

Co2+ acting as surrogate probe binds to the zinc-binding His3Asp motif and exhibits an electronic
transition at 556 nm.173 We can use this electronic transition to probe Zn2+ binding to S100A12 at different
pH conditions. It had been reported that Zn2+ binds to S100A12 with nanomolar binding affinity at neutral
pH conditions.173 Optical transition at 556 nm observed with the addition of one equivalent of Co2+ to apoS100A12 at pH 7.0 is in stoichiometric agreement with the amount of the protein used. We conducted a
pH titration of the Co2+-S100A12 complex by gradually increasing the pH of the solution to pH 10.4 and
monitoring optical absorbance, as shown in Figure 3.6 (orange trace). In the pH range of 7.0–10.4, we
did not observe a change in the 556 nm absorbance. This demonstrates that the metal-binding affinity
stays unchanged under neutral to alkaline pH conditions. Then we gradually decreased the pH of the
solution to pH 3.4. In the pH range between pH 5.3 -7.0, incremental lowering of pH demonstrated gradual
loss of the 556 nm absorbance. Negligible absorbance was observed in the pH range between pH 5.3 3.4, suggesting complete loss of metal-binding under these pH conditions.
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3.4.4 Calcium-binding restores the metal affinity at low pH

It has been reported that the binding affinity of Zn2+ to S100A12 is improved with calcium-binding.173
Similarly to apo-S100A12, we monitored pH-dependent zinc binding to calcium-loaded S100A12, using
spectroscopically active Co2+ surrogate to Zn2+ (Figure 3.6). A minor amount of precipitation at pH values
greater than 8.0 was observed, unlike the apoprotein, presumably from insoluble calcium salts. This
precipitation interfered with the baseline of the absorption spectra, as shown in Figure 3.6 (blue trace).
Therefore, we focused our investigation and analysis of titration results below pH 7.0. The optical
absorption spectrum of Co2+-S100A12 in the presence of the calcium stays the same as when we add one
equivalent of the Co2+ to apo-S100A12 at pH 7.0, which gives a 556 nm optical transition that is in
stoichiometric agreement with the amount of protein added to the sample. Our pH titration of the Ca2+S100A12 experiment, as shown in Figure 3.6 (blue trace), revealed that S100A12 can retain Co2+ binding
until to pH as low as pH 5.7 in the presence of calcium loading. These results, documented for the first
time in literature on the S100 proteins of the innate immune system, demonstrate that viable pH range for
sequestration of nutrient metal ions is indeed extended in the presence of calcium and in contrast to
apoprotein that shows the loss in the metal-binding under pH 7.0, S100A12 can retain Co2+ binding down
to pH 5.7 in the presence of calcium ions. In the pH range below pH 5.7, even in the presence of calcium,
protein starts to demonstrate diminished Co2+ binding affinity and gradually loses Co2+ binding in the pH
range of 5.7 – 5.0 (Figure 3.6). As we decrease pH below 5.0, only a negligible metal binding can be
observed in the presence of one equivalent of Co2+.
The metal binding motif of S100A12 consists of three histidine residues (H15, H85, and H89). Sidechain protonation of one or more of these histidine residues could be potentially responsible for the origin
of observed metal-binding pH-dependent behavior in the presence and absence of the calcium loading.
There are three possible tautomer forms the imidazole ring of histidine residues in polypeptide chains can
take: the protonated imidazolium and two neutral tautomeric forms (Nδ1H and Nε2H). The local electronic
environment can significantly impact the pKa of the titratable nitrogen atoms in the histidine imidazole ring.
For example, the literature value of pKa of the histidine in small peptide has pKa around 6.0. In contrast,
pKa values of histidine residues in the protein environment range between pH 3 and 10.222-227 The
protonatable nitrogen atoms of the imidazole ring of histidine residues induce metal ligation, and the
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protonation of these nitrogen atoms can inhibit metal binding. It is possible that calcium loading of
S100A12 can change the pKa values of histidine residues, promoting increased Zn2+/Co2+ binding at lower
pH values than protein in the absence of calcium. If the loss in Co2+ binding at low pH-values below pH
7.0 originates from the protonation of coordinating histidine residues in the metal-binding motif, then the
pH titration curves in Figure 3.6 suggest average pKa values of 5.2 and 6.3 for Ca2+ - and apo-S100A12,
respectively. All of this can indicate that despite the presence of two structurally distinct Ca2+ and Zn2+/Co2+
binding sites in S100A12, Ca2+ binding can modify Zn2+ binding to protein by modifying the apparent pKa
values histidine residues coordinating metal ion. To test this hypothesis, we established the protonation
states of imidazole rings of metal-binding histidine residues for both apo and Ca2+-S100A12 with NMR
spectroscopy at biologically relevant pH values of 6.0 and 7.5. The results are presented below.
3.4.5 The protonation state of histidine residues in apo and Ca2+-S100A12

While the crystal structures of both Ca2+ bound and apo-S100A12 had been presented in the
literature,117,213 these crystal structures do not have the resolution to resolve the protonation states of
titratable amino acids of interest. Instead of crystallography, we went to NMR spectroscopy to determine
the protonation states of histidine residues forming metal-binding motifs in S100A12. The rapid exchange
of the protons bonded to imidazole nitrogen atoms with solvent water molecules does not allow us to
observe these protons in 1H,

15

N HSQC NMR spectra. Instead, non-exchangeable aromatic protons (Hε1

and Hδ2) bound to Cε1, and Cδ2 carbon atoms can be resolved through 2JN-H coupling in long-range (LR)
1

H, 15N HMQC correlation spectra.217 We can use the intensities and the cross peak patterns observed in

1

H,

15

N LR-HMQC NMR spectra217-219 to resolve the tautomeric forms of histidine residues as shown in

Figure 3.2. The protonation state of imidazolium in histidine demonstrates that Nδ1 and Nε2 nuclei have
chemical shifts around 176 and 173 ppm, respectively, as shown in Figure 3.2. The neutral state of
imidazole demonstrates that Nε2H tautomer has Nδ1 and Nε2 chemical shifts around 249 and 164 ppm
respectively, while in Nδ1H tautomer, this pattern is reversed217-219 as shown Figure 3.2. The chemical shift
data corresponding to histidines from 1H, 15N LR-HMQC experiment collected in Table 3.1.
There are six histidine residues present in the S100A12 polypeptide chain. Of these six residues,
three (His15, His85, and His89) form the Zn2+ /Co2+ His3Asp metal-binding motif, and the other three (H6,
H23, and H87) do not participate in metal binding. Figure 3.7A demonstrates 1H,
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15

N HMQC spectra of

apo- S100A12 at pH 7.5 and 6.0. We can observe four out of six histidine side-chain resonances
originating from histidine residues in S100A12 at pH 7.5 (Figure 3.7A orange pattern). We presume that
the loss of the resonances from two other residues is due to signal broadening from the conformational or
fast chemical exchanges. The analysis of the cross peak pattern formed by observed four histidine
resonances and the Nd1 chemical shifts around 220 ppm suggests the presence of the neutral Nε2H
tautomeric form.
On the contrary, resonances originating from all S100A12 six histidine residues are observed when
we decrease the pH to 6.0 (Figure 3.7A blue pattern). The cross peak pattern with a

15

N chemical shift

between 170–190 ppm points out imidazolium form in all histidine residues. No neutral states of the
histidine residues were observed at pH 6.0.
As with apo-S100A12 at pH 7.5, the 1H, 15N HMQC spectrum of Ca2+-S100A12 demonstrates cross
peak patterns related to four out of S100A12 six histidine residues, while also same as with apoprotein at
pH 6.0, the resonances of all six histidine residues can be observed (Figure 3.7B). The neutral Ne2H
tautomeric form of imidazole rings of all observed histidine residues are seen at pH 7.5 (Figure 3.7B
orange pattern). Surprisingly, contrary to the apo-S100A12 at pH 6.0, the cross peak pattern
demonstrates that two histidine residues are present in neutral Nε2H form. In contrast, the rest four histidine
residues are present in protonated form. Once we established the tautomer forms of the histidine residues,
we needed to determine the identity of histidines binding metals. We performed additional 3D NMR
experiments that helped assign observed histidine resonances in the 1H,

15

N HMQC spectrum and site-

specific identification of imidazole ring of histidine protonation states in Ca2+-S100A12 at pH 6.0 (reported
below). The assignments established that at pH 6.0, the metal-binding histidine residues (H15, H85, H89)
and H87 exist in the protonated state (Figure 3.7B blue pattern). The residue H6 exists in neutral Nε2H
tautomeric form, and the protonation state of H23 residue cannot be explicitly determined. The equilibrium
between the protonated and neutral tautomers in H23 may be the origin of the exhibited line broadening
of signal from H23. Altogether, we determined that histidine residues forming His3Asp metal-binding motif
are all in the protonated form at pH 6.0, both in the absence and presence of Ca2+ loading, which suggests
that Ca2+ to S100A12 does not modify the side chain pKa of metal-binding histidine residues. These results
suggest that the effect of calcium addition to S100A12 on Zn2+ binding is not regulated by changes in the
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electronic environment of metal-binding histidine residues.

Figure 3.7. 1H, 15N HMQC spectra showing the tautomeric forms of histidine residues in A) apo (16.8 T),
and B) Ca2+-S100A12 (14.1 T) at pH 7.5 (orange) and pH 6.0 (blue). The cross peak patterns belonging
to a single residue are marked with colored boxes.
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Table 3.1: Side-chain chemical shift data of histidine residues from 1H,15N HMQC spectra in apo (16.8 T)
and Ca2+-S100A12 (14.1 T) at pH 6.0 and 7.5, (nd - non-determined, nd* - non resolved)

3.4.6 Side-chain resonance assignment for Ca2+-S100A12 at pH 6.0

To assign histidine side-chain resonances observed in 1H, 15N LR-HMQC spectra, we performed
3D (HB)CB(CGCD)HD, HN(CO)CACB, and HNCACB measurements (Figure 3.8). With the help of
HN(CO)CACB and HNCACB spectra, we established a correlation between Cβ nuclei and the backbone
amide (Figure 3.8C), and both (HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE established a correlation
between Hδ2/Hε1 and Cβ nuclei (Figure 3.8B). Then, based on previously recorded backbone
assignment,119 we assigned side-chain resonances for the histidine residues in 1H,

15

N LR-HMQC. While

the resonances from H87 and H89 were not separated in the spectra, we were able to indirectly assign
N-NOESY HSQC spectrum (Figure 3.8D). Table 3.2 has the

these residues with the help of the 1H,

15

assignments of resonances in the 1H,

N LR-HMQC spectrum, including tautomeric forms of S100A12

15

histidine residues. A similar strategy was attempted to assign histidine residues in Ca2+-S100A12 (pH 7.5)
and apo-S100A12 (pH 7.5 and 6.0). Unfortunately, unresolved assignments cannot be established for both
these states of the protein and pH since the absence of clear resolution in direct

13

C dimension of 2D

(HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE experiments. Although the assignments are not available
for the histidine side chains of both calcium bound (pH 7.5) and apo S100A12 (pH 7.5 and 6.0), it is not
critical for our investigation since we can see that with or without calcium, all six histidine residues in an
S100A12 polypeptide chain are in protonated tautomeric form at pH 6.0 and exhibit neutral Nε2H tautomeric
form at pH 7.5. Thus, although we could not make all site-specific histidine residue assignments, our
results demonstrate that calcium binding to S100A12 does not alter the protonation of the histidines of the

69

metal-binding motif. They are present in the protonated and the neutral states at pH 6.0 and 7.5,
respectively, respectively, both in the absence and presence of calcium.

Figure 3.8: 2D and 3D 1H,

15

N,

13

C experiments performed for the assignments of histidine residue side-

2+

chain nuclei of Ca -bound S100A12 at pH 6.0. A) 1H, 15N LR-HMQC; B) 2D 1H, 13C (HB)CB(CDCGCD)HD;
C) A strip plot of the 3D HN(CO)CACB (blue) and HNCACB (red) spectra; D) A strip plot of the 1H,

15

N

NOESY HSQC (orange) spectrum. Resonances associated with a residue are labeled and marked with the
same color across all spectra.
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Table 3.2: Side-chain resonance assignment of histidine residues in Ca2+-bound S100A12 at pH 6.0.

3.4.7 pH-dependent chemical shift perturbations in apo and Ca2+-S100A12

We monitored Cα and NH chemical shifts in the presence and absence of calcium at multiple pH
conditions to quantitatively determine the fluctuations in the backbone conformation due to changes in
pH. Although several factors will affect the local electronic environment of backbone amide nitrogen nuclei
to induce perturbation in NH chemical shift, it is a

13

Cα chemical shift associated strongly with protein

backbone conformation.228 We used the standard triple-resonance experiments described in a method
section to conduct a backbone chemical shift assignment for Ca2+- and apo-S100A12 at pH 7.0 and 6.0.
Figure 3.9 demonstrates calculated chemical shift perturbations (CSP). These two pH values are chosen
because they reflect two observed metal-binding behaviors: protein loses Ca2+ binding when pH changes
from pH 7.0 to 5.3 in the apoprotein. At the same time, the addition of calcium restores metal binding
affinity up to pH 5.7. Thus, the pH values from 6.0 to 7.0 represent both conditions under which Ca2+
loaded S100A12 preserves metal sequestration while the apo-S100A12 demonstrates a loss in metal
chelation.
The CSP data shows that most of the residues in apo-S100A12 do not have large perturbations of
both NH and Cα nuclei. However, residues in the C-terminal helix IV demonstrated CSP larger than 0.4
and 0.2 ppm for NH and Cα nuclei, respectively. This region of the protein polypeptide chain has three zincbinding histidine residues. The loop's residues (22-29) before helix II also show large CSPs. Also, these
residues are located in the calcium-binding EF-1 hand motif of the protein (Figure 3.1), which has
Co2+/Zn2+ binding D25 residue also participating in the calcium coordination. Collected data suggest that
conformation around the metal-binding His3Asp motif (H15, D25, H85, and H89), together with calcium-
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binding EF-1 hand loop, is indeed altered during pH changes. Similar to the apo-S100A12, the polypeptide
chain in the Ca2+-S100A12 demonstrates major perturbation in Helix IV on the same scale as in apoprotein
and minor perturbation in the rest of the polypeptide chain. The difference is that residues of the EF-1
hand, which has D25, do not demonstrate large perturbations as in the apoprotein. The above conclusions
can be made since most of the residues were assigned even if the EF-1 hand missed some assignments.

Figure 3.9. Site-specific absolute values of CSP between pH 7.0 and 6.0 for A) Cα and B) NH nuclei in
the absence (red) or presence (blue) of Ca2+. The negative values represent these residues for which
resonance assignments are not available. The secondary structure of the apoprotein determined from
the crystal structure (PDB ID: 2WCF) is displayed at the top: α-helices (blue bars), β-strands (red
arrows), and loop regions (cyan lines). The values of 1.38 and 3.33 in panel B refer to CSPs larger than
the plot's displayed range.
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3.4.8 Secondary structure propensities of apo and Ca2+-S100A12

Figure 3.10. SSP based Cα and NH chemical shifts at pH 6.0 (blue) and 7.0 (red) for A) Apo-S100A12
and B) Ca2+-S100A12. The secondary structure of the apoprotein determined from the crystal structure
(PDB ID: 2WCF) is displayed at the top: α-helices (blue bars), β-strands (red arrows), and loop regions
(cyan lines).
From the observed CSPs, it is reasonable to suggest that these perturbations are coming from pHproduced variations in the secondary structure of S100A12 (Figure 3.9). To investigate this effect of pH
variations on the secondary structure of the protein, we calculated secondary structure propensities (SSP)
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for S100A12 at both pH 7.0 and 6.0 in the absence or presence of calcium. Figure 3.10 has these SSP
values plotted against the protein residue numbers. From Figure 3.10, SSP values observed for all four
helixes in both apo and Ca2+-S100A12 show no significant pH-induced variations. This suggests that
changes in pH level do not alter the majority of the secondary structure composition in the protein. Even
though protein SSPs are not affected by changes in pH, the secondary structure of the calcium-binding
loop (residues 22-29), which belongs to the EF-1 hand motif, shows a difference when comparing SSPs
of both the Ca2+- and apo-S100A12. This part of the EF-1 hand demonstrates a coil-like secondary
structure in the absence of calcium loading. In contrast, when the calcium is added, these residues
demonstrate a β-strand conformation (Figure 3.10). From the above overall findings, in the discussion
below, we will go over the role of the EF-1 hand loop and how is calcium modulated Co2+/Zn2+ binding to
S100A12 is originated from the secondary structure of the EF-1 hand loop.

3.4.9 Evaluation of Co2+ binding to S100A12 with SEC

We conducted a size exclusion chromatography (SEC) to evaluate the formation of oligomers upon
adding the various metal ions to protein and compare Zn2+ binding with Co2+ binding since we use cobalt
ion as the spectroscopically active probe. One equivalent of divalent metal ion (Co2+), Zn2+), Cu2+ and
Cd2+) was added per monomer, and the results are presented in Figure 3.11. Cobalt and zinc bound
S100A12 eluted at 56.5 ml, which corresponds to 56 kDa molecular weight, based on the calibration of
the gel filtration column used in these experiments. Therefore, cobalt binding generates oligomers with
the same size as Zn bound S100A12 and most likely have a similar binding affinity to S100A12. However,
copper and cadmium do not induce oligomerization compared with cobalt due to lower metal binding
affinity. Therefore, cobalt can be used as a surrogate for zinc binding to S100A12.
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Figure 3.11: SEC analysis of 100 μM S100A12 titrated with 1.0 equivalent of different transition metals at
pH 7.5.

3.4.10 pH-dependent electronic environment of the metal-binding site

To understand the electronic environment and coordination geometry around the metal-binding site
of S100A12, we conducted EPR characterization of cobalt bound S100A12 in the presence and absence
of calcium at different pH conditions. Our SEC experiments showed that Co2+ binds to S100A12 to form
oligomers (Figure 3.11). Also, UV-Vis measurements demonstrate the formation of the Co2+-S100A12
complexes showing optical absorbance at 556 nm (Figure 2.3). Since Co2+ is a paramagnetic species, we
can use this metal as a paramagnetic probe substituting diamagnetic zinc to study different oligomeric
forms of S100A12.
EPR spectroscopy detects transitions between spin states of unpaired electrons. Only systems with
net electron spin angular momentum can be analyzed by EPR spectroscopy.231 The presence of the
magnetic field will lift the degeneracy of the spin states of unpaired electrons that can be observed
experimentally in the form of spectra.
The analysis of the EPR spectra based on the spin Hamiltonian for Co2+ with paramagnetic spin S = 3/2:
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where D is the axial, and E is the rhombic parameter of zero-field splitting, g is the g-tensor, S is spin
angular momenta, B is the external magnetic field strength, 𝛽𝛽 is Bohr Magneton constant, A is the
hyperfine tensor, and I is the nuclear spin.231

Well resolved EPR spectrum can be analyzed with computer simulation to characterize the metal
center. In our experimental approach, we studied the interactions of the electron spins of the Co2+ ions
with their coordinative environment to obtain structural and electronic information about the S100A12
metal-binding scaffold using continuous wave (CW) EPR methods. The CW EPR spectra of our prepared
samples are recorded by exposing the samples to a microwave radiation field of constant frequency while
applying a sweeping external magnetic field until the resonance condition is fulfilled. EPR spectra of Co2+
can be described by electronic parameters of the metal center232 derived from the spin Hamiltonian
described above. The g-tensor reflects the contributions of the spin-orbit coupling to the g-values of the
metal center. E parameter describes the rhombic distortion, with E/D = 1/3 as the limiting value. The Dtensor represents the zero-field splitting of the magnetic doublets and describes the axial distortion.233
We performed EPR measurements at pH 7.5 and 6.0 to observe how different pH influence
geometry at the metal-binding site. The resulting EPR spectra are presented in Figure 3.12. The EPR
spectra Co2+-S100A12 complex shows resonances at g = 6.11, 2.54, and 1.79, which indicates that bound
cobalt is in a high spin (S = 3/2) state (Figure 3.12a). Upon adding calcium to the Co2+-S100A12 complex,
we observe changes in resonances (g = 6.53, 1.92) (Figure 3.12b) indicative of changes in the geometry
of the metal-binding site. At pH 6.0, cobalt has a low binding affinity to the S100A12, as shown from UVVis experiments (Figure 3.6). The addition of the calcium at pH 6.0 restores the binding affinity of cobalt
to S100A12. EPR spectrum of Ca2+-Co2+-S100A12 at pH 6.0 and 7.5 (Figure 3.12b and Figure 3.12c)
are identical, demonstrating that the geometry of the metal ion in the Ca2+ bound form is not altered by
pH. From the apparent g values, we can determine that the EPR spectrum demonstrates rhombic
symmetry.
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3.5 Discussion

Even minor pH variations induce noticeable changes in the amide backbone chemical shifts
throughout the whole S100A12 polypeptide chain, as demonstrated by 1H,

15

N HSQC spectra (Figure

3.13). The CSPs observed in Figure 3.13 demonstrate that conformational changes are pH-dependent.
Also, HSQC NMR measurements demonstrated that in pH range 4.5 to 8.0, the tertiary structure of
S100A12 stays folded both in the presence and absence of Ca2+. Although it seems that pH values in the
neutral range are best to describe in vivo cellular conditions, clinical reports show that pathogen invasion
induces extracellular acidosis during which human neutrophils overexpress and secrete S100A12.215,216
The extracellular acidosis can lead to conditions when the extracellular milieu can fall to pH 5.5. Therefore,
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metal sequestration by S100A12, which is relevant to its antimicrobial functions of innate nutritional
immunity, is necessary to be researched at pH conditions below of these of normal extracellular space. At
pH 7.0, S100A12 exhibits high Zn2+ sequestration affinity, enhanced with calcium ion binding.173 Our
results demonstrated that while the secondary structure of S100A12 is resistant to changes in the range
of pH 4.5 – 10.4, the metal-binding efficiency of protein in the absence of the calcium greatly decreased
in the range of pH 5.3–7.0. However, adding calcium can preserve Co2+/Zn2+ chelation when we decrease
pH up to pH 5.7. Bellow pH 5.7 protein losses metal-binding even when calcium loaded.

Figure 3.13. Combined site specific

15

NH and 1H CSPs for apo- S100A12 as at different pH conditions.

Top: CSP between pH 6.15 and 6.0 (yellow); CSP between pH 6.40 and 6.15 (red); CSP between pH 6.63
and 6.40 (blue). Middle: CSP between pH 6.90 and 6.63 (yellow); CSP between pH 7.17 and 6.90 (red);
CSP between pH 7.41 and 7.17 (blue). Bottom: CSP between pH 7.55 and 7.41 (yellow); CSP between 8.0
and 7.55 (red); CSP between pH 8.29 and 8.00 (blue).
At the neutral pH conditions, apo-S100A12 demonstrates strong nanomolar zinc ion binding affinity,
making it difficult to evaluate the biological role of calcium-binding at neutral pH in the protein’s antimicrobial
function. The extracellular space has a high concentration of Ca2+ and released by neutrophils S100A12
will participate in Zn2+ homeostasis in the calcium bound form and not us apo. Our investigation presents a
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reasonable explanation of how calcium binding affects the metal sequestration functions to S100A12. We
propose that when neutrophils are activated by extracellular acidosis, S100A12 is secreted into extracellular
space or serum participates in the antimicrobial activities experiencing pH conditions in the sub-neutral
range pH 5.5-6.0. The apo-S100A12 would not be efficient in its metal chelating function at this pH range.
However, thanks to the high concentration of calcium in the extracellular space, S100A12 exists in the
calcium loaded stated upon secretion. Contrary to the apo-S100A12, calcium-loaded protein can still
efficiently bind zinc ions in sub neutral pH range of pH 5.5–6.0 and therefore execute its antimicrobial
functions.
Also expressed and released by neutrophils S100A8/A9 and S100A12 constitute around 50% of
all cytoplasmic protein in neutrophils. S100A8/A9 heterodimer also participates in the sequestration of
various transition metal ions through the His3Asp metal-binding motif, identical to S100A12 and His6 motif.
The His3Asp motif in S100A12 and S100A8/A9 shows significant resemblances, and both include aspartic
residue of the calcium-binding EF-1 hand motif.229 Also, as in S100A12, calcium-binding enhances the
nanomolar Zn2+ binding affinity of S100A8/A9.113. Both S100A12 and S100A8/A9 are similar in zinc
sequestration, and we suggest that both have a similar metal-binding regulation by pH variations. Therefore,
we suggest a general mechanism used by neutrophils after activating the immune system when metal
sequestration is pH-depended and modulated by calcium loading of the expressed and secreted proteins.
Below we discuss the Ca2+ mediated enhancement mechanism of Zn2+ binding to protein during pH change.
Figure 3.6 shows apparent binding affinities of the S100A12 to Co2+ in the presence and absence
of calcium and how Co2+ binding to protein depends on pH with calcium extending the metal-binding pH
range. There are two logical explanations of how calcium tunes Co2+ binding to S100A12. First, we can
reasonably suggest that Kd for Co2+/Zn2+ metal-binding His3Asp motif not affected by variations of pH and
observed differences in apparent Kd during pH titration with or without the addition of calcium comes from
the changes of the side chain pKa histidine residues from the metal-binding site. Due to the protonated
imidazole rings of three histidine residues (H15, H85, and H89), the metal-binding motif in S100A12 can
respond to pH variations, especially since side chains of the histidine residues in various protein
environments have pKa values in the range of 3-10. Therefore, while calcium binding to S100A12 may not
change the Kd of the metal-binding motif, it can change the pKa of the histidine side chains. This will result
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in different protonation states of the coordinating histidine residues and observed differences in the metalbinding affinity between Ca2+- and apo-S100A12. However, the results of the

1

H,

15

N LR-HMQC

measurements demonstrated the tautomeric states of the histidine residues, which do not support our first
hypothesis. As observed in the 1H, 15N LR-HMQC spectra, all resolved histidine residues at pH 7.5 have a
neutral tautomeric state for both calcium bound and apo-S100A12 (Figure 3.7). From the pH titration curves
presented in Figure 3.6, the histidine apparent pKa values are 5.2 and 6.3, respectively, for S100A12 in
the presence and absence of calcium. If we assume pKa of 6.3, at pH 6.0, apoprotein will have a near equal
concentration of the protonated and neutral tautomers. However, 1H,

15

N HMQC measurements of

apoprotein (Figure 3.7A) show no presence of the neutral tautomers, and all histidine residues exist in
protonated tautomer state.
The restoration of protein’s ability to bind metals at pH 6.0 in the presence of calcium predicts the
dominant presence of the neutral tautomers in Ca2+-S100A12. Similarly, assuming a pKa value of 5.2 for
the histidine residues binding to metals in Ca2+-S100A12, we would expect a six times greater concentration
of the neutral tautomers than protonated tautomeric forms at pH 6.0. This hypothesis is also disproved by
1

H, 15N HMQC measurements demonstrating that all metal-binding histidine residues in Ca2+-S100A12 are

similar to the apo form present in a protonated tautomeric form (Figure 3.7B). These experimental results
suggest that the point of inflection observed in metal binding curves from the pH titration experiments does
not originate from the protonation of metal coordinating histidine residues. It does not explain the origin of
metal-binding loss.
The second possible explanation for the observed effect of the calcium-binding to S100A12 on
metal sequestration in the sub-neutral pH range is that this calcium-binding changes the inherent metal
binding affinity of the Zn2+ motif. We propose that calcium binding to protein promotes structural variations
to the metal-binding motif. To test our hypothesis, we analyzed CSPs of the specific residues during pH
titration in the absence of calcium. For CSPs, we choose data from 1H, 15N HSQC measurements at pH 6.0
and 7.0. In the range of these pH values, apo-S100A12 demonstrates a gradual decrease in Co2+ binding,
while at the same time, Ca2+-S100A12 can retain Co2+. Also, this pH range is functionally relevant since
extracellular acidosis during pathogen invasion triggers neutrophil activation.215,216 Most residues in helix
IV are reported large CSPs in both calcium loaded and without calcium samples (Figure 3.9). Helix IV
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contains two histidine residues (H85 and H89) in the Co2+/Zn2+ binding motif. Significant CSP proposes that
pH modulated conformational changes produce the perturbation. Also, it suggests that conformations in
helix IV of S100A12 are not modulated by calcium-binding.
The residues of the calcium-binding EF-1 hand motif exhibit noticeably different CSPs for Ca2+S100A12 and apo-S100A12. The calcium-binding induces minor pH-dependent CSPs in the EF-1 hand
loop (Figure 3.6). On the other hand, we can observe large perturbations in this EF-1 hand loop in the apoprotein. This loop includes Asp25, which also participates in metal binding, and the addition of calcium to
protein can exert specific structural restraints to Asp25. Our results discovered that adding calcium to
S100A12 reduces pH-induced conformational changes to the EF-1 hand loop. This minimization of
perturbations can, in turn, give specific structural stability to the metal-binding motif through Asp25.
Therefore, calcium-binding regulates the pH-dependent metal binding by S100A12.
Furthermore, our EPR experiments demonstrated that the addition of calcium to S100A12 changes
the geometry of the metal-binding site (Figure 3.6). At pH 6.0, Ca2+, Co2+-S100A12 showed identical EPR
spectra as Ca2+, Co2+-S100A12 at pH 7.0. Both pH metal-binding sites have rhombic symmetry, reflecting
magnetic moments' nonsymmetrical distribution.
Secondary structure propensities (SSP) analysis demonstrated that while conformational
perturbations during pH variation do not change the secondary structure of S100A12, binding of calcium
had induced a β-strand conformation for selected residues in EF1 hand loop (D25-L27). In the apoprotein,
these residues occupy a coil-like structural configuration. The β-strand conformation of these residues
induced by adding the calcium to the protein is prevented from disruption by pH variations (Figure 3.10).
This β-strand conformation in the calcium-loaded S100A12 may introduce necessary structural constraints
critical to enhancing zinc binding affinity. On the other hand, in the apoprotein, as shown from CSP analysis,
the coil-like configuration is sensitive to pH-induced conformational changes (Figure 3.9). Therefore, we
propose that while in the absence of Ca2+, EF1-hand loop residues are in the flexible coil conformation and
are sensitive to pH changes. Adding calcium to protein promotes β-strand structural conformation,
producing necessary structural resistance from pH variations. This structural resistance expands the metalbinding pH range below pH 7.0.
These results explain how calcium binding to S100A12 plays an essential role in antimicrobial activity.
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The presence of calcium at the high concentration in the extracellular space can help the S100A12 conduct
antimicrobial functions at the site of the pathogen invasion in the conditions of the extracellular acidosis by
extending the biologically relevant pH range for Zn2+ sequestration. Our previous report demonstrated the
structural perturbations in S100A12 induced by binding to metal ions of zinc and calcium to apoprotein at
pH 7.0.119 We determined that zinc binding induces specific structural changes in helix II which is also part
of the calcium-binding EF1 hand motif. The results reported here suggest further investigations of the effect
of pH variations on the zinc-bound S100A12 using solid-state NMR spectroscopy. We predict that new data
will provide a new understanding of structural changes depending on pH variations.
3.6 Conclusion

S100A12 is a member of the S100 family of calcium-binding proteins and exhibit high nanomolar
Zn2+ binding affinity under neutral pH conditions. The zinc sequestration function allows S100A12 to have
an important role in the innate immune response to microbial invasion. Also, we know that Zn2+ metal
binding affinity is enhanced by calcium binding to protein two calcium-binding motifs. The exact mechanism
of this enhancement is not clearly understood. We demonstrated that S100A12 loses its metal-binding
affinity when we decrease pH below 7.0 even though protein has a strong affinity to metals at neutral pH.
Adding calcium to protein allows extending the metal-binding pH range to pH 5.7. Therefore, calciumbinding has two roles: it improves zinc binding affinity to S100A12 and enhances zinc sequestration in the
sub-neutral pH range. We propose that this biologically important role of calcium could be the evolutionary
response of the host organism to adapt to the cellular acidosis at the site of the infection. Without calcium
at sub-neutral pH conditions of cellular acidosis, S100A12 will not be efficient in its antimicrobial function.
By recruiting calcium to restore the metal binding affinity during conditions of cellular acidosis, the host
organism can combat infections efficiently. The calcium-binding role might also be observed in other S100
proteins participating in the innate immune system, such as the S100A8/A9 complex. We show that the
protonation state of the imidazole rings of zinc-binding histidine residues is not responsible for the observed
differences in metal binding between apo and calcium loaded protein below pH 7.0. Instead, we discovered
that reason for these differences originates from the introduction of β-strand conformation to noncanonical
S100 specific EF1 calcium-binding motif by calcium loading. This β-strand provides a necessary structural
resistance from conformational changes due to pH variations.
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Chapter 4 - S100A12 C-terminal residues exhibit control of the protein oligomerization
4.1 Abstract

We started an investigation of the role of C-termini in the S100A12 oligomerization. Zinc binding
induces structural changes in protein, which should be considered an essential part of the mechanism of
action of S100A12 in human immune system response and inflammatory pathways. The residues at the Cterminal of the oligomeric assemblies exhibit significantly increased α-helical propensity suggesting an
extension of helix IV upon zinc binding. Therefore, we prepared several mutants by deleting or substituting
several C-terminal residues. We further conducted size exclusion chromatography (SEC), UV-Vis, and
NMR experiments to gain insight into the role of these residues in oligomerization. The SEC results show
that mutation of the C-terminal residues causes the S100A12 to be less prone to oligomerization. NMR
measurements show that zinc-bound protein also has less of an oligomeric profile than wild type. These
results demonstrate the importance of the C-terminal residues for the function of the S100A12, and more
studies are needed to gain insights on the artificial promotion of the higher oligomeric states locked even
in the absence of the zinc ions.
4.2 Introduction

Before, we had suggested that it would not be proper to consider S100A12 to exist in specific
discrete tetrameric or hexameric oligomeric forms but as a protein concentration-dependent continuum.119
On the other hand, our analytical ultracentrifugation analysis demonstrated that adding zinc ions to protein
is two orders of magnitude more effective than calcium addition in inducing S100A12 self-assembly.119 This
somehow contradicts to observed crystal structures of the S100A12 hexamers only in the presence of the
calcium181 when it is necessary for zinc to co-participate to achieve this high level of self-assembly. This
self-assembly regulation by both metals is extremely biologically important as high-order oligomers of
S100A12 were determined to participate in cellular signaling84,184,187,188,190,234-236 through interaction with
various membrane receptor targets by the initiation of the proinflammatory signaling downstream cascade.
The above discussion of the self-assembly of S100A12 is essential given the clinical importance of the
protein. It had been found that in the case of autoinflammatory diseases, often S100A12 was found to be
overexpressed.178,237,238 The level of S100A12 is now routinely clinically monitored during therapy as a
biomarker for diseases and cancer.178,237,238 It was reported that the plasma level of zinc during
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autoinflammatory diseases dramatically exceeds the level of zinc in healthy organisms, which is the
opposite of the zinc level during normal inflammation resulting from infection.52,239,240 It is evident that this
high zinc concentration during autoinflammatory diseases induces the formation of the high oligomeric
forms of the S100A12, which in turn induces proinflammatory signaling in the absence of the infection.
Therefore, we propose the strategy to lock the confirmation of the S100A12 to prevent its oligomerization.
Our previously reported work determined that upon zinc binding, the residues at the C-terminal of the
oligomeric assemblies exhibit significantly increased α-helical propensity suggesting an extension of helix
IV. We propose that these residues are important for protein self-assembly, and by affecting these residues
through mutations, we can prevent S100A12 from forming high-level oligomers.

4.3 Materials and Methods

4.3.1 Production of the recombinant S100A12 and its variants
In a previous publication, we had shown that residues at the C-terminal exhibit significantly increased
α-helical propensity upon metal binding.119 Therefore, to study the role of the residues at the C-terminal
region in the oligomerization of the S100A12, we introduced several mutations in this region. The mutated
residues are located in the vicinity of the two residues participating in metal binding (H85 and H89) at the
C-terminal. The first mutant (AAA90Stop_A12) had three residues at the C-terminal substituted by alanines
(Y86, H87, and T88), and the last residue, E91, was deleted. The second mutant (88A_91A_A12) had T88
and E91 substituted by alanines. The third mutant (90Stop_A12) had only the last residue deleted. The
fourth mutant (86A_87A_88A_A12) had three residues substituted by alanine residues (Y88, H87, and T88)
without deleting E91 (Table 4.1). We argue that the helix IV conformation changes could affect the protein's
oligomerization while retaining the metal binding. Therefore, we can learn more about the role of helix IV in
oligomerization. All mutants had been expressed and purified using a previously reported protocol for the
overexpression and purification of wild type S100A12.119
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Table 4.1. S100A12 C-terminal mutants.
Mutant Name
Mutated Residues

Deleted residues

AAA90Stop_A12

Y86A, H87A, and T88A

E91

88A_91A_A12

T88A, E91A

none

90Stop_A12

none

E91

86A_87A_88A_A12

Y86A, H87A, and T88A

none

4.3.2 Size Exclusion Chromatography (SEC) of S100A12 mutants
Concentrated stocks of S100A12 variants were diluted to 100 µM concentration. Protein concentration
was determined spectroscopically by monitoring the 280 nm band (ε = 2980 M-1 cm-1). The holo-S100A12
variants were prepared by the addition of four equivalents of Zn2+ samples were loaded into HiLoad 16/600
Superdex 75 prep grade gel-filtration (GF) column (GE Healthcare Life Science) connected to an ÄKTA
FPLC (Amersham Pharmacia Biotech) instrument. The GF column was equilibrated with 50 mM Tris, 400
µM Zn2+, and 150 mM NaCl buffer at pH 7.5. Flow rate for all Size exclusion chromatography (SEC)
experiments was kept at 1.0 mL/min.
4.3.3 UV/Vis spectroscopy
The sample of AAA90Stop-S100A12 at 0.125 mM concentration was prepared for UV/Vis
spectroscopy. The buffer for the samples was 50 mm Tris, 150 mm NaCl, pH 7.0 buffer. The cobalt was
added to the protein sample stepwise, and Co2+-S100A12 complexes were detected and monitored by
observing the absorbance at 556 nm. All quantification used previously reported molar extinction coefficient
of Co2+-S100A12 complex (ε = 820 M-1 cm-1 for S100A12 dimers).173
4.3.4 NMR sample preparation
Uniformly 15N-labeled samples of AAA90Stop-S100A12 at 0.8 mM concentration for the solution NMR
measurements were prepared in 20 mm HEPES, 150 mm NaCl pH 7.0 buffer or in 20 mm 2-(N-morpholino)
ethanesulfonic acid (MES), 150 mm NaCl at pH 6.0 buffer, with the addition of 10% D2O. 200 mm 4,4dimethyl-4-silapentane-1-sulfonic acid (DSS) was also added to the NMR samples. To prepare zinc-bound
AAA90Stop-S100A12 NMR samples, four equivalents of Zn2+ were added to 0.8 mM apo-protein. For the
NMR samples containing calcium bound AAA90Stop-S100A12, twenty equivalents of Ca2+ were added to
the apo-protein samples.
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4.3.5 NMR Spectroscopy and data processing
We performed 2D 1H−15N HSQC193 solution NMR experiments at 14.1 T (600 MHz) on a Varian NMR
spectrometer outfitted with an HCN cryoprobe and 3D 1H−15N NOESY-HSQC194,195, and 1H−15N TOCSYHSQC197 solution NMR experiment was performed at the New York’s Structural Biology Center (NYSBC)
at 18.8 T (800 MHz) on a standard bore Bruker Avance III HD spectrometer equipped with a 5 mm
quadruple resonance inverse QCI-F cryoprobe. The Larmor frequencies were 599.93, 150.87, and 60.79
MHz for 1H, 13C, and 15N, respectively. 25 °C was maintained for all apo-samples, and 37 °C was maintained
for all samples with added metals through the NMR experiments. The acquired NMR spectra were first
processed with NMRpipe202 and then analyzed with Sparky software203 as reported before119. 2D 1H,
HSQC193, 3D 1H−15N NOESY-HSQC,194,195 and

15

N

1

H−15N TOCSY-HSQC experiments were used for

backbone assignments of Cα and NH.
4.3.6 Chemical Shift Perturbations (CSPs) analysis
To calculate chemical shift perturbations (CSP) for backbone amides between apo- AAA90StopS100A12 and Ca2+- AAA90Stop-S100A12 states we followed formula (1).
4.4 Results
4.4.1 Size exclusion chromatography of C-terminal S100A12 mutants
We conducted a size exclusion chromatography of the C-terminal S100A12 mutants to evaluate
the formation of oligomers upon adding the four equivalents of zinc metal. Data shows (Figure 4.1) the
effects of various mutations on the oligomerization of the protein. It can be determined that the
AAA90Stop_S100A12 mutant has the most profound effect to inhibit oligomerization. There are two
possibilities for this observed restriction of self-assembly. First, the mutant might not bind zinc and cannot
form oligomers. Second, while protein retains the ability to bind zinc, a mutation causes enough structural
changes to C-terminal, so the protein cannot form oligomers. We want to investigate if this mutant retains
the ability to bind zinc by collecting UV-Vis data.
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Figure 4.1. Size exclusion chromatograms of wild type S100A12 and its mutants in the presence of 4
equivalent of Zn2+ at pH 7.5. The column is equilibrated with zinc.

4.4.2 UV-Vis spectroscopy of cobalt binding to AAA90Stop_S100A12 mutant
The binding of the Co2+ to AAA90Stop_A12 mutant had been investigated with UV-Vis at pH 7.0 and
6.0. Our previous SEC data demonstrated that this mutant has the least size change upon the addition of
zinc. Following the SEC experiment, we now investigated if Zn2+ binding was affected. We used the UVVis method to observe if a mutant still binds to cobalt and reaches protein saturation at a 1:1 per monomer
ratio. Our UV-Vis experiment at pH 7.0 had shown that Co2+ binding was not affected by mutation (Figure
4.2). If this is true and if to take SEC data into account, we can predict that mutant disruption of C-terminal,
but not metal-binding suppression decreased the ability of protein for self-assembly.
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Figure 4.2. UV-Vis spectra of cobalt binding to 0.123 mM apo-AAA90Stop-S100A12 at pH 7.0. a) Signal
from the apo-AAA90Stop-S100A12. Cobalt was added to apo AAA90Stop-S100A12 in a step-wise manner.
Protein is saturated with cobalt at the ratio of 1:1. The addition of cobalt (1.3 equivalent) did not increase
absorption at 557 nm.
4.4.3 NMR spectroscopy of apo and Ca2+ bound AAA90Stop-S100A12 mutant

Figure 4.3. 1H-15N HSQC spectra of apo-AAA90Stop_S100A12 (14.1 T).

88

Our previous SEC experiments determined the AAA90Stop mutant (Y86A, H87A, T88A, and E91
deleted) as the best candidate for further investigations. We used several NMR experiments to study this
mutant. First, we obtained 1H-15N HSQC for apo, Ca2+ bound, and Zn2+ bound protein at pH 7.0 at 37 °C.
Second, we assigned residues in these 1H-15N HSQC spectra by conducting 3D 1H-15N-TOCSY-HSQC193
and 1H-15N-NOESY-HSQC194,195. We determined 84 out of 90 backbone assignments for the residues in
the apo mutant (Figure 4.3) and 72 out of 90 backbone assignments for the residues in the Ca2+-bound
mutant (Figure 4.4).

Figure 4.4. 1H-15N HSQC spectra of Ca2+-AAA90Stop_S100A12 (14.1 T).
4.4.4 NMR spectroscopy of Zn2+- AAA90Stop_S100A12
After assigning the mutant’s residues, we looked at how the protein structure of the mutant
responded to the addition of Ca2+ and Zn2+ versus wild-type protein. 1H-15N HSQC of wild-type zinc bound
S100A12 is completely unresolved due to significant broadening as protein forms high order oligomers
(Figure 2.8B). On the other side, the NMR spectra of Zn2+- AAA90Stop_S100A12 mutant show better
resolution (Figure 4.5), which might indicate decreased oligomerization due to mutation (the line across
the spectra at 115 ppm is an artifact from the water signal).
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Figure 4.5. 1H-15N NOESY-HSQC spectra of Zn2+-AAA90Stop_S100A12 at 14.1 T at pH 7.0
4.4.5 Chemical shift perturbations in apo and Ca2+-AAA90Stop-S100A12
We investigated chemical shift perturbations (CSP) of specific residues and how the secondary
structure changed due to mutation. We assume that zinc binding of mutant did not change, only its ability
for self-assembly to form high-oligomer forms. We wanted to investigate how the protein structure perturbed
to account for these changes in protein function. From Figure 4.6, by comparing to wild type protein, we
deducted that mutation of S100A12 protein did not change the way protein behave than it changes from
apo to calcium bound state. Unfortunately, the comparison of changes in the C-terminal is not possible due
to missing assignments in the mutant. Interestingly, we observed four distinct regions most susceptible to
change into the calcium-bound state of both wild type and the mutant protein. Three of these are expected:
two regions of calcium-binding motives and C-terminal, the last in wild type. The C-terminal side of the Helix
II (residues 43 to 48) region is also experiencing similarly significant perturbation upon binding to calcium
in the wild type and mutant protein. This region is part of a hinge, plays an important functional role.182
These similarities in perturbations of both mutant and wild-type protein indicate that mutation did not alter
protein binding to calcium by introducing a mutation in the C-terminal region.
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Figure 4.6. Site-specific absolute values of CSP for transitioning from apo to calcium loaded states for wild
type S100A12 (red) and AAA90Stop variant (blue). Twenty equivalents of calcium were added to
apoproteins.
4.5. Discussion
4.5.1 C-terminal mutants of S100A12 cause disruption of self-assembly in the presence of zinc
Previously, we reported that analysis of the secondary structure propensities for zinc bound S100A12
revealed changes in the conformations of several residues at the C-terminal.119 Few residues following helix
IV in the apoprotein with β-sheet propensity upon adding Zn2+ to protein obtain an α-helical conformation.
Therefore, we decided to gain insight into the role of these residues in S100A12 oligomerization. We
created mutants affecting different residues at the C-terminal (Table 4.1). We avoided mutating H85 and
H89 as they participate in zinc binding, and we did not want to make protein non-functional. To determine
which mutants have the most significant effect on the oligomerization of S100A12, we consequently
conducted size exclusion chromatography of mutants in the presence of zinc (Figure 4.1). The results of
SEC demonstrate that the AAA90Stop_S100A12 mutant has the most inhibited oligomerization.
Interestingly, the results of SEC experiments demonstrate that the last residue (Glu91) contributes
most to the protein size increase (Figure 4.1). The crystal structure of zinc bound S100A12 (PDB 2WC8)
reveals E91 of one chain to be in proximity from residues of calcium-binding EF-1 Hand loop from another
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chain (Figure 4.7). There is a probability what E91, through interactions with residues of the EF1 loop, can
affect the self-assembly of the protein. The nature of this interaction is not clear, and more investigations
are needed.

Figure 4.7. Position of C-terminal E91 residue of one chain in reference to EF-1 hand of another chain from
the overlay of two crystal structures of zinc bound S100A12 (PDB: 2WC8).
While there are two possibilities for this observed inhibition of self-assembly, the first possibility is that
the mutant cannot bind zinc ions anymore and therefore cannot proceed to oligomerization. This seems
unlikely because the last residue in the chain is located far from the metal-binding center and cannot expect
to influence it. The second possibility is that while protein retained the ability to bind Zn2+ ions, a protein
mutation caused enough structural changes to C-terminal to prevent protein from oligomerization. We
conducted a UV-Vis test using Co2+ as a probe to test the first possibility if this mutant retains the ability to
bind zinc (Figure 4.2). If Zn2+ could not bind to protein, then Co2+ could not bind either, and therefore, we
would not see the signal at 557 nm. On the contrary, our test demonstrated that not only is there the signal
from bound Co2+ but that the addition of one equivalent of Co2+ saturates mutant protein as in the case of
wild type. These results suggest that Zn2+/Co2+ binding was not affected by mutations and that most likely
structural changes were behind restricted self-assembly.
4.5.2. NMR analysis of AAA90Stop-S100A12
Once we determined that metal binding is not affected through mutation of C-terminal residues, our
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next task was to observe if a mutation changes the protein's overall structure. If the structure is greatly
affected by the mutation, we cannot propose to have the same protein and inquire about the role of the C
terminal. To get insight into the protein structure, we turned to NMR spectroscopy. To study the AAA90StopS100A12 mutant, we first measured apo and calcium-bound protein (Figures 4.3 and 4.4) and compared
results with the wild-type protein (Figures 2.5 and 3.4B). We determined that no changes were introduced
into apo and Ca2+-AAA90Stop-S100A12 as they are two different proteins. We also assigned residues for
AAA90Stop-S100A12 using 3D 1H-15N-TOCSY-HSQC and 1H-15N-NOESY-HSQC. We achieved a nearcompleted assignment of 84 out of 90 residues for apoprotein, and for Ca2+-AAA90Stop-S100A12, we
assigned 72 out of 90 residues. The results suggest that mutation did not introduce significant structural
changes in the protein's apo and calcium-bound form. Following NMR measurements of apo and Ca2+AAA90Stop-S100A12 forms, we analyzed chemical shift perturbations (CSPs) of specific residues from apo
to calcium bound forms for wild-type and mutant proteins. Results showed that the mutant's overall CSPs
are the same as wild-type (Figure 4.6), and mutation did not alter how protein responds to calcium-binding.
Unfortunately, we could not assign several residues at the C terminal and could not compare results
there. During the analysis of CSPs, we observed that different regions of the proteins sequence act similarly
in different ways, with some regions most susceptible to transition into the calcium-bound state from apo
form. While large CSPs in two calcium-binding EF-hands were expected, we observed large CSPs in the
C-terminal side of the Helix II (residues 43 to 48) region, which is part of the “hinge” region connecting two
EF-hand motifs. Large CSPs were observed in the hinge region due to calcium-binding. The hinge region
plays a vital role in recognizing S100A12 targets and promoting inflammatory signaling. Following NMR
measurements of apo- and Ca2+-AAA90Stop-S100A12, we turned to NMR spectroscopy of zinc-bound
mutant. Previously we reported problems in obtaining good resolution of Zn2+-AAA90Stop-S100A12
complex with regular solution NMR due to protein oligomerization. Due to significant broadening, 1H-15N
HSQC of wild-type zinc bound S100A12 is completely unresolved (Figure 2.8B). The only way to
characterize the zinc-bound complex of wild-type S100A12 was to do a series of solid-state NMR
experiments.119
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demonstrating better resolution (Figure 4.5), indicative of decreased oligomerization of the zinc-bound
mutant protein. Spectra in Figure 4.5 most likely reflects interstate between apo and zinc-bound forms if to
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accept inhibited self-assembly introduced by mutations in the C-terminal.
4.6. Conclusion
The self-assembly of S100A12 has an essential biological function allowing the protein to interact with
its cellular targets to induce inflammatory responses. Therefore, it is crucial to understand the mechanism
that leads to protein self-assembly. Previously we reported that several residues at the C terminal undergo
structural changes upon Zn2+ binding to the apoprotein: residues with β-sheet propensity obtain an α-helical
conformation. We logically assumed this change might have an important consequence in promoting the
oligomerization of S100A12 after adding the Zn2+. Here we report the construction of the C-terminal mutant,
which significantly restricted the self-assembly of S100A12 while not affecting the protein's overall structure,
and propose a possible role of Glu91 in the protein oligomerization.

94

Chapter 5 - Studies of selective calcium binding in S100A12 oligomerization and its role in
S100A12 function
5.1 Abstract

We have started to study the role of selective calcium binding to S100A12. Important questions are
how specific EF-hands are responsible for the protein's function and oligomeric assembly. We have
conducted our investigation by inhibiting the EF-2 calcium-binding loop through mutation two of its five
calcium coordinating residues. Calcium-binding to S100A12 induces major conformational rearrangements,
improves zinc sequestration, and saves metal binding at a sub-neutral pH range. Such a diverse role of
calcium in the functioning of the S100A12 deserved a detailed investigation. We hypothesize that EF motifs
of S100A12 have distinct roles in the S100A12 function. Different Kd of EF-hands hints at these differences
in the protein (EF-2 hand binds to Ca2+ with high affinity (Kd ~ 10-5–10-7 M), while non-canonical N-terminal
EF-1 hand binds Ca2+ with lower affinity (Kd ~ 10-3–10-4 M)) and their structural differences. Our results
show that calcium binding to the EF-2 hand motif induces conformational changes in the S100A12 and
controls metal binding to the His3Asp motif by restricting calcium binding to EF-hand I loop, possibly through
long-range intramolecular interactions across the protein polypeptide chain. More studies using EF-1 hand
mutants are needed to understand how both EF-hands interact.
5.2 Introduction

From the structural point, S100A12 consists of two structural domains. Each domain has one EF-hand
motif (N-terminal EF1 and C-terminal EF2) and binds a single calcium ion. In S100A12. The N-terminal
calcium-binding motif can be found only in S100 proteins among calcium-binding proteins. This “noncanonical” motif has 31 residues with 14 in the calcium-binding loop where calcium ions through main-chain
carbonyl O atoms.246 In S100A12, calcium ion coordinated by peptide carbonyls of Ser18, Lys21, His23,
Thr26, and a bidentate carboxylate group of Glu31 (Figure 5.1). On the other hand, 29 residues long
“canonical” EF-2 motif at C-terminal closely resembles EF-hand motifs of other calcium-binding proteins
such as troponin,247 parvalbumin,248 and calmodulin249. In the C-terminal EF-2, 12 calcium-binding loops
coordinate calcium ions by five side-chain oxygen atoms, one main-chain carbonyl oxygen, and water. In
the S100A12 EF2 hand, calcium ion is coordinated by the monodentate carboxylate groups of Asp61,
Asn63, Asp65, the peptide carbonyl group of Gln67, the bidentate carboxylate group of Glu72, and a water
molecule (Figure 5.2). Differences are also reflected in different calcium-binding affinities. EF2 hand binds
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with a stronger micromolar binding affinity, while non-canonical EF1 binds calcium ions with a weaker
millimolar binding affinity.177,206 EF-hand motifs are structurally highly conserved in many calcium-binding
proteins.250 On the other hand, observed differences in sequences, structures, and binding modes95 could
reflect the high adaptivity of the proteins in engagements of the multiple cellular targets in a calciumdependent manner.

Figure 5.1: Coordination of Ca2+ ion in EF-1 hand loop of S100A12 (PDB: 1E8A)

Figure 5.2: Coordination of Ca2+ ion in EF-2 hand loop of S100A12 (PDB: 1E8A)
Further, the hinge region links two calcium-binding motifs in S100A12 (Figure 3.1A). The hinge region
plays an important role in the cellular target recognition to propagate inflammatory signaling.182,189 The
hinge region shows different EF-hands dynamics upon calcium-binding. When EF-hand becomes more
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rigid due to the coordination of calcium ions, the hinge region becomes more flexible.251,252 Still, the
dynamics of hinge regions are not identical in S100 proteins. In S100A4, both apo and Ca2+-bound form
hinge regions demonstrate significant flexibility.251 The apo-S100A1 hinge region demonstrates rigidity,
which becomes highly flexible with the addition of calcium.252 The flexibility of the hinge region is essential
for protein targets. Calcium-binding to S100 proteins while, as in the case of S100A12 on two orders of
magnitudes weaker to induce oligomerization than zinc ion binding119, promotes enough conformational
changes to allow for exposure predominantly hydrophobic residues of target-recognition docking area of
the hinge253,254.
Since intracellular calcium ion concentration is about 100 nM241 in the eukaryotic cells, S100A12 inside
the cells exists in a calcium-free state since calcium ion binding affinity in S100A12 ranges from micromolar
to millimolar177,206. On the other hand, calcium presented at a high millimolar concentration in the
extracellular space.255 It is logical to expect that upon excretion from the cell during the infection, S100A12
will exist in the calcium-bound form. Further, extracellular acidosis associated with inflammation reactions
induces a transient elevation of calcium ion concentration,215,216 consequently increasing the predominance
of the calcium-bound state of S100A12 to modulate pro-inflammatory signaling. Such a response to high
calcium concentration outside the cell and low calcium concentration inside the cells naturally allow
S100A12 protein to exercise its antimicrobial and pro-inflammatory functions.
In addition to calcium ion sensing and propagation of the inflammatory signaling, calcium ion binding
participates in the modulation of zinc-binding to protein thus, enhancing antimicrobial activities of S100A12.
Prior studies demonstrated that calcium-binding increases binding affinity to zinc and improves the
antimicrobial activity of S100A12 and S100A9/A8 complex.113,173 Further, we reported that the addition of
calcium rescues metal binding to S100A12 in sub-neutral pH range,256 which can be associated with
conditions of cellular acidosis during infection, as we mentioned above. The addition of calcium, as we
demonstrated, introduces β-strand conformations in several residues of EF1 hand (D25-L27). During apostate, these residues have a coil-like configuration. This β-strand conformation prevents disruption by
changes in pH and might necessary structural constraint to allow the protein to bind zinc ions.
Given the role of the calcium-binding in different biological functions of S100A12, we decided to study
the different effects of EF-hands. Structural differences and binding affinities between two EF-hands motifs
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motivated us to look at the functional role of these EF-hands alone and a cooperativity effect that we could
observe between them. Previously, it had been suggested that despite lower calcium-binding affinity in EF1 hand in calcium-binding Dk9 protein, calcium ion binds first to EF-1 hand, which in turn changes the
conformation of EF-2 hand to allow it to bind calcium ions.257 NMR relaxation experiments tend to determine
the mode regulation of calcium-binding in both EF-hands, specifically, if binding to one EF-hand motif
changes dynamics in another. In our hypothesis, we proposed that the role of N-terminal “non-canonical”
EF-1 would be enhancing zinc-binding, given our previous studies and that D25 of EF1 hand is shared by
metal binding His3Asp motif. On the other hand, we propose for the EF-2 hand to have more of a structural
function to induce conformational changes and participate in the protein self-assembly.
5.3 Materials and Methods

5.3.1 Recombinant expression of S100A12-N63AE72A mutant and purification
To study the role of selective calcium binding in the S100A12 function, we mutated EF-2 hand to inhibit
calcium binding to this domain. Two residues from EF-2 hand involved in calcium ion binding were selected
for mutation: N63 and E72. These two residues were selected based on the data from the previously
published research.213 We generated S100A12-N63AE72A mutant by site-directed mutagenesis using four
primers

(N63A

forward:

GGATGCGGCCCAGGACGAACAAGTG,

N63A

reverse:

GTCCCAGACCTACGCCGGGTCC, E72A forward: TTCAAGCATTCATTAGCCTGGTTGC, E72A reverse:
GCTTGTTCACCTAAAAGTTCGTAAGTA) and then expressed the mutant in E coli. Following expression,
we isolated and purified the mutated protein by following previously reported protocol for the overexpression
and purification of wild-type S100A12.119
5.3.2 Size Exclusion Chromatography (SEC) of S100A12 mutants
Concentrated stocks of EF-2 hand S100A12 variants were diluted to 100 µM. Protein concentration
was determined spectroscopically by monitoring the 280 nm band (ε = 2980 M-1 cm-1). The calcium bound
mutants were prepared by the addition of 20 equivalents of Ca2+ samples and were loaded into HiLoad
16/600 Superdex 75 prep grade gel-filtration (GF) column (GE Healthcare Life Science) connected to an
ÄKTA FPLC (Amersham Pharmacia Biotech) instrument. The GF column was equilibrated with 20 mM
HEPES, 2.0 mM Ca2+, and 150 mM NaCl buffer at pH 7.0. Flow rate for all Size exclusion chromatography
(SEC) experiments was kept at 1.0 mL/min.
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5.3.3 UV-Vis spectroscopy
The sample of EF-2 hand S100A12 variants and wild-type protein at 0.2 mM concentration were
prepared for UV/Vis spectroscopy with the addition of 1 equivalent of cobalt. Tris, HEPES, and MES buffers
were used for pH titration experiments to adjust pH 8.0 to 5.0. The sample of the calcium bound to EF-2
hand S100A12 variants and wild type for UV/Vis measurements were prepared by adding 20 equivalents
of calcium to cobalt bound proteins. Cobalt-bound complexes with and without calcium were detected and
monitored by observing the absorbance at 556 nm. All quantification used previously reported molar
extinction coefficient of cobalt bound complex (ε = 820 M-1 cm-1 for S100A12 dimers).173
5.3.4 NMR sample preparation
Uniformly

15

N-labeled samples of apo-S100A12-N63A_E72A and apo-S100A12-N63A at 0.8 mM

concentration for the solution NMR measurements were prepared in 20 mm HEPES, 150 mm NaCl pH 7.0
buffer, with the addition of 10% D2O. 200 mm 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) was also
added to the NMR samples. To prepare four NMR samples containing calcium bound S100A12N63A_E72A and S100A12-N63A, five, ten, twenty, and forty equivalents of Ca2+ were added to the apoprotein samples.
5.3.5 NMR 2D 1H−15N HSQC Spectroscopy and data processing
We performed 2D 1H−15N HSQC193 solution NMR experiments at 14.1 T (600 MHz) on a Varian NMR
spectrometer outfitted with an HCN cryoprobe and at the NYSBC at 11.7 T (500 MHz) on a standard bore
Bruker Avance III HD spectrometer. The Larmor frequencies were 599.93, 150.87, and 60.79 MHz for 1H,
13

C, and

15

N, respectively. 25 °C was maintained for all samples through the NMR experiments. The

acquired NMR spectra were first processed with NMRPipe202 and then analyzed with Sparky software203 as
reported before119. Calcium titration NMR experiments were conducted with step-wise addition of calcium
from 5 to 40 equivalents for both S100A12-N63A_E72A and S100A12-N63A protein samples.
5.3.6 NMR Relaxation measurements and data processing
We performed NMR relaxation measurements at the City University of New York’s NYSBC at 11.7 T
(500 MHz) on a standard bore Bruker Avance III HD spectrometer. All measurements were performed at
37 oC. All S100A12 samples were

15

N labeled, and protein was purified as previously reported.119 All apo

S100A12 and Ca2+-S100A12 samples were prepared in HEPES buffer (20 mM HEPES and 150 mM NaCl,
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10% D2O, pH 6.0 or 7.0). Ca2+-S100A12 samples were prepared by adding 20 equivalent of Ca2+ to 0.8
mM apo-protein. 15N longitudinal (R1 = 1/T1) and 15N transverse (R2 = 1/T2) relaxation rates were measured
using the sensitivity enhanced 1H–15N HSQC pulse sequence258 with the option to measure either R1 or
R2259. For both R1 and R2 measurements, the acquisition parameters on each spectrometer were identical,
with only differences in the delay between π (1H) pulses. We had also obtained a heteronuclear nuclear
Overhauser effect ({1H}-15N NOE) relaxation data. R1 and R2 values were obtained through a non-linear
least-square method by fitting the amide cross-peak intensities to a two-parameter exponential decay (𝑡𝑡) =
(−𝑅𝑅t)
.

NOE relaxation data was obtained as a ratio of peaks intensities with or without pre-saturation pulses.

Uncertainties in R1, R2, and NOE data measurement were estimated using the root-mean-square (rms)
spectral noise obtained in NMRPipe.
5.3.7 Chemical Shift Perturbations (CSPs) analysis
To calculate chemical shift perturbations (CSP) for backbone amides between an apo-protein state to
calcium-loaded protein state, we followed formula (1).
5.4 Results
5.4.1 Addition of calcium to S100A12 EF-2 hand mutants induces minor changes in the size of the
protein
We conducted size exclusion chromatography (SEC) to evaluate how mutations introduced in the EF2
loop affected the size of the protein in comparison to the wild-type protein (Figure 5.3) in the presence and
absence of calcium. From the elution volume for the samples, we observed that both apo and calcium
saturated mutants have the same size, while in wild type, the addition of the calcium leads to the increase
of the size. These results imply that mutation indeed inhibits the conformational changes in the protein. Still,
the questions stayed. Did we completely inhibit calcium binding to the protein or only its binding to the EF2
loop?
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Figure 5.3. Size exclusion chromatograms of wild type S100A12 and its EF2 variant in absence and
presence of 20 equivalent of Ca2+ at pH 7.0. A: wild-type Ca2+-S100A12. B: wild type apo-S100A12. C:
apo-N63A_E72A-S100A12. D: Ca2+-N63A-E72A_S100A12. E: Ca2+-N63A_S100A12.
5.4.2 The addition of calcium to the S100A12 EF-2 hand mutants does not save protein metal
binding at low pH compared to the wild-type protein

Figure 5. 4. pH-dependent Co2+ binding to wild type S100A12 and N63A-S100A12. Wild type S100A12 in
the absence (green) and presence (red) of Ca2+. N63A-S100A12 variant in the presence of Ca2+ (blue)
and absence of Ca2+ (yellow). The plot shows the absorbance at 556 nm versus pH.
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We further investigated how mutations in the EF2 loop can affect the protein's function.
Previously, we learned that wild-type protein rescues the protein function of binding the metals at the low
pH range by constraining the structural changes. The D25 of the EF1 loop participates in the metal
binding at the active site. We hypothesized that if there is no cooperativity between two calcium-binding
loops, the changes at the EF2 should not affect the metal binding.

Figure 5. 5. pH-dependent Co2+ binding to wild type S100A12 and N63A_E72A-S100A12. Wild type
S100A12 in the absence (green) and presence (red) of Ca2+. N63A_E72A-S100A12 variant in the
presence of Ca2+ (blue) and absence of Ca2+ (yellow). The plot shows the absorbance at 556 nm versus
pH.
We looked into how the N63A mutant can bind to cobalt at different pH in the presence of 20
equivalents of calcium. We observed the weak shift of the absorption curve to the left (lower pH) when we
added 20 equivalents of Ca2+ to a mutant with cobalt (Figure 5.4, blue trace). This shift is significantly
smaller when one observed in wild type (Figure 5.4, red trace). As we reduce the pH, calcium bound
mutant can sustain cobalt binding only to up to pH 6.5. In the wild-type protein, the pH range where
metals can bind to S100A12 is extended to pH 5.7 (Figure 5.4: red trace). Without the calcium, the
protein mutant demonstrates loss of metal-binding when we reduce pH below 7.0 (Figure 5.4 yellow).
The pH titration of the N63A-E72A mutant shows that adding the calcium does not improve cobalt binding
as pH decreases below pH 7.0 (Figure 5.5: blue trace). The absorptions curves of cobalt binding in the
presence or absence of calcium are identical.
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Figure 5.6. Calcium-dependent Co2+ binding to S100A12 at pH 5.5. A. Binding of Co2+ to 0.190 mM wt
S100A12. B. Binding of Co2+ to 0.140 mM N63A_S100A12.
From the pH titration experiments, we observed that all mutants lose binding Co2+ at pH 5.5. We
decided to conduct calcium titration at this pH of both mutants and wild-type protein to gain insight on the
EF-2 Kd through observation of the cobalt signal (Figure 5.6). Few things were detected. To ultimately
save cobalt binding, we would have to add hundreds of times more calcium to a mutant, reflecting a
significantly decreased binding affinity for the calcium. Since it is expected for the EF-1 loop to bind
calcium first, it suggests that mutation at EF-2 hand had an inhibiting effect on EF-1 hand to bind calcium.
Also, we observed that while the binding curve for the wild type shows a standard saturation binding
curve (Figure 5.6 A), the binding curve for the mutants shows a certain allosteric effect (Figure 5.6 B).
5.4.3 The addition of calcium to N63A-E72A S100A12 affects binding to the EF-1 loop
We conducted 15N–HSQC to determine the calcium-binding to EF loops and compared it to the
wild type. In addition, we compared the chemical shift perturbations (CSP) of both proteins. When we
compared the NMR spectrum of calcium bound mutant, it resembles spectra of apo mutant and apo wild
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type protein (Figure 5.7 A and B).

Figure 5.7. Overlay of 14.1 T 1H-15N HSQC spectra at pH 7.0 of the wild type S100A12 (gold) and S100A12N63A-E72A (red). A. Overlay of the apo-S100A12 (gold) and apo-S100A12-N63A-E72A (red). B. Overlay
of the apo-S100A12 (gold) and Ca2+-S100A12-N63A-E72A (red). The selected residues involved in the
EF1 and EF2 Calcium-binding motifs are labeled.

5.4.4 Chemical shift perturbations of Calcium bound S100A12 EF-2 hand mutants
Average CSPs (Figure 5.8) for mutant have a value of 0.010 ppm, while average CSPs for the wild
type S100A12 (Figure 5.9) is equal to 0.659 ppm when both are loaded with calcium. Residues of the EF1
loop have only slight CSPs. This suggests the role of EF2 in regulating the EF1 loop to bind. Calciumbinding to wild-type protein produces significant conformational changes reflected in the NMR spectra,
which we do not observe in the mutant.
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Figure 5.8. Site-specific values of CSP for N63A-E72A_S100A12 (EF2) and N63A_S100A12 from apo to
20 equivalents of calcium loaded states at pH 7.0

Figure 5.9. Site-specific values of CSP for S100A12 wild type from apo to 20 equivalents of calcium added
states at pH 7.0.
5.4.5 NMR Relaxation measurements of apo- and Ca2+-S100A12
Figures 5.10 to 5.11 show results for the S100A12 at pH 6.0 run at 11.7 T. We used data from R2/R1
(Figure 5.10) and NOE (Figure 5.11) to identify residues with too fast internal motions. These residues
would have low R2/R1 ratios and low NOE. Also, residues with high R2/R1 ratios will have pointed to residues
having conformational exchanges on a slow time scale. The identified residue was excluded from diffusion
tensor determination. Figure 5.10 shows that R2/R1 for apo and calcium-bound S100A12 are very close.
To model fast scale protein backbone dynamics, we determined rotational time (τm) for S100A12 using a
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ratio of R2/R1260 as input to r2r1_tm program261. Next, we used the pdbinertia program261, which calculated
appropriate moments of inertia for atoms of S100A12 protein using proper crystal structures (PDB: 2WCF
for apo-S100A12 and 1E8A for Ca2+ bound S100A12). The calculated rotational diffusion time for Ca2+S100A12 at pH 6.0 τm = 10.1 ns and for apo-S100A12 at pH 6.0 τm = 9.6 ns. Both R2/R1 data and data from
pdbinertia were further used to estimate rotational diffusion tensors to determine the appropriate motional
model (spherical, axially symmetric, or fully anisotropic) with the help of the quadratic_diffusion program261.
We have selected fully anisotropic models for both protein samples based on comparing chi-square (Χ2)
and F statistics for each model and model with the smallest chi-square, and an F value was selected. F and
X2 values for apoprotein are 0.02 and 34.8, respectively. F and X2 values for Ca2+-S100A12 are 0.9 and
130, respectively. The diffusion tensor for Ca2+-S100A12 are: Dxx/Dyy = 0.92 ± 0.02, 2Dzz / (Dxx+Dyy) = 1.22,
Diso = 1.65·107 s-1. The diffusion tensor parameters for apo S100A12 are: Dxx/Dyy = 0.93 ± 0.04, 2Dzz /
(Dxx+Dyy) = 1.11, Diso = 1.64·107 s-1. Finally, we applied diffusion tensor and other relaxation parameters
in the FastModelFree program48 to obtain S2 values through data fitting to one of the five mathematical
models (Figure 5.12).

Figure 5.10: Plots of 15N-R2/R1 at 11.7 T for apo S100A12 (blue) and Ca2+-S100A12 (red).
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Figure 5.11: Plots of {1H-15N-NOE at 11.7 T for apo (blue) and Ca2+-S100A12 (red).

Figure 5.12: Plot of order parameter S2 for apo-S100A12 (blue) and Ca2+-S100A12 (red)
5.5 Discussion
The presence of two structurally different calcium-binding motifs in S100A12 raises a question about
the origin of this difference. The crystallographic studies demonstrate that the C-terminal EF-2 hand motif
is a canonical motif in which calcium ion is coordinated by peptide carbonyls of Ser18, Lys21, His23, Thr26,
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a bidentate carboxylate group of Glu31, and a water molecule (Figure 5.1). In the “canonical” C-terminal
EF-2 hand motif, calcium ion is coordinated by a water molecule, the monodentate carboxylate groups of
Asp61, Asn63, Asp65, the peptide carbonyl group of Gln67, and the bidentate carboxylate group of Glu72
(Figure 5.2). The ligands in both calcium-binding loops demonstrate the same pentagonal bipyramid
geometry.213 The motivation for the investigation was to determine the differences in the functioning of EFhand motifs and to observe if any the cooperative effect between these two motifs. We wanted to see how
one calcium-binding loop can affect the function of the other calcium-binding loop.
To study the function of selective calcium binding in the S100A12 protein, we decided to knock out the
function of the EF-2 hand loop. EF-2 hand loop does not have D25 which participates in the metal binding
at the His3Asp active site and therefore should not affect the metal binding by protein. We decided to
prepare two mutants where one has N63 residue substituted with alanine (S100A12-N63A) and the second
mutant had two residues, N63 and E72, substituted with alanine (S100A12-N63AE72A). Both N63 and E72
are primary calcium-binding residues in the EF2-Hand motif (Figure 5.2). These residues were already
selected in the previously published works to address the role of calcium-binding in tuning autoinflammation
signaling pathways in the cells.176
Once we expressed and purified EF-2 hand mutants following our lab's previously established
protocols, we applied SEC to observe if restricting calcium binding to the EF-2 hand would affect the
oligomer self-assembly. The results of SEC were compared with the behavior of wild-type S100A12 at the
same conditions of the calcium loading. The wild type apo-S100A12 elutes at the 71 mL of elution volume,
while the calcium-loaded sample elutes at 68 mL (Figure 5.3 A and B). The shift in the elution volume
suggests an increase in the protein's size due to the addition of calcium. When we applied calcium to both
mutants, we observed that elution volume for the apo- and calcium-loaded mutant samples are the same
(around 70 mL), suggesting the absence of the protein’s size change in the presence of calcium (Figure
5.3 C-F). Indeed, these differences during SEC experiments suggest that S100A12 conformational changes
depend on calcium-binding to the EF-2 hand loop. Still, we had made sure that our mutants selectively
inhibit calcium binding at EF-2 hand but not also EF-1 hand.
Once we demonstrated that mutants restricted self-assembly of S100A12 in the presence of calcium,
we conducted NMR spectroscopy to observe if the protein structure was affected by mutation and if mutants
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can still be considered structurally similar to the wild type protein. We wanted to ensure that mutants can
be considered the same S100A12 protein, and all insights we could from the mutants could be relevant to
the wild type. To do so, we conducted 2D 1H-15N HSQC experiments on both apo and calcium-loaded
samples of the mutants and then overlaid the results with results from the wild type S100A12. In the analysis
of the results, we used previously determined by us peak residue assignments for both apo and calcium
bound wild type protein.119,256 The results of the overlay of spectra from the HSQC experiments show that
both apo wild type protein and mutants are similar (Figure 5.7), suggesting that mutation did not introduce
major structural perturbations. Also, we observed that adding 40 equivalents of the calcium to the mutant
did not alter the protein structure, and it is very similar to the apo-protein (Figure 5.7 B). At the same time,
the observed that the only residues with the noticeable chemical shift from the spectra of an apostate to
calcium loaded state were demonstrated by selected residues in the EF-2 hand loops and with few in the
EF-1 hand loop (Figure 5.7). This suggests that while the EF-2 hand loop experienced the effect of the
calcium addition probably through weak non-specific binding, the protein's overall structure did not change
due to self-assembly restriction induced by mutation.
We conducted CSPs analysis to determine the extension of the structural perturbations in the mutants
and compare it with perturbations induced by calcium addition in the wild-type protein (Figures 5.8 and
5.9). We calculated that the average CSP for the mutants is about 70 times less than the wild type. We
observe that mutants demonstrate uniform CSP across the polypeptide chain residues, except the residues
at both EF-hands. There is no significant perturbation at the hinge region of the mutant’s contrary to very
significant CSPs of the residues in the hinge region of wild type S100A12. Differences in the magnitude
and the ways CSPs presented suggest that CSPs in the mutants are originated not from the calcium-binding
but its nonspecific and/or weak binding at the calcium-binding motifs.
We compared how mutation at the EF-2 hand affects the pH-dependent metal-binding function of the
protein in the presence of calcium we reported previously.256 Investigation showed that calcium-binding
extends the function of S100A12 to bind Co2+/Zn2+ in the sub-neutral pH range by constraining the structural
changes in the protein.256 With D25 located in the EF-1 hand loop and participating in the metal binding, we
suggested that if there is no cooperative effect between two calcium-binding loops, the mutation in the EF2 hand will not prevent metal binding. The results UV-Vis experiment of the pH-dependent metal binding
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function of the mutants (Figures 5.4 and 5.5) in the presence of 20 equivalents of the calcium showed that
mutation at EF-2 hand prevents the protein from binding cobalt in sub neutral pH range as we observed in
the wild type S100A12 (Figure 3.6). At the same time, both EF-2 hand mutants do not disrupt metal binding
at neutral and above-neutral pH ranges. This suggests that calcium binding to EF-2 modulates structural
changes at the EF-1, as evident at low pH. It would be valuable to conduct mutational studies on how
mutations at the EF-1 hand motif affect EF-2 hand and protein function. We further decided to use the
cobalt binding signal as a probe for the calcium-binding at the EF-1 hand. For this reason, we conducted
Ca2+ titration of wild type and mutant at pH 5.5 (Figure 5.6). We observed that calcium-binding was greatly
reduced with apparent Kd for EF1-hand around 20-25 mM. We also observed that the binding curve for the
mutant is sigmoidal, hinting presence of the allosteric effect. We hypothesize that allosteric regulation in
wild type is not observed due to the high efficiency of calcium binding to restore cobalt binding (Figure 5.6
A). After adding two equivalents of the calcium, almost all metal-binding sites are already occupied. These
two equivalents of calcium bind to EF-hand 1, and we cannot see further allosteric regulation since the
cobalt signal is already maximized. On the other hand, in the mutant, we add much more than two
equivalents of calcium without saturation of cobalt signal, which allows us to observe a presence of the
allosteric regulation. This allosteric regulation is possibly due to the reported earlier regulation by calciumbinding at the EF-1 loop to change the geometry of the EF-2 loop in Dk9 calcium-binding protein.257
We also conducted NMR relaxation measurements to learn about the dynamics of the backbone
residues of S100A12 and particularly residues at the calcium-binding EF-hand loops. It is possible to
characterize the internal protein motions by conducting backbone NH NMR relaxation measurements,
which provide information on proteins' rotational and internal dynamics.263,264 We can interpret relaxation
data with the help of Lipari-Szabo model-independent formalism, which allows us to determine the internal
dynamics of bond vectors independently from the overall rotation of the molecule. The relaxation data
interpreted with this model-free formalism can be used to determine the order parameter, S2, for the N-NH
backbone amide vector in protein.260,265 The S2 parameter is a function of the amplitude of internal motion
and can be used for thermodynamic parameters such as entropy and enthalpy.266-268 Also, S2 is a function
of rigidity, where 1.0 is rigid, and 0.0 absolute flexibility and distribution of its values can measure the
mobility of protein segments such as helixes. From Figure 5.12, we can observe that the EF-2 hand loop
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and hinge region exhibit flexibility in the apo-S100A12 compared to an overall protein with an average S2
at 0.85 (canonical calcium-binding motif 63-72) and are more flexible when the rest of the protein. We do
not have enough data about the EF-1 hand loop to infer its dynamics. As we add calcium, both flexible
regions become more rigid.
Interestingly, residues at the N-terminal become more flexible as we add calcium (Figure 5.12).
Overall, the structural dynamics of S100A12 are following the trend observed in other S100A12, where the
addition of calcium leads to decreased flexibility of EF2 hand loops.251,252 Noted exception observed at
several residues next to C- and N-terminal, where they exist in a more relaxed state upon addition of calcium
than during the apostate.
5.6 Conclusion
S100A12 protein, as a member of the S100 calcium-binding family of the protein, have two calciumbinding EF-hand motifs. In S100A12, these motifs are not identical, with “canonical” at C-terminal and “noncanonical” at N-terminal. We argue that this difference in the structure of calcium-binding motifs generates
their different functions. The EF-1 hand motif is responsible for Zn2+ binding through D25 residue and
modulation of Zn2+ binding. The EF-2 hand is possibly responsible for the overall structural change of the
protein and participates in protein self-assembly necessary for target recognition of the cell membrane
receptors such as RAGE or TLR4. Here our NMR and SEC experiments show that mutation of EF-2 hand
is indeed prevented protein self-assembly and preserve the apo-like state. Also, we observed that EF-2
possibly exerts effects on the EF-1 hand loop as the EF-2 hand mutants inhibit metal sequestration at subneutral pH range opposite to that seen in wild type. We also conducted NMR relaxation studies and showed
that both EF-hand motives become more rigid upon adding calcium. In the end, we propose the necessity
of mutational studies to isolate the effects and function of the EF-1 hand motif in S100A12 and determine
the cooperativity effect between two calcium-binding motifs.
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6.1 Abstract

Chapter 6 - Gentisate 1, 2-dioxygenase enzymes: Introduction

The industrial pollution of the environment represents a problem in today's world. To combat this
pollution, many ways are proposed and applied. These include passive removals through mechanical
filtration systems and active removal using natural or synthetic compounds that degrade polluting
compounds, such as plastic or oil spills. Many bacterial organisms were found to degrade aromatic
compounds by enzymatic ring cleavage. This ability of microbes can be directly applied to remove waste in
the petroleum, agricultural, chemical, and other industries. The group of bacterial enzymes known as
dioxygenases plays an essential role in the degradation of various aromatic compounds contributing to
waste removal and synthesizing biologically essential compounds. Many aromatic compounds are
converted to two groups of monohydroxylated and dihydroxylated aromatic intermediates in the bacteria.
In bacteria, the predominantly aromatic ring intermediates are degraded in catechol forms such as
homoprotocatechuate. Although, some bacterial enzymes can perform ring scission of monohydroxylated
compounds such as salicylic acid. In both cases, the dioxygenases perform ring scission with the help of
Fe2+ or Fe3+ at the active site, which coordinates both aromatic substrate and molecular oxygen. Here we
review the different classes of dioxygenase enzymes that have distinct aromatic cleaving strategies and
discuss a class of non-heme iron gentisate 1, 2-dioxygenase enzymes.
6.2 Introduction
The ability of certain microorganisms to degrade aromatic compound draw particular interest in the
industry from an environmental protection perspective.269-275 The aromatic benzene ring has a circular π
bond system formed from overlapping conjugated p-orbitals of the carbon atoms. Delocalization of electron
density around the rings introduces stability to the molecule. Chemically, the electrophilic addition would
require breaking one π bond into two σ bonds. In such an aromatic system, the aromatic ring in the organic
compounds has enough negative resonance energy to allow the stability of the benzene and its derivatives,
which pose a problem of degradation.
There are at least a couple of reasons we can point out behind the interest in studying bacterial
dioxygenases structurally and functionally. First, aromatic benzene compounds are common industrial
contaminants of groundwater and soil. Many synthetic compounds are introduced into the surrounding
environment as benzene derivatives: pesticides, herbicides, waste from petroleum, oil, pharmaceutical, and
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other such industries. If these chemicals were resistant to decomposing by microbial organisms, their
accumulation in the environments would lead to serious health and ecological issues. Harmful pollutants
could accumulate in the animal tissues and eventually introduce into human organisms through the food
chain. Luckily, some microorganisms can completely degrade aromatic compounds under different
conditions in nature. Therefore, we can see an important reason for understanding how various bacterial
microorganisms can degrade a wide range of synthetic and natural chemical compounds. Currently, safe
and efficient removal of these pollutants with current means represents a problem. Therefore, the potential
use of natural microorganisms seems like a great idea to combat environmental problems posed by
industrial waste. Second, the reason for interest in aromatic dioxygenase is dictated by the industry’s
investigation of ways to use environmentally friendly procedures to synthesize various chemical
compounds. We can say that various types of bacterial dioxygenases are fulfilling this “green-chemistry”
prerequisites to be a source of different ways to manipulate aromatic compounds not possible by regular
chemical synthesis.
There are three approaches to investigating the microbial degradation of aromatic chemical
compounds. First involves studying the metabolic intermediates produced during the enzymatic reaction of
degradation of various aromatic native and synthetic substrates.276,277 The second involves investigating
the mechanisms of ring cleavage and preceding substrate hydroxylation, which is a necessary step for
aromatic ring degradation.278,279 Lastly, investigations concentrated on controlling the enzymatic reaction
for the metabolism of different aromatic chemicals.
To enzymatically cleave aromatic chemical compounds, enzymes require the activation of oxygen. This
is a two-step process involving two classes of enzymes. In the first step, bacterial enzymes which can
activate molecular oxygen use oxygen to add one or two hydroxy groups to the aromatic ring for the
following degradation step. Oxygenases incorporate oxygen atoms into the chemical. As the name
suggests, Monooxygenases catalyze a single atom into a product. Dioxygenases introduce both oxygen
atoms into the product, which in most cases requires a metal cofactor (Fe2+ or Fe3+). Choice of Fe2+ or Fe3+
depends on the class of dioxygenase, and each will be discussed later in this introduction.
6.2.1 Aromatic compound degradation under anaerobic conditions
Before discussing the degradation of the aromatic compounds under aerobic conditions, we first cover
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this degradation under anaerobic conditions. The first report showing that some bacteria can degrade
aromatic chemical compounds under anaerobic conditions was published almost 100 years ago.280 This
initial report showed how several aromatic compounds such as tyrosine, cinnamic, hydrocinnamic,
phenylacetic, and benzoic acids are completely degraded by methanogenic bacteria.280 On the other hand,
toluene, benzene, and benzaldehyde were not degraded by this bacteria. In 1952, a report showed that
these bacteria do not attack catechol or protocatechuate substrates.281 These substrates are commonly
formed during the degradation of benzene compounds in aerobic bacteria, and therefore the report
suggested different metabolic pathways in aerobic and anaerobic bacteria.
Naturally, the absence of diatomic oxygen in the environment demands different strategies for
aromatic compounds degradation. Two strategies were described, which involved the reduction of the
aromatic ring.282 The absence of diatomic oxygen, which is required to reduce the aromatic ring during
oxygen-dependent reactions, demands reducing agents with redox potential much more negative than
physiologically available. Consequently, the anaerobic bacteria developed a mechanism to go around this
problem. If, in the case of oxygen-dependent reactions, electron-rich hydroxy substituents of the
intermediates prevent the transfer of electrons to the ring and reduce the intermediates, in the absence of
the intermediate oxygen, the electron-withdrawing substituents of the intermediates induce transfer of
electrons from the ring. The benzoyl-CoA in which electron-withdrawing substituent is carboxy-thioester
group is the most common intermediate in the degradation of the aromatic compounds under anaerobic
conditions.283-285 In both oxygen-independent strategies, the benzoyl-CoA intermediate is reduced by
reductases to the cyclic conjugated compound cyclohexa‑1, 5‑diene‑1‑carboxyl-CoA (1, 5‑dienoyl-CoA).
In enzymatic reactions for substrate–product pairs, this conjugated compound is reported to have the lowest
redox potential of -622 mV.286 Reduction of the benzoyl-CoA is highly endergonic and must be paired by
some exergonic reaction. This is achieved by two strategies: ATP-dependent and ATP-independent
aromatic ring reduction.
In ATP-dependent strategy, the aromatic substrate is directly coordinated to Fe–S or tungsten
cofactors which significantly stabilize radical intermediates of reaction. This strategy involving benzoylCoA reduction is driven by ATP hydrolysis, utilizing class I benzoyl-CoA reductases (Figure 6.1).287-289 The
non-aromatic product is further degraded through the benzoyl-CoA degradation pathway.290,291 In ATP-
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independent strategy class II, benzoyl-CoA reductase is used to catalyze benzoyl-CoA, as discovered in
Geobacter metallireducens292 and others anaerobes293,294 (Figure 6.1).

Figure 6.1. Anaerobic degradation of Benzoyl-CoA. Both the ATP-independent and ATP-dependent
pathways are shown to convert benzoyl-CoA into cyclic 1, 5‑dienoyl-CoA. ATP-dependent pathway proteins
(BcrABCD, Dch, Had, Oah, Fdox, and Fdred) belong to Thauera aromatic. Proteins for ATP-independent
pathways (BamBCDEFGH, BamR, BamQ, and BamA) are in Geobacter metallireducens.
6.2.2 Oxygen activation by metal cofactors during oxygen-dependent aromatic compound
degradation
Compared to anaerobic bacteria, aerobic bacteria adapted to use molecular oxygen to oxidize and
cleave substrate’s aromatic ring. In bacteria, oxygen atoms from molecular oxygen are incorporated by
oxidoreductases called oxygenases into their substrates. Chemically, the hydrocarbon oxidation reaction is
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exothermic, which is proven by comparing the sum of energies required to form C-O and O-H bonds against
the sum of bond energies of broken O-O, O-H, C-C, and C-H.295 Still, molecular oxygen is kinetically stable
and unreactive without a catalyst. This is due to 3O2 “triplet” state with two unpaired electrons. These two
electrons occupy the highest π* orbitals in the ground state, and 3O2 cannot react with spin-paired singlet
species as spin-forbidden.296
On the other hand, 1O2 with its pair of valence electrons is highly reactive.296 Unfortunately, 1O2 is
higher energy than 3O2, and therefore, oxygenases require transition metal ions or FAD cofactor to activate
molecular oxygen.297 For example, the dihydroxylated aromatic compounds such as protocatechuate,
catechol, or gentisate are cleaved in an oxygen-dependent manner by the dioxygenases in the presence
of transition metal cofactors and activated molecular oxygen.298 To activate 3O2, the transition metal ions
cofactors which contain unpaired electrons can use three different strategies.
The first strategy is achieved by orbital overlap with transition metal ion cofactor, which has unpaired
3d electrons. In this case, O2’s unpaired electrons located in π* orbitals can overlap with unpaired electrons
of the transition metal cofactor.299 Such reaction will now be allowed under the condition that the total
number of unpaired electrons on the O2-Metal complex stays the same.296
A single electron transfer achieves the second strategy. In known metalloenzymes that can activate
molecular oxygen, the transition metal ions have oxidation states that differ by 1, for example, Fe2+ and
Fe3+.296 This indicates that the metal center in these enzymes can transfer a single electron to coordinated
O2 at the active site. Also, ground state 3O2 can take an electron from superoxide to activate oxygen through
single electron transfer.300,301 This strategy of oxygen activation has a serious criticism as it is not
energetically favorable as the total redox potential to activate molecular oxygen in water at pH 7.0 by Fe2+
is -0.93 V (O2/O2- redox potential equals to -0.16 V and redox potential for Fe2+/Fe3+ equals to 0.77 V).301
In the metalloenzymes, this redox potential to activate oxygen in the proteins depends on the active site
environment by stabilizing cofactor ions at the active site in oxidized or reduced form.302 An enzyme can
make a reaction favored if it forms interactions with superoxide versus O2. For example, this type of
interaction had been reported in EDTA–Fe3+ complexes.303 Thus, metalloenzymes can use this strategy,
and the extradiol catechol dioxygenases can utilize this approach. This single electron transfer approach
for activating molecular oxygen is possible through access to a stable radical reaction intermediate. The
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flavoprotein hydroxylase enzymes use reduced flavin cofactor to activate oxygen to form superoxide and
flavin semiquinone and to combine them into hydroperoxide intermediate.298
Finally, the third alternative strategy to activate molecular oxygen at the active site is through reaction
with substrate radical because it is a spin-allowed process. It was suggested that in intradiol catechol
dioxygenases, the substrate is activated through this method, where formed catechol semiquinone reaction
intermediate reacts with molecular oxygen to produce a hydroperoxide radical.305
The formation of alkyl hydroperoxide intermediate from the incorporation of the atoms of oxygen into
the product of reaction by the dioxygenase enzymes are commonly done in a stepwise manner: formation
of one C-O bond with substrate before O-O bond cleavage. Formed organic hydroperoxides are chemically
reactive and can react with other chemicals due to their O-O bond weakness. These organic peroxides in
the presence of the transition metal ion catalysts at the active site can further be cleaved homolytically to
form an alkoxy radical, which in turn can also proceed through adjacent C–C bond homolytic cleavage.306308

If to assume that coordination with Fe2+ took place to proceed with O-O bond cleavage, the product of

such homolytic cleavage will be a high oxidation state Fe3+-oxo complex, for example, a catalytic
intermediate in reactions catalyzed by heme cytochrome P450 and non-heme dioxygenases.309
6.2.3 Aromatic compound degradation under aerobic conditions
In the previous section, we saw that molecular oxygen must be activated to react with substrate in
the presence of transition metal or radical cofactor. At the same time, the substrate must be ready to
participate in the aromatic ring degradation. The activation of substrates for aromatic ring cleavage can be
successful only if the preceding step of hydroxylation of the aromatic ring has happened. 298,305,310 For
example, benzoate 1,2‑dioxygenase turns benzoate into catechol. Due to electron-rich functional groups
on the aromatic rings in their ortho or para position, these substrates are readily activated for the oxidative
ring cleavage.311 Based on how the aromatic ring of the substrate cleaved, there are two types or classes
of the enzyme: intradiol and extradiol.269,297,312-314 In intradiol dioxygenases with use of non-heme Fe3+ cofactor, aromatic ring cleaved in ortho position to hydroxyl groups (between both), while in extradiol
dioxygenases non-heme divalent transition metal (ex: Fe2+, Mn2+) is utilized to cleave aromatic ring in meta
position to a hydroxyl group (next to one of them). Studies suggest that extradiol dioxygenases can convert
a much larger variety of aromatic compounds than intradiol dioxygenases.298,296
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Hayaishi, in 1955 was the first to discover the ability of oxygenases to incorporate oxygen atoms into
substrates.315,316 It was soon discovered that oxygenases are widely represented in nature and responsible
for degrading a great variety of aromatic compounds. In 1962, Hayaishi discovered that catechol
compounds are central intermediates in the degradation pathway and substrate cleavage performed by
intradiol oxygenase enzyme, catechol 1, 2-oxygenase.317 This enzyme and other intradiol enzymes, which
were studied right after, had shown that they are specific to their substrates.318,319 Around the same time in
the sixties, an extradiol type of enzymatic cleavage which first was found in catechol 2, 3-oxygenase, was
also found in other organisms.320-323 In 1966, Hayaishi published important work. He established that
catechol compounds can be oxidatively cleaved by two different classes of oxygenases: extradiol
dioxygenases that utilize Fe2+ for their activity and intradiol dioxygenases that utilize Fe3+.324
6.2.3.1 Intradiol oxygenases

Figure 6.2. Aromatic cleavage reactions catalyzed by intradiol and extradiol dioxygenases.
Many pathways led to catechol and protocatechuates, with aromatic rings cleaved between hydroxyl
substituents. Intradiol dioxygenases catalyze these catechols and protocatechuates substrates. In 1955,
Hayaishi, in his work, with the help of labeled oxygen 18O2 demonstrated that the product of the reaction of
catechol 1, 2-dioxygenase isolated from Pseudomonas had two inserted oxygen atoms from the molecular
oxygen.316 Hayaishi showed that the four-membered dioxetane ring of the reaction intermediate got cleaved
to form a final reaction product (Figure 6.2 A). Works by Ornston and Stanier in 1966 gave a complete
account of the degradation of catechol and protocatechuate by Pseudomonas putida.319 They had
demonstrated that catechol and protocatechuate while degraded by the different parallel mechanisms
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converge on the same reaction product (8-ketoadipate enol-lactone), which later turns into succinate and
acetyl-CoA.319,325,326 They also demonstrated that enzymes involved in the reaction with either catechol or
protocatechuate are highly specific and cannot react with switched substrates.

Figure 6.3. Structure of active site in apo 3, 4-PCD from Pseudomonas putida (PDB: 1EO2).
The first X-ray structure of intradiol type dioxygenases was solved much later from its discovery. In
1988, the X-ray structure of protocatechuate 3, 4-dioxygenase (3, 4- PCD) from Pseudomonas putida was
obtained.327 Within the family of intradiol dioxygenase enzymes, 3, 4-dioxygenase has been studied to the
greatest extend.328 The non-heme Fe3+ ion was found to be ligated by four residues through imidazole rings
of His460 and His462 and phenols of Tyr408 and Tyr447 (Figure 6.3).327,329 A water ligand completes the
final trigonal bipyramidal structure. The ligation by two tyrosine residues stabilizes Fe3+ and gives the deep
red color to the enzyme solution.327 In another example of catechol dioxygenase, crystal structure also
revealed that mononuclear Fe3+ center of catechol 1,2-dioxygenase from Acinetobacter have coordinating
Tyr164, Tyr200, His224, and His226.329 This His2Tyr2 motif is identical to the one resolved in
protocatechuate 3, 4-dioxygenase (3, 4-PCD).327 These and other crystal structures and X-ray absorption
data proved that intradiol dioxygenases have a Fe3+ center in a trigonal bipyramidal geometry.327,329-333 The
analysis of substrate-bound structures of 3, 4-PCD showed a monodentate substrate complex formation
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when the substrate's addition displaces Tyr447 and water ligands from the Fe3+ center.333,334 Displacement
of Tyr447 from Fe3+ center induces approximately octahedral geometry leaving an accessible site for
ligation opposite from His460. Studies using NO and CN2 demonstrated a ternary complex's formation when
these chemicals occupy a vacant coordination site (Figure 6.4).334-336

Figure 6.4. Structure of CN bound 3, 4-PCD from Pseudomonas putida (PDB: 1EOA). Tyr447 rotates
away from Fe3+ upon the addition of CN.
Previously, several models of intradiol ring cleavage had been published in the comprehensive
review.337 These models demonstrate how substrate catechol aromatic ring cleavage results in muconic
anhydride

or

furanone

muconic

acid

derivatives.337

First,

the

catechol

substrate

binds

to

Fe3+ as a dianion transferring two protons to displaced ligands: tyrosyl and hydroxide.333,335,338 Interaction
of catecholate and iron center then produces semiquinonate radical character in the substrate. This is
followed by the reaction of semiquinone substrate intermediate with molecular oxygen to form an
alkylperoxo-Fe3+ intermediate. Criegee rearrangement in alkylperoxo-Fe3+ intermediate leads to breaking
O-O the bond which produces a cyclic anhydride and hydroxide or iron-bound oxide. Finally, anhydride gets
hydrolyzed

to

yield

a

final

enzymatic
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reaction

product

(Figure

6.5).339,340

Figure 6.5. Intradiol dioxygenases mechanism of ring cleavage
6.2.3.2 Extradiol oxygenases
As in the case of the intradiol dioxygenases, the catecholic aromatic substrates appearing in the many
metabolic pathways in the cells are also cleaved by the enzymes but at the meta position to the hydroxyl
substituents. These enzymes are called extradiol dioxygenases and give a 2-hydroxymuconaldehyde as a
product with the help of Fe2+ as a cofactor at the active site (Figure 6.2 B). The extradiol dioxygenases
have been placed in different evolutionarily independent type groups based on structure-validated
phylogenetic analyses.328,371 Type I extradiol dioxygenases are considered “canonical” and are included in
the vicinal oxygen chelate superfamily341,372, type II dioxygenases consist of multimeric enzymes, which are
not included in type I. In contrast, the last type III group of extradiol dioxygenases are combined based on
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the presence of the “cupin” structural element357. It has been suggested that the difference between intradiol
and extradiol dioxygenases is due to the recruitment of acid-base supporting reaction by extradiol
dioxygenases.370

Site-directed

mutagenesis

investigations

of

Escherichia

coli

2,

3-

dihydroxyphenylpropionate 1,2- dioxygenase (MhpB) had determined that few residues (His115 and
His179) are catalytic acid-base residues during the reaction and that the bell-shaped pH profile of catalytic
activity is indicative of the presence of the effect of this acid-base chemistry. In contrast, the intradiol
dioxygenases demonstrate a flat pH profile of catalytic activity.370,381

Figure 6.6. Coordination of Fe2+ in type I extradiol dioxygenases
6.2.3.2.1 Canonical Extradiol oxygenases
The canonical extradiol dioxygenases are part of the vicinal oxygen chelate superfamily, in which
coordination environment for divalent transition metal ions such Fe2+ and Mn2+ provided by paired βαβββ
motifs. The members of this family catalyze the different types of reactions, for example, epimerization,
nucleophilic substitutions, isomerization, and oxidative C-C bond cleavage.341 The common metal ion
binding motif in this type of dioxygenases includes two histidines and one glutamate residue, which are
located on one face of a (pseudo)octahedral coordination sphere with the three other coordination sites at
the opposite side available for the solvent molecules and are occupied by the binding substrates (Figure
6.6). This metal-binding 2His-1carboxylate facial triad motif is observed in many non-heme iron
oxygenases.342-344 In contrast to the intradiol enzymes, which use molecular oxygen for the electrophilic
attack on the activated substrate, the extradiol dioxygenases activate both substrate and O2 at the same
time to form than two metal-bound radicals (Figure 6.7). The enzymatic reaction displaces two or three
water molecules substrates coordinate metal cofactor as catecholate monoanion.345,346 When the substrate
binds to the metal ion, it also greatly increases the binding affinity of metal ions for O2.347 The two substrates
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in the active site now connected by metal ions forming the ternary complex allow electron transfer from
organic substrate to molecular oxygen forming semiquinone- Fe2+-superoxide intermediate.345 This, in turn,
leads to the quick formation of the alkylperoxo intermediate. Following rearrangement of oxygen atoms and
O-O bond cleavage produces lactone intermediate with a final release of the 2-hydroxymuconate
semialdehyde product (Figure 6.7).298,348-352

Figure 6.7. Type I extradiol dioxygenases mechanism of ring cleavage
The example of type I extradiol dioxygenases is 2, 3 -dihydroxybiphenyl 1, 2-dioxygenase (BphC) from
Pseudomonas LB400. This bacteria can degrade chlorinated biphenyls. Enzymes structure was solved in
1996.353 The enzyme has a tertiary structure with two βαβββ domains. Fe2+ cofactor had been found only
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in one of these domains. The active site with Fe2+ center has a metal ion coordinated by three residues:
Glu260, His210, and His146 (Figure 6.8).353

Figure 6.8. Structure of active site of 2, 3 -dihydroxybiphenyl 1, 2-dioxygenase (BphC) from Pseudomonas
LB400 (PDB: 1LKD).

6.2.3.2.2 The cupin superfamily non-canonical extradiol oxygenases
While in many bacteria, the substrates for the bacterial degradation pathways are catecholic
compounds. In some bacterial degradation pathways, the substrate can also be a gentisate (para-diol).
These mono-hydroxylated aromatic carboxylic acids are catalyzed differently from canonic type I extradiol
dioxygenases. These non-canonical enzymes are members of the cupin superfamily. Proteins of this family
have single (“monocupins”) or doubled (“bicupins”) domain structures consisting of “cupa” (barrel in Latin),
which is a six-stranded β-barrel fold (Figure 6.9). The non-enzymatic and enzymatic proteins of the cupin
superfamily are found in many organisms where they participate in different biological processes. For
example, non-enzymatic cupin proteins act as transcription regulators and storage proteins in the plants,
while some enzymatic cupins act as oxygenases and decarboxylases.353-356
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Figure 6.9. Crystal Structure of a Gentisate 1, 2-Dioxygenase from Silicibacter Pomeroy (PDB: 3BU7). Iron
ions (brown) inside of cupin (“barrel”) motifs made of β-strands (red).
The cupin domain is characterized by the presence of the two conserved amino acid residue motifs
with the typical sequences for both as G(x)5HxH(x)3-4E(x)6G and G(x)5-7PxG(x)2H(x)3N.357 Structurally,
each of these motifs consists of two double β-sheet separated by the intervening loop. The primary
coordination sphere for divalent transition metal ions in the active site located on the two motifs interface
consists of one glutamate and two histidine residues of the first motif and one histidine of the second motif.
This coordination sphere was reported in different cupin active sites, for example, in acireductone
dioxygenase358,359 and flavonol 2, 4-dioxygenases360,361. While most often Fe2+ or Mn2+ occupy the active
site, other divalent transition metal ions are also were found as cofactors (Ni2+, Zn2+, Co2+, Cu2+), suggesting
that choice of metal ion and coordination environment in the active site determines reaction chemistry. The
coordination geometry of the metal center is octahedral or disordered octahedral most of the time. The
extradiol dioxygenases of the cupin superfamily such as gentisate 1,2 dioxygenase (GDO), cysteine
dioxygenase (CDO), salicylate 1,2 dioxygenase (SDO),

quercetin 2,3-dioxygenase (QDO), 3-

hydroxyanthranilate-3,4-dioxygenase (HADO), homogentisate dioxygenase (HGDO) and others usually
have a single catalytic site in one of the two cupin domains, while the other domain in noncatalytic.360,361,369,364,365
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Figure 6.10. Fe2+ center of Gentisate 1, 2-Dioxygenase from Silicibacter Pomeroyi (PDB: 3BU7)
Some cupin enzymes have a “reduced” metal-binding motif, such as gentisate 1, 2-dioxygenases,
where water molecule replaces glutamate (Figure 6.10).362 Also, some cupin enzymes have glutamate
replaced by the fourth histidine, as in polyketide cyclase RemF, which also has zinc at the active site.363 In
comparison to the 2His-1carboxylate metal-binding motif of the type I extradiol dioxygenases and other
families of extradiol dioxygenases, the 2/3His-1Glu or 3His- metal-binding motifs of the cupin dioxygenases
are less selective regarding utilizing divalent metal ions.344,342 To highlight the mechanism of the cupin
extradiol dioxygenases, we can refer to the 3-Hydroxyanthranilate 3, 4-dioxygenase (HAD) from R.
metallidurans. This protein depends on Fe2+ for its catalytic activity.364,365 Structurally, it is a homodimeric
protein in which catalytic iron site located in monocupins domain.364 Its crystal structure shows the distorted
octahedral coordination geometry with iron bound to bidentate glutamate, two histidine residues, and two
water molecules.364 The substrate, 3- Hydroxyanthranilate in phenolate form, binds to iron as a bidentate
ligand and displaces one carbonyl oxygen of the coordinated glutamate and one water molecule (Figure
6.11). The reaction mechanism is similar to canonical extradiol dioxygenases (Figure 6.7).364,366
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Figure 6.11. The cupin superfamily extradiol dioxygenases mechanism of ring cleavage
6.2.3.2.3 Gentisate 1, 2-dioxygenases
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Figure 6.12. Substrates and products of catalytic reactions by GDO (A), SDO (B), and HNDO (C).
The bacterial degradation of many different types of aromatic compounds leads to the formation of 3chloro- and 3-hydroxybenzoate from which in turns forms gentisate.367 Gentisate 1, 2-dioxygenases (GDOs)
(EC 1.13.11.4) are non-heme iron enzymes expressed in many soil microorganisms and bacteria that
perform ring scission of its dihydroxylated aromatic substrate, gentisate (2, 5-dihydroxybenzoate) through
the oxidation (Figure 6.12) but not monohydroxylated salicylic acid. The microorganisms worldwide widely
employ GDOs to act as the key intermediate and central point in utilizing many aromatic
compounds.269,341,356,357,360,368,371,374-376 GDO and, for example, salicylate 1,2-dioxygenases (SDOs) with 1hydroxy-2-naphthoate 1,2-dioxygenases (HNDOs) perform substrate’s aromatic ring cleavage between
adjacent carbon atoms with hydroxyl and carboxylate groups turning gentisate substrate into
maleylpyruvate (Figure 6.12). Isolated from Pseudomonas species, GDO utilizes Fe2+ to catalyze gentisate
and also convert 5-aminosalicylate but at a lower kinetic rate. In contrast, salicylate acts as a competitive
inhibitor and is not converted.269,368 Structurally, all GDOs are part of the cupin family discussed above
(Figure 6.9).362.369 It was shown that GDO, similar to other members of the cupin superfamily, have a highly
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conserved metal-binding motif I (G(X)5HXH(X)3,4E(X)) and motif II (G(X)5PXG(x)2H(x)3N).369 All members
of the GDO family are homo-tetramers, with a size of monomer about 41.5 kDa depending on the bacterial
strain, and each monomer contains one catalytic iron cofactor in bicupin coordinated by three histidine
residues (Figure 6.10) and the solvent molecules. The addition of the substrate releases three solvent
molecules from coordination with iron ions.368 In GDOs, the glutamate residue of motif 1 participating in the
Fe2+ coordination as in other cupin dioxygenases is replaced by other non-ligating residues. The EPR
studies on GDO from Pseudomonas testosteroni suggest that glutamate substitution in GDO represents an
adaptation to simultaneously bind molecular oxygen and carboxylate of gentisate to the Fe2+ cofactor.368
From the structural and spectroscopic studies done previously by Chen274, Lipscomb, Harpel271, and
others on GDO or similar enzymes such as 2, 3-HPCD327,349,370, the mechanism of gentisate cleavage was
proposed (Figure 6.13). The reaction cycle begins with bidentate coordination of iron ion by gentisate
substrate with deprotonated carboxylate at C1 and phenolic hydroxyl at C2. Two residues in the secondary
coordination sphere are also involved in interacting with the hydroxyl group at C5. Asp175 forms a hydrogen
bond with hydroxyl at C5 and, at the same time, is stabilized by Gln108. Formed hydrogen-bond network
and coordination with metal center allows the optimum position of the gentisate. The addition of gentisate
displaces two molecules of the solvent and activates the Fe2+ cofactor to allow for simultaneous binding of
molecular oxygen. This allows for electron density distribution from substrate’s aromatic ring through the
iron to iron-bound oxygen forming Fe–superoxide complex as had been previously shown in other extradiol
dioxygenases.349 Formed Fe–superoxide also stabilized by His162 by hydrogen-bond formation. The ironbound oxygen of Fe-bound superoxide complex then C-1 of the gentisate forms an alkylperoxo
intermediate. Ketonization of the hydroxyl group at C-5 through the transfer of the proton from hydroxyl
group to Asp175 induces subsequent Criegee bond rearrangement, insertion of one of the oxygen atoms
into substrate’s ring followed by O-O bond cleaving generating anhydride intermediate (Figure
6.13).271,362,368 Finally, transfer of the hydroxyl group to C2 from iron ion followed by resonance
rearrangement produces maleypyruvic acid as a final product of the catalytic reaction (Figure 6.13).
Mutagenic studies had shown key roles of the several residues involved in the secondary sphere (Gln108,
Arg127, His162, and Asp175) to support the above-described mechanism of catalytic reaction by GDO.362
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Figure 6.13. Schematic mechanism of GDO catalytic cycle including residues of the secondary coordination
sphere.
GDO’s kinetics had been studied extensively, starting with a 1975 paper by Chapman.377 The UV-Vis
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spectroscopic data observed during the catalytic reaction of the gentisate with GDO reflects changes from
substrate absorption (Absorption max at 322 nm and ε = 3.6 Mm-1 cm-1) to maleylpyruvate product
(Absorption max at 330 nm and ε = 13.4 Mm-1 cm-1).286 Studies of the homogentisate 1, 2-dioxygenase
(HGO), which belongs to the same class of enzymes as GDO, demonstrated that to study enzyme kinetics,
it is necessary to add Fe2+ to buffer solution along with reducing agents such as ascorbic acid.378 The
highest activity was observed when 2mM of Fe2+ was present in the buffer, several times more than usually
used in enzyme assays.378 The formation of maleylpyruvate products in HGO and GDO was not observed
when Fe2+ was replaced with other divalent metals such as Co2+, Zn2+, Ni2+, and Cu2+.369,378,379 To preserve
the activity of the GDO, it is necessary to add Fe2+ during protein purification.379 Reactivation of the GDO’s
activity is possible with the addition of Fe2+ even after a prolonged storage time.379 Enzyme assay
demonstrated that GDO is a highly efficient enzyme to turn gentisate. Previous studies had shown that
GDO’s Km is around 10-130 µM and Kcat/Km is 230-430 s-1 M-1 104 depending on bacteria
strain.281,286,369,379 The pH-dependent kinetic activity measurements had shown that GDO from Moraxella
osloensis is most active in the 7.0-8.5 pH range.377 The pH range where GDO is stable also depends on
the bacteria strain. For example, GDO from Pseudomonas alcaligenes NCIB 9867 (P25X) is most stable at
a low pH range (5.0 – 7.5) while GDO from Pseudomonas putida NCIB 9869 (P35X) is most stable at pH
7.0 – 9.0 while maximum activity reported at pH 8.0 in both GDOs.117 Interestingly, GDOs from P25X and
P35X is the most active at somewhat high 50 °C temperature compared to 30 °C optima for GDO from K.
pneumoniae.379,380
The kinetic studies also showed the effects of the different substituents on the aromatic ring of gentisate
substrate. The catalytic activities depending on the substituents at C3, C4 of the aromatic ring showed
results of the steric and electronic effects of the substituents.271,379 For example, adding halogens in place
of the C3 or C4 reduced the catalytic activity. Interestingly, both addition of electron-withdrawing groups
and electron-donating groups to gentisate resulted in the reduction of the catalytic activity suggesting the
complex character of the effect of these groups during the enzymatic reaction.271,379 Also, the gentisate
substrate was altered at its C1, C2, and C5 position.286 Changes at C1 and C2 significantly reduced or
eliminated catalytic activity, and the only gentisate with the amine group at C5 was able to catalyze
substrate.286 The GDO can turnover amine substituted gentisate at C5 because it can proceed to
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ketonization as an original hydroxyl group at this carbon (Figure 6.13). Reduced or eliminated substrate
turnover due to substitution of the functional groups at C1 and C2 is expected as these groups should
participate in Fe2+ ligation.
The high kinetic activity of the GDO towards its substrate poses an obstacle to studying the reaction
intermediates. The intermediates are not only short-lived, but they are also spectroscopically silent.
Therefore, there are still questions of how steps of catalytic reaction appear, the roles of the specific
residues, and interplay with molecular oxygen for the reactions. Also, we need to learn more about how
and why the “reduced” active site motif in the extradiol dioxygenases enzymes such GDOs differs from the
more general 3His-1Asp motif.
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Chapter 7 - Exploration of various strategies to enable the study transient kinetics of the 1, 2dioxygenases (GDOs) catalytic cycle
7.1 Abstract
The gentisate 1, 2-dioxygenases (GDOs) from Corynebacterium glutamicum utilizes an active site
Fe2+ and O2 to catalyze proximal extradiol cleavage of the substrate aromatic ring of its natural substrate,
gentisate (2,5-dihydroxybenzoate). The transient kinetics of the GDO’s catalytic cycle are challenging to
study because the Fe2+ in the active site is nearly colorless and spectroscopically EPR silent. On the other
hand, GDO demonstrates very fast catalytic activity, which poses a significant obstacle to observing
reaction intermediates using the natural substrate. Here we report a synthesis of the nitro-substituted
substrate (2, 5-dihydroxy-4-nitro-benzoic acid) from 4-nitrosalicylic acid precursor and its characterization.
The nitro-substituted substrate dramatically slows down protein kinetic activity and is easily detected by
UV-Vis. Also, we report the production of three GDO’s mutants where each of the histidine-forming
coordination spheres in the active site is replaced by the aspartic acid. From the analysis of the catalytic
activity of these mutants toward the natural substrate, we demonstrated that each histidine is critical in the
function of the protein. The results of this work can be further used to study the enzymatic reaction of the
GDO.
7.2 Introduction
Gentisate is an important intermediate in aerobic bacterial pathways responsible for the metabolism
of many aromatic compounds.369 The critical step of these metabolic pathways is a catalytic reaction by
GDO, which performs oxidative aromatic C–C bond cleavage of the substrate to form maleylpyruvate
(Figure 6.1).382,383 The initial step at the start of the catalytic cycle was proposed by binding the gentisate
to Fe2+, followed by the binding of O2 to the metal cofactor.384,385 The primary coordination sphere of the
ferrous iron cofactor in GDO is consists of a 3-His scaffold,369,362 which is different from most iron-containing
non-heme dioxygenases bearing a 2-His-1-carboxylate-binding scaffold386,387. Extensive mutational studies
have been performed to study different structural elements of both SDO and GDO to cleave their respective
substrates.388,389
We aim to study the reaction mechanism of GDO during the formation of the reaction intermediates
by slowing down enzymatic reaction by substituting gentisate with a nitro substituted analog (DHNBA: 2,5-
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dihydroxy-4-nitro-benzoic acid) of the natural substrate, gentisate, or/and by mutating histidines of the GDO
active site. Ferrous-oxy complexes and other reactive species formed during enzymatic reactions are shortlived and pose a problem for their accurate characterization. Slowing down the reaction will allow us to
detect the important intermediates of the enzymatic reaction. We will be able to probe and characterize
these intermediates. We can affect the reaction by substituting native substrate with analogs with added
different functional groups. The literature reported that adding a nitro group to the Homoprotocatechuate 2,
3-Dioxygenase (HPCD) enzyme’s natural substrate slows the reaction.390,391 The reason for this is the
different electronic characters of the substrates. When the natural substrate binds to the enzyme, it transfers
electron density to the Fe center, facilitating the reaction with O2. Strong electron withdrawal functional
groups, such as -NO2, hinder the electron transfer between the substrate and iron cofactor.391 We expect a
nitro-substituted substrate analog to slow down enzymatic steps enough to observe reaction intermediates
in GDO and SDO based on the considerations mentioned above. If we look at the HPCD case, the
substitution of the natural substrate with nitro-substituted analog decreased Kcat at 22 °C from 10 s-1 to 0.4
s-1, and Kcat decreased even more at the 4 °C: from 3.2 s-1 to 0.05 s-1.390 In GDO from the bacterium
Corynebacterium glutamicum, Kcat equals 300 s-1 at 23 °C.392 This high Kcat value will pose a significant
obstacle to observe reaction intermediates using natural substrates. Also, the nitro group of the substrate
analog is easily detected by the UV-Vis. 390
7.3 Materials and Methods
7.3.1 Protein expression and purification
The gentisate 1, 2-dioxygenase cDNA from the bacterium Corynebacterium glutamicum (UniProt
entry A0A1R4GQZ9) was synthesized and subcloned into the pET- 41a(+) vector by GenScript and
transformed into Escherichia coli BL21 (DE3). Pre-culture of Escherichia coli BL21 (DE3) containing pET41a(+) plasmids were grown overnight at 37 °C in 10 mL LB medium containing (50 μg/ml) kanamycin. The
10 mL pre-culture was then transferred to a 1000 mL LB medium with kanamycin (50 μg/ml) and grown to
an optical density (OD600nm) of 0.6–0.8. Protein expression was induced by adding 1.0 mM IPTG, and the
cultures were incubated for an additional 5.0 h at 37 °C and 200 rpm. The cells were harvested by
centrifugation (4,000 rpm, 4.0 °C, and 20 min) and resuspended in 10 ml 50 mM Tris/HCl-buffer, 100 mM
NaCl, and pH 8.0. The cell-free crude extract was obtained by ultra-sonication (45% power with microtip for
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20 min of total processing time with 4 sec on and 1 sec off) and centrifugation of resulting lysate (17,000
rpm, and 4.0 °C for 50 min). Cell-free crude extracts were applied to the His-trap column pre-equilibrated
with loading buffer (50 mm Tris-HCl, 100 mM NaCl, pH 8.0). For purification with the His-trap column, we
gradually applied a gradient of 0–25% over the volume of 125 mL (buffer A, 50 mm Tris-HCl, 100 mM NaCl,
pH 8.0; buffer B, 50 mm Tris-HCl, 100 mM NaCl, 0.8 mM imidazole, pH 8.0). The desired His-tagged
proteins were eluted at a 100-150 mM imidazole concentration. The imidazole was then removed from the
eluted protein by buffer exchange (50 mm Tris-HCl, 100 mM NaCl, pH 8.0) with microcentrifuge using
Centricon concentrator with a 10.0 kDa molecular weight cutoff membrane. SDS-Page gel electrophoresis
was used to determine fractions with GDO and its purity. An example of an SDS-PAGE gel of a purified
enzyme is presented in Figure 7.1. The molar extinction coefficient for the GDO (from Expasy: ε = 73510
M-1 cm-1) was used to determine its concentration by observing the 280 nm absorbance. The purified protein
was stored at -80 oC.

Figure 7.1. 10% SDS-PAGE gel showing the purity of the GDOC enzymes after purification. Lane 1 is
protein molecular weight standard; lane 2 is insoluble fraction after sonication and centrifugation; lane 3 is
soluble fraction after sonication and centrifugation; lane 4 is a sample of GDO collected after His-Trap.
7.3.2 The recombinant expression of GDO mutants and purification
To study the role of histidines of the GDO active site and slow down the enzymatic reaction to
characterize the intermediates, we created three mutants: H119D, H121D, and H160D. From the sequence
analysis of the PDB structures for SDO with its substrate and GDO, we determined the location of the
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histidines of the active site. GDO-Histidines mutants were generated by site-directed mutagenesis. H119D
forward:

ACGCGCCGGAAGCCGGAAGATCGTCACAGCCAAAAC,

H119D

reverse:

TGACGATCTTCCGGCGCGTTCTC, H121D forward: CACCGTGATAGCCAAAACGCGTTCC, H121D
reverse: GCGCCGGAACACCGTGATAGCCA, H160D forward: AACTATGATGGCCACCACAACATTGC,
H160D reverse: CCGGGTTGGAACTATGATGGCCAC, and expressed in E coli. PCR product after Dpn I
digestion had been transformed into HD5α competent cells, which were left to grow overnight on
LB/kanamycin plate. 10 mL LB had been then inoculated and incubated at 37 degrees overnight. Extracted
plasmids were sent to GeneWiz, New Jersey, for sequence analysis. Once proper mutation had been
confirmed, the mutants had been expressed in BL21 (DE3) cells and purified using previously established
lab protocol for the overexpression and purification of wild-type GDO reported above.
7.3.3 Synthesis of 2, 5-dihydroxy-4-nitrobenzoic acid (nitro-substrate) and its characterization by
NMR

Figure 7.2. Conversion of the 2, 5 dihydroxy-4-nitrobenzoic acid from 4-nitrosalicylic acid. –OH group (red)
is added during the Elbs persulfate oxidation reaction.
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Figure 7.3. Mechanism of Elbs persulfate oxidation
As reported before, the 2, 5-dihydroxy-4-nitrobenzoic acid was synthesized (Figure 7.2).393,394 The
protocol utilizes Elbs persulfate oxidation (Figure 7.3) to add hydroxyl group to fifth position on the ring (in
para position from C2-OH) in the 2-hydroxy-4-nitrobenzoic acid acting as starting reagent. 0.5 g of the 2hydroxy-4-nitrobenzoic acid and 10.0 mL of 2N NaOH were mixed in a 50 mL round‐bottomed. 0.55g of
potassium persulfate dissolved in 20.0 mL of water was added to the resulting brown-colored solution. After
stirring the mixture for four days at room temperature, the solution was carefully acidified to pH 3 with dilute
H2SO4 in an ice bath, and a yellow precipitate was observed. The resulted solution was separated from the
unreacted 2, 4‐dinitrobenzoic acid with diethyl ether (3 x 10 mL). The unreacted 2, 4‐dinitrobenzoic acid
was removed in the ether layer. The reacted aqueous solution was then made strongly acidic with
concentrated sulphuric acid. The resulting solution was refluxed for 1 hour, then cooled down to room
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temperature, and kept in the refrigerator at 4 °C for two days. The dark brown crystalline precipitate was
filtered and dried under the vacuum. The collected dark brown product was dissolved in hot water and
treated with charcoal. The solution was then filtered from the charcoal using gravity filtration and cooled
down to room temperature. The product was allowed to precipitate for two days in the refrigerator at 4o
Celsius. The orange crystals of the pure product (0.12g, 24% yield) were filtered and dried under the
vacuum. The theoretical mass of nitro-substitute is 199.107, and Electrospray Ionization (ESI) spectroscopy
data confirmed the mass of the product as 199 (not shown).
The small amount of dry nitro-substitute was then used to prepare the NMR sample by dissolving
in 0.5 mL of deuterated DMSO (DMSO-d6).
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C-NMR and 1H-NMR NMR spectra were acquired at 14.1 T

(600 MHz) on a Varian NMR spectrometer. The sample temperature was maintained at 25 °C.
7.3.4 Isolation of the product of the reaction of nitro-substrate and gentisate 1, 2-dioxygenase (GDO)
enzyme
The product of turnover of the GDO and the nitro-substrate was prepared enzymatically with
previously purified GDO. The reaction was conducted in 20 mM Tris, 100 mM NaCl buffer (pH 8.0) at room
temperature in the 1mL quartz cuvette. The reaction started with adding the 0.2 mM of GDO (final
concentration) to 0.4 mM in the solution of nitro-substrate (final concentration). The reaction was carried in
the dark to avoid degradation of the product until all the nitro-substrate was completely converted. The
progress of the reaction was monitored with UV-Vis at 460 nm. The product was separated from the
macromolecular contamination by microconcentration using Centricon with membrane cutoff at 30 kDa and
collecting protein-free filtrate. The presence of the product of the reaction in the collected flow-through is
then verified by UV-Vis at 460 nm.
7.3.5 Sample preparation and characterization of product of the reaction of nitro-substrate with GDO
by NMR
The product of turnover of the GDO and the nitro-substrate was isolated as described in the above
method. The product was lyophilized and then dissolved in methanol to replace inorganic substances. The
supernatant was separated from precipitated salts and dried with air. The procedure was repeated one
more time to a dry organic product. The dried product was then used to prepare the NMR sample by
dissolving it in 0.5 mL of deuterated DMSO (DMSO-d6). 13C-NMR and 1H-NMR NMR spectra were acquired
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at 14.1 T (600 MHz) on a Varian NMR spectrometer. The sample temperature was maintained at 25 °C.
7.3.6 Enzyme assay
Conversion of 1 µmol of substrate per min by Gentisate 1, 2-dioxygenase was defined as one unit
of enzyme activity. We measured activities of gentisate 1, 2-dioxygenase spectroscopically for conversion
of gentisate at 350 nm (ε350 = 10.2 mM-1 cm-1)395,396 and at for conversion of the nitro-substitute (ε460 = 1.03
mM-1 cm-1 at pH 8.0). To determine the kinetic constants, the cuvettes contained the constant concentration
of the GDO or GDO mutant variants with varying amounts of the substrate (from 1 µM to 2 mM). To prevent
oxidation of the Fe2+ to Fe3+, we incubated samples with ten equivalents of the Fe2+ and ten equivalents of
the ascorbic acid. The enzymatic reactions were recorded for one minute. The buffer consisted of a mixture
of HEPES, Tris, MES, CHES, and NaOH for the pH titration experiment, adjusted with HCl to obtain the
desired pH. The kinetic constants were calculated non-linear regression using a regression algorithm by
Dr. John C. Pezzullo.

Figure 7.4. UV-Vis spectra show the formation of maleypyruvic acid (blue) from gentisic acid (red) as we
add GDO at pH 8.0.
7.3.7 UV-Vis spectroscopy of reactions of gentisate and its nitro-substitute with GDO, SDO, and
their mutants
The samples GDO, SDO, and their variants were prepared at different concentrations (1 µM to 100
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µM) for UV/Vis spectroscopy. As shown in Figure 7.4, the presence of gentisate was observed at 322 nm
(ε322 = 3.6 mM-1 cm-1), and the formation of the product of reaction (maleypyruvic acid) exhibits maximum
absorption at 330 nm (ε330 = 13.4 mM-1 cm-1).368 The presence of the nitro-substitute is observed at 470 nm,
and the formation of the product of the reaction exhibits maximum absorption at 380 nm (Figure 7.5).

Figure 7.5: UV-Vis spectra showing the formation of the product (blue) after adding 10.0 μM GDO to 10
μM nitro-substrate (red).

7.3.8 Fe concentration assay
The Fe content of the purified gentisate 1, 2-dioxygenase was determined spectrophotometrically.
Fe2+ complex of 1, 10-phenanthroline shows characteristic absorbance at 510 nm with a molar extinction
coefficient of 1100 M−1 cm−1 as previously reported.397
7.4 Results
7.4.1 Synthesis of 2, 5-dihydroxy-4-nitrobenzoic (nitro-substrate) acid
We synthesized the nitro-substrate from the 4-nitrosalycilic acid following the mechanism of Elbs
persulfate oxidation (Figures 7.2 and 7.3). The percent yield was consistently at around 25%. We observed
that it is critical to make sure that during separation with ether, the top layer containing the impurities should
be as clear as possible to prevent product contamination after several additions of ether and eliminating
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the top layer. The purity of the synthesized product was analyzed with NMR spectroscopy (Figure 7.6) and
UV-Vis spectroscopy. The synthesized product was stored as dry crystals at room temperature. It was
observed that nitro-substitute is shelf-stable. To prepare high concentration stock solutions of the nitrosubstrate, we dissolved crystals in highly alkaline water since its solubility significantly decreases with a
decrease of pH.
7.4.2 NMR characterization of the synthesized 2, 5-dihydroxy-4-nitrobenzoic (nitro-substrate) acid
H NMR spectra of the nitro-substrate were obtained (Figure 7.6B). We observed that the signal

1

from the proton at the fifth position (Figure 7.6A: δ = 7.68) on the benzene ring of the starting reagent, 4nitrosalicylic acid, disappeared due to substitution with -OH group. We also obtained
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C‐NMR spectra of

nitro-substitute (Figure 7.7).

Figure 7.6. A: 1H‐NMR (DMSO‐d6) of 4-nitrosalicylic acid: δ = 7.97 (dd, 1H), 7.68 (dd, 1H), 7.68 (dd, 1H) at
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14.1 T. B: 1H‐NMR (DMSO‐d6) of 2, 5-dihydroxy-4-nitrobenzoic acid ((nitro-substitute)): δ = 7.48 (s, 1H),
7.37 (s, 1H) at 14.1 T.

Figure 7.7. 13C‐NMR (DMSO‐d6, 14.1 T) of 2, 5-dihydroxy-4-nitrobenzoic acid (nitro-substitute): δ = 169.8,
152.1, 142.8, 141.4, 119.4, 118.9, 112.2 at 14.1 T
7.4.3 Product of turnover of the reaction of GDO with nitro-substrate analysis with UV-Vis and NMR
To characterize the product, the reaction of GDO and nitro-substrate, we determined a wavelength
at which nitro-substrate and product absorb. First, we determined the maximum absorption wavelength of
the synthesized nitro-substrate. The dissolved nitro-substrate at pH 8.0 has a maximum absorption
wavelength of 460 nm (Figure 7.5). Upon adding the GDO, we can observe the formation of the product at
380 nm (Figure 7.5).
H NMR spectra of the product were obtained (Figure 7.8), and we observed two proton signals

1

after aromatic ring cleavage (Figure 7.8: δ = 5.95 and δ = 6.11). The observed spectra are in agreement
with predicted spectra obtained with the online tool at nmrdb.org.398,399
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Figure 7.8: 1H‐NMR of the product of the reaction of GDO with nitro-substrate: δ = 6.11 (s, 1H), 5.95 (s, 1H)
at 14.1 T and 25 °C.
7.4.4 The UV-Vis investigation of reactions of nitro-substitute with GDO and SDO
Nitro-substituted substrate without enzyme shows a maximum at 470 nm at pH 8.0. As we added
GDO, we observed changes in the spectra, with a new peak appearing at 380 nm and a nitro-substitute
peak at 470 nm, gradually decreasing (Figure 7.5). This indicates that the absorbance represents an
unknown reaction product or one of the intermediates at 380 nm. We observed that it takes three hours for
GDO to completely turn over one equivalent of nitro-substituted analog versus less than a minute for the
gentisate as a natural substrate. Therefore, it is clear that adding the NO2 group to the gentisate slowed
the enzymatic reaction.
Interestingly, we observed that the species showing maximum absorbing at 380 nm is light
sensitive. If we leave the reaction vessel exposed to light, we observe the disappearance of the 380 nm
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signal (Figure 7.9) as it degrades and converts to non-detectable by UV-Vis compound. We also tested
nitro-substitute in reaction with SDO. UV-Vis spectra of the reaction of SDO with nitro-substitute are
identical to that of the reaction with GDO (Figure 7.10) and show the reaction product's formation as the
peak at 380 nm.

Figure 7.9. UV-Vis spectra show degradation (red) of the reaction product of GDO with nitro-substitute
when exposed to light for over 5 hours.

Figure 7.10. UV-Vis spectra showing the reaction of SDO with nitro-substitute (blue), resulting in the
formation of an unknown product (red).
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7.4.4 The UV-Vis investigation of reactions of nitro-substitute with GDO and SDO mutants
The mutants of both GDO and SDO proteins were used extensively to investigate their function,
structure, and the mechanism of catalytic reactions.388,389,392,400 In the course of mutational studies, it was
found out that a single point mutation can convert traditional GDO to SDO and SDO to GDO.388,392 For
example, A106G SDO loses its ability to convert salicylate but preserves the ability to convert gentisate.388
At the same time, A116G GDO gains the ability to convert salicylate.392 From the SDO crystal structure, it
has been determined that Leu176 makes contact with the aromatic ring of the substrate (23). These single
point mutations can significantly extend our understanding of the reaction mechanism of ring-fission
dioxygenases and the adaptations undertaken by various classes of ring-fission enzymes to extend the
range of the substrates.
On the other hand, His119 is one of the histidines which coordinates iron ions in the active site.401
Our investigation used three available mutants: two SDO’s mutants (L176F and H119E) and one GDO
mutant (A112G). Unfortunately, a high reaction rate of enzymes and the absence of the detectable
intermediate chromophores present a problem with using these mutants entirely. With the use of nitrosubstituted analog, we expect to alleviate these difficulties. Also, the UV-Vis test shows that nitro-substitute
does not react with the three mutant enzymes (Figures 7.11) or that reaction is extremely exceptionally
slow.

Figure 7.11. UV-Vis spectra show the nitro-substitute reaction with A. A112G GDO, B L176F SDO, and C.
H119E SDO at pH 8.0. Before the addition of enzyme (blue spectra) and three hours later (red spectra)
7.4.5 The importance of the His119, His121, and His160 for conversion of gentisate substrate:
enzyme kinetics studies
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Figure 7.12. GDO active site. Iron ion coordinated by three histidine residues and gentisate.
Table 7.1. Kinetic parameters of wild-type GDO and its mutants in reaction with gentisate
Enzyme

Km [μM]

kcat [s-1]

Km/kcat [s-1M-1]

wt GDO

64.3

194.2

3.02 x 106 (100%)

H119D GDO

311.5

0.132

424.1 (0.014%)

H121D GDO

57.5

0.179

1574.9 (0.052%)

H160D GDO

71.0

0.077

1090.1 (0.036%)

wt GDO + nitro-substitute

141.5

0.023

162.7 (0.005%)

To experimentally analyze the importance of the histidine residues located at the active site on the
conversation of gentisate, we constructed H160D, H121D, and H119D mutants. We subsequentially
performed several enzyme assays. The results of these assays are combined in Table 7.1. The assays
had been performed at pH 8.0 with various enzyme concentrations (5 μM for the mutants and 1nM for the
wild-type GDO) and substrate concentration ranging from 10 μM to 1 mM.
From the data of Table 7.1, we can observe that both H119D, H121D, and H160D variants
demonstrate significantly reduced activity. However, the H121D variant demonstrated the highest activity
among mutants and preserved Km similar to the wild type. Interestingly, all three mutants had higher
catalytic activity than wild-type protein reacting with nitro-substitute. Thus, it seems that the electronic
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character of the substrate is more critical than the coordination of the iron ion at the active site.
7.4.6 pH-dependent kinetic activity of GDO in reaction with nitro-substitute
We also analyzed the GDO catalytic activity as a function of pH (Figure 7.13). The enzyme assays
were performed at several pH levels with the nitro-substitute substrate. The catalytic efficiency was highest
at pH range from pH 7.75 to pH 8.1. The enzyme concentration was 5.0 μM, and the concentration of nitrosubstitute ranged from 10 μM to 2 mM. Before the assay, the enzyme was incubated with ten equivalence
of Fe2+ and ten equivalences of ascorbic acid to prevent oxidation of Fe2+ to Fe3+ to keep the enzyme active.
The experiment demonstrated that the enzyme had a pH-optimum to react with nitro-substitute at about pH
7.5 – 8.0 and was still active at pH 6.0 and 9.5 (Figure 7.13). Furthermore, the inflection points of the curve
obtained suggested that ionizable groups with pKa-values of about 6.0-7.0 and 8.5-9.5 participated in the
nitro-substitute substrate oxidation.

Figure 7.13. The pH-dependent enzymatic efficiency of GDO in reaction with nitro-substitute. The 5.0 μM
of GDO reacted with a nitro-substitute at various pH levels. The buffer is a mixture of MES, HEPES, and
CHES. 100 mM NaCl, and pH adjusted by HCl or NaOH.

7.5 Discussion
7.5.1 Nitro-substitute can be used as a probe to GDO enzymatic reaction
Previously had been shown that Fe2+ in the GDO active site coordinates carbonyl oxygen and
hydroxyl oxygen from the gentisate.368 With additional coordination of O2, the active site Fe2+ ion’s
coordination sphere has three sites for access by the ligands. The substrates that can bind to Fe2+ but are
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not catalyzed have the C5 hydroxyl group missing, hinting at the importance of that group. Indeed, this
group acts as an electron-donating group and is required for the reaction.368 Ketonization of 5 hydroxyl
group promotes heterolytic cleavage of the O-O bond and insertion oxygen atom into the ring due to the
transfer of electron density into the ring.368 The importance of the electron-donating group for GDO’s
substrate is illustrated by the inability of GDO to catalyze salicylate. Salicylate, a native substrate of SDO,
also catalyzed gentisate, does not have an electron-donating group. These observations are essential for
slowing down the GDO enzymatic reaction rate to study the reaction mechanism and the reaction
intermediates. We needed a substituted substrate with an electron-donating group and a new functional
group, providing the inhibitory effect. We know from the previously reported works that -NO2 is an electronwithdrawing group and can slow down the enzymatic reaction of dioxygenase.390,391,402 The addition of the
NO2 group to the native substrate slowed the enzymatic kinetics and provided an easily detected UV-Vis
chromophore.
To synthesize nitro-substituted substrate, we used a 4-nitrosalycilic acid (2-hydroxy-4-nitrobenzoic
acid) as a precursor. Adding the hydroxyl group is simpler and safer than adding the nitro group to gentisate.
The mechanism known as Elbs Persulfate Oxidation requires the oxidation of o-nitrophenol to nitroquinol
by the action of potassium persulfate in the presence of a base.403 During the synthesis, it is critically
important to remove impurities that are not reacted precursor during treatment of the reaction with ether.
To determine the purity of the product, we conducted a UV-Vis test and 1H and

13

C NMR measurements

(Figures 7.6 and 7.7). The UV-Vis measurement demonstrates that nitro-substitute has a maximum
absorption at λmax = 470 at pH 8.0 (Figure 7.5). Figure 7.6 demonstrates that 4-nitrosalicylic acid
synthesized into the desired product with duplets resolved into singlets as 5-H was replaced with 5-OH
group.
The conversion of a new nitro-substitute substrate by the GDO results in a product with an observed
absorption maximum at λmax = 380 at pH 8.0 (Figure 7.5). This product compound has been isolated as
described in the method section and characterized with 1H NMR measurement (Figure 7.8). The formation
of the product can also be seen by changing the coloration of the sample. At pH 8.0, the reddish color of
the solution containing substrate changes to the yellow color when the product forms. Further, we observed
that the reaction product is light sensitive as there was a UV-Vis signal from the product after a few hours
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when the product solution was left exposed to light (Figure 7.9). The careful identification of the product of
the light degradation would be required in the future. As of now, it is not clear by that mechanism that the
product of the reaction degrades in the presence of light. Having a new substrate, we tested it with available
SDO and some GDO and SDO mutants (Figure 7.11). UV-Vis measurements showed that in these
mutants, the substrate with –NO2 group inhibits enzymatic reaction completely or slows down reaction even
more than in GDO.

Figure 7.14. GDO’s active site with shown Tyr298 (PDB: 2BU7).
One thing is clear the new nitro-substitute reacts much slower than native gentisate. It took several
hours to turn over one equivalent of nitro substitute during 1 to 1 reaction with GDO. To assess the reaction
of GDO with nitro-substitute, we conducted an enzyme assay and compared results with the reaction of
GDO with gentisate. The results showed that Kcat of GDO with a new substrate is only 0.012%, and
Kcat/Km is only 0.005% compared to the reaction of GDO with a native substrate (Table 7.1). These results
prove the dramatic effect of the -NO2 group on the reaction with GDO. We also measured the pH-dependent
enzymatic efficiency of GDO in reaction with nitro-substitute (Figure 7.13). The experiment demonstrated
that at pH 7.5-8.0, GDO has optimum activity with nitro-substitute. The observed inflection points of the
curve suggest the residues with ionizable groups and pKa values of about 6.0-7.0 and 8.5-9.5 that
participate in the nitro-substitute substrate oxidation. The pKa of 6.0-7.0 suggests that there is most likely
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to be one or more histidine participating in the reaction. On the base of pKa 8.5-9.5, we can suggest some
tyrosine residue participating in the reaction.404 The analysis of the residues in and vicinity of the active site
suggests several candidates for these histidine and tyrosine residues. From Figure 7.14, based on the Fe2+
active site of GDO from the crystal structure (PDB: 3BU7), we can observe Tyr298 located in the vicinity of
Fe2+. Overall, the nitro-substitute can be a substrate to probe the active site of GDO and investigate details
of its enzymatic reaction.
7.5.2 Fe2+ coordinating histidine are equally important
We created three mutants to assess the importance of each histidine coordinating Fe2+ ions (Figure
7.12: His119, His121, His160) in the active site. Each mutant has one of the histidine residues substituted
with aspartic acid. To determine which residue is more critical than others, we conducted kinetic
measurements of the mutants in reaction with native substrate gentisate. Comparing the catalytic efficiency
(kcat/KM) of the H119D, H121D, and H160D variants of the GDO with their respective wild-type enzymes
demonstrated about 0.014–0.052% of the wild-type efficiency (Table 7.1). This demonstrates that each of
these histidines is equally critically important for the functioning of the GDO.
Interestingly Km for H121D_GDO and H160D_GDO are about the same as wild-type GDO (57.5
μM and 71.0 μM vs. 64.3 μM) (Table 7.1). The comparison of catalytic efficiency of the mutants with catalytic
efficiency GDO to react with nitro-substitute demonstrated what mutants are 3 to 10 times more efficient
(Table 7.1). This suggests that these mutants can also be used to study the mechanism of the enzymatic
reaction of GDO as the reaction was sufficiently slowed down.
7.6 Conclusion
The gentisate 1, 2-dioxygenases (GDOs) utilizes an active site Fe2+ and O2 to catalyze proximal
extradiol cleavage of the substrate aromatic ring of its natural substrate, gentisate (2,5-dihydroxybenzoate).
The transient kinetics of the GDO’s catalytic cycle are challenging to study because, on the one hand, iron
in the active site is nearly colorless and spectroscopically EPR silent. On the other hand, GDO
demonstrates very fast catalytic activity, which poses a significant obstacle to observing reaction
intermediates using the natural substrate. Here we demonstrated the synthesis of a new nitro-substituted
substrate: 2, 5-dihydroxy-4-nitro-benzoic acid. The UV-Vis easily detect this new substrate, and it
significantly slows down the enzymatic reaction, which can be utilized to study transient kinetics of the
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GDO’s catalytic cycle. The measurement of pH-dependent catalytic activity of GDO with nitro-substitute
revealed possible tyrosine residue participating in the reaction. From the GDO crystal structure, we can
suggest Tyr298. Further studies can answer the question of the role of this residue.
Our mutational studies demonstrated that each of the three Fe2+ coordinating histidines is critical
for the catalytic activity of the protein. We showed that these mutants have a significantly reduced kinetic
activity of the protein and, along with the synthesized nitro-substituted substrate, can also be used to study
transient kinetics of the GDO’s catalytic cycle. Overall, this work can be considered a steppingstone in our
investigation of the GDO, and more research is needed.
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Chapter 8 – Future Directions
Our recent NMR data from the calcium titration experiments suggest that the mutation of the
calcium-binding residues on the EF-2 hand in S100A12 affects the binding affinity of the EF-1 hand.
By fitting CSP data of the calcium-binding residues of EF-1 hand to the formula describing the binding
events, we were able to determine new Kd at EF-1 hand about 30 mM, which is one order of magnitude
weaker when in wild type S100A12. Effect of this mutation on efficiency to bind Co2+/Zn2+ ions while
not observable under the neutral pH range is greatly pronounced as we decrease pH when calcium
binding to mutant have greatly reduced ability to preserve metal binding in contrary to wild type protein.
Observed phenomena raise questions about the modulation of metal-binding between both calciumbinding sites of the protein, and we seek to investigate this modulation further. To achieve this, we will
further study (1) pH-depended Ca2+ and Co2+/Zn2+ binding affinity between EF-hands of S100A12, (2)
structural changes and residues responsible for the crosstalk between EF-hands. Further, from our
data, we determine that E91, the last residue in the peptide chain, has a possible role in the
oligomerization of S100A12, and we propose investigating this role. For the GDO, our preliminary
kinetic data provides promising results on the use of nitro-substitutes substrate to get insight into the
details of the catalytic reaction.
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